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 Abstract 
New methodologies have been developed for the synthesis of 2,5-disubstituted 
tetrahydropyrans and for the asymmetric synthesis of P-stereogenic phospholene 
boranes.  
Synthesis of 2,5-disubstituted tetrahydropyrans in a racemic fashion was 
achieved via Grignard addition, O-alkylation, ring-closing metathesis and 
hydrogenation. Using this route, seven potential perfumery compounds were 
produced in good overall yield. Olfactory evaluation of the potential perfumery 
molecules accessed the majority of products as having a predominant 
characteristic of citrus note and others having a floral note. In addition, 
asymmetric synthesis of two saturated cyclic ethers was achieved using an 
asymmetric deprotonation approach. An alternative route to an enantioenriched 
alcohol using catalytic asymmetric deprotonation and trapping with Andersen’s 
sulfinate was briefly studied and proved successful. 
The asymmetric synthesis of P-stereogenic phospholene boranes was 
investigated. First, three chiral diamines were synthesised and their asymmetric 
induction was tested in the asymmetric lithiation of t-butyl phosphine boranes. 
Subsequently, the asymmetric synthesis of P-stereogenic vinylic phospholene 
boranes was carried out. Using s-BuLi/(_)-sparteine as a base, alkylated 
phosphine boranes were isolated with good yield and high enantioselectivity. A 
telescoped regioselective deprotonation/trapping of paraformaldehyde and 
elimination reaction was developed to gain access to the dienes. Finally, 
ring-closing metathesis afforded the desired vinylic phospholene boranes. The 
application represents the first example of asymmetric synthesis of P-stereogenic 
vinylic phospholene boranes. 
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Chapter 1. Introduction 
1.1 Project Overview 
This thesis contains the results of two projects aimed at developing new 
methodologies for the synthesis of 2,5-disubstituted tetrahydropyrans (THPs) 1 
and the asymmetric synthesis of P-stereogenic phospholene boranes 2 (Figure 
1.1). In both projects, ring-closing metathesis featured as the key step for ring 
formation. 
Figure 1.1: Structure of 2,5-disubstituted tetrahydropyrans (THPs) 1 and 
P-stereogenic phospholene boranes 2 
 
We identified 2,5-disubstituted THPs 1 as an attractive synthetic target because 
they are potential fragrance molecules. For example, they could be used as a 
fragrance ingredient for the preparation of perfumery compositions as well as 
perfumery goods. From a synthetic point of view, there are not many routes for 
the synthesis of 2,5-disubstituted THPs 1. Therefore, it was important to develop 
general synthetic methodology to access the 2,5-disubstituted THP framework, 
including diastereo- and enantioselective aspects. The results are described in 
Chapter 2.  
In a separate project, we were interested in developing a route for the asymmetric 
synthesis of P-stereogenic phospholene heterocycles 2. There are limited general 
routes to access phosphine heterocycles and the asymmetric synthesis of 2 was 
unknown. Furthermore, phosphine heterocycles 2 may have application as 
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precursors to chiral phosphine catalysts. Chapter 3 describes our results on this 
topic. 
1.2 Ring-Closing Metathesis in Organic Synthesis 
The synthesis of 2,5-disubstituted THPs 1 and phospholene boranes 2 relied on 
key ring-closing metathesis reactions. Hence, a brief overview of ring-closing 
metathesis is provided in this section. 
1.2.1 Background on Ring-Closing Metathesis 
Olefin (or alkene) metathesis has had a profound impact on the formation of 
carbon-carbon bonds, and is one of the truly significant reactions in modern 
organic chemistry. In 2005, the Nobel Prize in Chemistry was awarded jointly to 
Chauvin, Grubbs and Schrock for the development of alkene metathesis in 
organic synthesis.1 The first report of double-bond formation using alkene 
metathesis was actually in 19552 N. G. (Du Pont de Nemours & Co.) U.S. Patent 2,721,189.1955 
#155but Calderon and co-workers introduced the term ‘olefin metathesis’ thirteen 
years later.3 There are several different alkene metathesis reactions: ring-closing 
metathesis (RCM), ring-opening metathesis polymerization (ROMP), 
cross-metathesis (CM), ring-opening metathesis (ROM) and acyclic diene 
metathesis polymerization (ADMET). A selection of the most common types of 
alkene metathesis reactions is shown in Scheme 1.1. These various alkene 
metathesis reactions allow access to molecules and polymers that would be 
difficult to obtain by other means. 
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Scheme 1.1: Selection of alkene metathesis reactions 
 
Three commonly used alkene metathesis catalysts are shown in Figure 1.2. In 
1990, Schrock and co-workers introduced the molybdenum-based catalyst 3.4 
Catalyst 3 displayed superb metathesis reactivity but its pronounced sensitivity to 
oxygen, moisture and certain functional groups means that it is not often used in 
synthesis. Grubbs and co-workers subsequently introduced the ruthenium-based 
catalysts 4 and 5, and they are more widely used due to their increased tolerance 
to most functional groups and their greater stability to atmospheric oxygen and 
moisture.5-7  
Figure 1.2: Structures of alkene metathesis catalysts 
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1.2.2 Ring-Closing Metathesis in Modern Natural Product Synthesis 
Two examples of natural product syntheses via ring-closing metathesis are 
presented in Schemes 1.2 and 1.3. The first example is the synthesis of 
(_)-griseoviridin 7, a streptogramin antibiotic, featuring a 23-membered 
unsaturated ring.8 Here, ring-closing metathesis was utilized for the macrocyclic 
ring formation. Thus, ring-closing metathesis using 30 mol% of Grubbs 1st 
generation catalyst 4 was carried out on 6 to furnish the cyclized product in 42% 
yield (Scheme 1.2). Acidic removal of the diol protecting group gave 
(_)-griseoviridin 7 as a single diastereoisomer in 68% yield. 
Scheme 1.2: Synthesis of (_)-griseoviridine 7 
 
Musk odorants are of central importance for the fragrance industry and 
(_)-muscone 11 is the main odorous principle from the animal kingdom.9 The 
synthesis of (_)-muscone 11 was achieved by Grubbs and co-workers using 
ruthenium-based Grubbs 1st generation catalyst 4, where sequential alkene 
ring-closing metathesis, hydrogen transfer and hydrogenation reactions were 
mediated in a tandem process (Scheme 1.3).10 Diene 8 bearing an alcohol 
functionality was treated with 7 mol% of Grubbs catalyst 4 in 1,2-dichloroethane 
at 50 ºC to afford the desired macrocyclic alkene 9 as a mixture of geometrical 
isomers. Subsequent in situ treatment with 3-pentanone and sodium hydroxide 
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then initiated ruthenium-catalysed transfer of hydrogen to furnish ketone 10. 
Under hydrogenation conditions, the still-present ruthenium complex was 
converted into a ruthenium hydride species, which chemoselectively reduced the 
alkene in the presence of the ketone group. (_)-Muscone 11 was thus obtained in 
56% yield from this one-pot protocol.  
Scheme 1.3: A three-step synthesis of (_)-Muscone 
 
1.2.3 Synthesis of Oxygen Heterocycles via Ring-Closing Metathesis 
One part of our project (Chapter 2) is concerned with the synthesis of cyclic 
ethers using ring-closing metathesis. The use of such an approach to 5- and 
6-membered cyclic ethers is well-known. In 1992, Grubbs and co-workers 
reported the first application of catalytic ring-closing metathesis to the synthesis 
of oxygen heterocycles using molybdenum-based catalyst 3 (Scheme 1.4).11 As 
an example, cyclic ether 13 was synthesised in high yield from diene 12 using 5 
mol% of molybdenum-based catalyst 3. It is worth noting that trisubstituted and 
tetrasubstituted double bonds could be formed efficiently with prolonged 
reaction times. 
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Scheme 1.4: Formation of 5- and 6-membered cyclic ethers via ring-closing 
metathesis 
 
Later, the Grubbs group also investigated the ring-closing metathesis reaction 
employing ruthenium-based catalyst 16 (Scheme 1.5).12 For example, using 2 
mol% of catalyst 16, monosubstituted cyclic ether 15 was formed from diene 14 
in 86% yield. Ruthenium-based catalyst 16 is much more convenient to handle as 
it is not oxygen and moisture sensitive. 
Scheme 1.5: Synthesis of a 2-substituted dihydropyran 
 
Ring-closing metathesis of vinyl ethers is known to be problematic.13, 14 
Therefore, the synthesis of cyclic enol ethers using this approach could not be 
achieved easily. To solve this problem, Snapper and co-workers reported the 
synthesis of cyclic enol ethers via a tandem ring-closing metathesis-alkene 
isomerization sequence.15 As an example, treatment of diene 17 with 10 mol% of 
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Grubbs 2nd generation catalyst 5 in a 95:5 mixture of nitrogen and hydrogen gas 
afforded 6-membered ring enol ether 18 in 57% yield (Scheme 1.6). The 
metathesis catalyst was activated by treatment with diluted hydrogen to allow the 
isomerization step, presumably via a ruthenium hydride intermediate. The 
reaction is also applicable to 5- and 7-membered cyclic enol ethers. 
Scheme 1.6: Synthesis of cyclic enol ether via a tandem ring-closing 
metathesis-alkene isomerization reaction 
 
Later, Schmidt and co-workers reported a similar ring-closing metathesis-alkene 
isomerization approach to the synthesis of cyclic enol ethers from allyl 
homoallylic ethers (Scheme 1.7).16, 17 For example, upon treatment with 5 mol% 
Grubbs 1st generation catalyst 4 followed by addition of sodium hydride at 110 
ºC, cyclic enol ether 19 was generated in 87% yield from diene 14. In this case, 
the ruthenium-based catalyst was activated in a separate step using a hydride 
donor, such as sodium hydride, to afford the isomerization product. 
Scheme 1.7: Synthesis of cyclic enol ether via a tandem ring-closing 
metathesis-alkene isomerization reaction 
 
Laulimalide 20, which is a metabolite that has been isolated from various marine 
sponges, stabilises microtubules and has high activity against multidrug resistant 
cell lines (Figure 1.3).18-21 Mulzer and co-workers completed the total synthesis 
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of Laulimalide 20, where the synthesis of the C1-C12 dihydropyran segment of 
Laulimalide 20 was achieved via ring-closing metathesis (Scheme 1.8).22, 23  
Figure 1.3: Structure of Laulimalide 20 
 
Diene 22 was prepared from alcohol 21 in five steps. Upon treatment with 
Grubbs 1st generation catalyst 4, diene 22 underwent smooth cyclisation to afford 
cyclic ether 23 in 94% yield. Subsequent displacement of the allylic ethoxy 
group with a silyl enol ether in the presence of montmorillonite K-10 as a Lewis 
acid furnished the desired tetrahydropyran 24. 
Scheme 1.8: Synthesis of tetrahydropyrans 24 
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1.2.4 Synthesis of Phosphine Heterocycles via Ring-Closing Metathesis 
The second part of our project (Chapter 3) focuses on a ring-closing metathesis 
approach to novel phosphine heterocycles. Indeed, ring-closing metathesis has 
facilitated the construction of various phosphine heterocycles. In 1995, Basset 
and co-workers reported the first example of ring-closing metathesis to access a 
phosphine heterocycle.24 They used a tungsten-based catalyst, previously 
developed in their group.25 For example, diallyl phenylphosphine 25 was treated 
with 5 mol% of tungsten-based catalyst 27 to furnish the desired cyclic 
phosphine 26 in 95% yield (Scheme 1.9).  
Scheme 1.9: Synthesis of a phosphine heterocycle via ring-closing metathesis 
 
Subsequently, Hanson and co-workers developed the first synthesis of phosphine 
heterocycles utilising Grubbs ruthenium-based catalyst 4.26 Thus, cyclic 
phosphonate 29 was synthesised from diallyl allyl phosphonate 28 using 3 mol% 
of Grubbs catalyst 4 (Scheme 1.10). This approach allowed access to a range of 
5-, 6- and 7-membered phosphonates and phosphinates, although the formation 
of trisubstituted alkenes was unsuccessful. 
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Scheme 1.10: Synthesis of a phosphonate heterocycle via ring-closing 
metathesis 
 
Several examples of ring-closing metathesis to access other phosphine 
heterocycles such as phosphonates and phosphinates are also known. A selection 
of examples is shown in Figure 1.4. These include racemic phosphonates 3027 
and 31,28 racemic phosphinate 3229 and single diastereoisomers of phosphinates 
3330 and 34.31 The remainder of this section will focus on the synthesis of 
carbocyclic phosphine heterocycles, which is of most relevance to the results 
presented in Chapter 3. 
Figure 1.4: Examples of phosphine-containing heterocycles 
 
Gouverneur and co-workers studied the synthesis of cyclic phosphine oxides and 
phosphine boranes via ring-closing metathesis.32, 33 Using Grubbs 1st generation 
catalyst 4, ring-closing metathesis of bis(alkenyl)phosphine oxides and 
phosphine boranes afforded the corresponding cyclic products in good yield 
(Scheme 1.11). For example, phosphine oxide 35 was treated with 4 mol% of 
Grubbs catalyst 4 to give cyclic phosphine oxide 36 in 75% yield, whereas with 2 
mol% of Grubbs catalyst 4, phosphine borane 37 readily provided cyclic 
phosphine borane 38 in  81% yield. In contrast, diallyl phenyl phosphine 25 
gave no conversion into the desired cyclic product 26 using Grubbs catalyst 4. 
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Scheme 1.11: Ring-closing metathesis of phosphine dienes 
 
Later, the Gouverneur group expanded the scope of cyclic phosphine heterocycle 
synthesis by carrying out reactions on phosphine boranes, employing 
ruthenium-based catalyst 5 and molybdenum-based catalyst 3.34 Generally, the 
yield of the reactions improved dramatically compared with using Grubbs 1st 
generation catalyst 4 (Table 1.1). Using catalyst 5, diene 37 was quantitatively 
transformed into the corresponding cyclic phosphine borane 38 (entry 1). With 
trisubstituted alkene 39, cyclic phosphine borane 40 was formed in 90% yield 
using ruthenium catalyst 5 (entry 2). In contrast, with sterically hindered 
tetrasubstituted alkene 41, either ruthenium- or molybdenum-based catalysts with 
extended reaction times of up to 192 h gave none of the desired product 42 (entry 
3). This demonstrated the difficulty presented when synthesising sterically 
demanding cyclic phosphines. It is worth noting that in the presence of 
molybdenum-based catalyst 3, transformation of unprotected phenylphosphine 
25 into the desired product 26 was achieved in an excellent 95% yield (entry 4). 
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Table 1.1: Synthesis of phosphine heterocycles via ring-closing metathesis 
Entry Catalyst 
(mol%) 
Substrate Product Time (h)  Yield 
(%) 
1 
5  
4 mol% 37 
38 
18 100a 
2 
5  
6 mol% 
39 
40 
26 90b 
3 
5 and 3  
4-14 mol% 
41 42 
Up to 
192 
0 
4 
3  
12.5 mol%  25 
 26 
84 95b 
a Yield after purification by chromatography. b Conversion as determined by 1H NMR spectrum 
of the crude mixture. 
 
Recently, the asymmetric synthesis of P-stereogenic phosphinates and phosphine 
oxides was developed by Gouverneur and co-workers.35 Trienes such as 43 were 
desymmetrised by asymmetric ring-closing metathesis using chiral 
molybdenum-based catalysts. For example, triene 43 was cyclised using 10 mol% 
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of molybdenum catalyst 45 to furnish cyclic phosphine oxide (R)-44 in 61% 
yield and 98:2 er. Crucially, by modifying the structure of the achiral imido 
group in molybdenum complex 46, the opposite enantiomer, (S)-44, could be 
synthesised in 48% yield and 86.5:13.5 er (Scheme 1.12). 
Scheme 1.12: Asymmetric synthesis of P-stereogenic phosphinates 
 
A model was proposed to explain the enantioselectivity of the reaction (Figure 
1.5). Both molybdenum-based alkylidenes 45 and 46 have identical diolate 
ligands and are only distinguishable through their achiral imido ligand.  
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Figure 1.5: Proposed model for Mo-based ARCM reactions of 
phosphine-containing trienes, leading to the formation of (+) and (_) 
enantiomers 
 
Intermediate anti-47 reveals a significant steric repulsion between the group of 
the alkylidene and one of the o-i-Pr groups of the imido ligand. Therefore, 
anti-47 was preferred to give cyclic phosphine oxide (R)-44. However, when the 
steric repulsion between the imido ligand and the alkylidene is small, syn-48 was 
formed to give the opposite enantiomer. A range of chiral phosphine heterocycles 
were synthesised using this procedure but the seven-membered rings were 
produced with the highest enantioselectivity 
In summary, ring-closing metathesis is a powerful reaction in organic synthesis 
and has become a routine transformation for the construction of cyclic systems, 
such as oxygen and phosphine heterocycles. Although sterically demanding 
oxygen heterocycles do not present a problem for ring-closing metathesis, the 
synthesis of tetrasubstituted phosphine heterocycles still remains a synthetic 
challenge. 
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Chapter 2. New Synthetic Routes to 2,5-Disubstituted 
Tetrahydropyrans 
This part of the thesis contains the results of a project aimed at developing new 
synthetic routes for the synthesis of 2,5-disubstituted tetrahydropyrans (THPs) 1 
(Figure 2.1). First, the origin of the project and its link to fragrance chemistry are 
presented in section 2.1. Then, a brief overview of the routes that have previously 
been developed for the synthesis of 2,5-disubstituted tetrahydropyran 
frameworks is provided (section 2.2). Section 2.3 states the overall aims of the 
project and provides an outline of the proposed research. Sections 2.4-2.6 are 
dedicated to the development of methodology for the synthesis of 
2,5-disubstituted THPs in a racemic fashion, followed by the attempted synthesis 
of a specific target molecule. An asymmetric deprotonation and ring-closing 
metathesis route to cyclic ethers is then described (section 2.7). Finally, 
conclusions and future work for this part of the project are discussed in section 
2.8.  
Figure 2.1: Structure of 2,5-disubstituted tetrahydropyrans 1 
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2.1 Introduction to Fragrance Chemistry 
Fragrance is ubiquitous in the natural world, and its chemistry is a fascinating 
area of research. Generally, all compounds with a smell fall within the category 
of fragrance chemicals. Compounds with sufficiently high vapour pressure, i.e. 
typically those with molecular weight of less than 300, and containing a limited 
number of functional groups will have an odour. Some examples are shown in 
Figure 2.2. For example, methyl dihydrojasmonate, perhaps the most important 
fragrance ingredient, has a jasmine-like odour, which gradually becomes 
powerful when left to stand. This material differs from methyl jasmonate, the 
natural jasmine component, by the saturation in the side chain. Civetone and 
(_)-muscone 11 are responsible for the main musk odours among the animalic 
family. The presence of functional groups is not always essential to the odorous 
properties of a compound.36 One example is 2,4,4-trimethylpentane, an alkane 
with a pronounced camphoraceous odour. 
Figure 2.2: Examples of perfumery molecules 
Stereoisomers also play important roles in determining the odorous properties of 
molecules. In most cases, the odour differences are very small and are often 
attributed to the presence of trace impurities. A very striking difference in odour 
properties is found for the two enantiomers of carvone 49 (Figure 2.3).37 This has 
drawn attention to the fact that the absolute stereochemistry of a molecule can 
have a considerable influence on its odour properties. While (R)-49 has typical 
spearmint character, (S)-49 is described as caraway-like. Another example comes 
17 
 
from the two diastereoisomers of Florosa® (Figure 2.3).38 Both diastereoisomers 
have a muguet odour but cis-50 is more potent than the trans-51. Therefore, for 
an accurate description of the odour profile, a purity of above 98% is normally 
required before a compound is submitted to be evaluated by the research 
perfumers.   
Figure 2.3: Enantiomers of carvone and florosa® 
 
Another interesting example of structure-odour relationship is illustrated by the 
design of a new class of compounds related to commercially available perfumery 
compounds. There is so-called ‘character-impact structure’ within a category of 
the fragrance compounds. By modifying the substituents on the character-impact 
structure, the resulting compounds can have similar odour profiles to the original 
compounds. For example, the i-butenyl group in rose oxide can be replaced by a 
phenyl group, and the resulting compound Doremox® still possesses a strong 
floral-green, rose odour reminiscent of rose oxide.39, 40 Similarly, replacement of 
the electron dense oxygen atom in cyclogeranylacetate by an alkene gives 
alpha-ionone, which also possesses a violet note. Likewise, a fruity note is 
presented by both ethyl safranate and damascenone (Figure 2.4).41 
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Figure 2.4: Examples of perfumery molecules that illustrate the 
structure-odour relationship 
 
Conversely, the electron density of an alkene group could be replaced by an 
oxygen atom and the resulting compound may still possess a similar odour 
profile. Since there is a wide range of perfumery compounds that contains the 
cyclohexene motif, we considered replacing the cyclohexene with a cyclic ether 
(tetrahydropyran, THP). The design of four potential new perfumery compounds 
is shown in Figure 2.5. These are based on four known perfumery compounds: 
orange flower ether, cyclal, myraldene and nectaryl. By replacing the electron 
density on the oxygen atom with an alkene group, a range of cyclic ethers can be 
created. All of the “oxa” target molecules share a common feature: they have 
substituents at the 2- and 5-positions of the tetrahydropyran. The overall aim of 
this part of the project is to develop a general route to 2,5-disubsitituted THPs 
with a view to the synthesis of the oxa-analogues shown in Figure 2.5. The 
strategy should proceed via a short reaction sequence and allow the preparation 
of THPs with a wide variety of substituents. We also planned to explore racemic 
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and enantioselective syntheses of these compounds. Finally, it was hoped that the 
2,5-disubstituted THPs would have attractive properties in the olfactory 
evaluation, which would be carried out by our industrial collaborator, Givaudan. 
Figure 2.5: Design of potential perfumery compounds 
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2.2 Previous Strategies for the Synthesis of 2,5-Disubstituted 
Tetrahydropyrans (THPs) 
Tetrahydropyran (THP) and its derivatives are present in many classes of natural 
products and are important intermediates in organic synthesis. There are, 
however, very few naturally occurring 2,5-disubstituted THPs. For example, both 
(+)-hippospongic acid A and the rhopaloic acids A and C contain 
2,5-disubstituted THPs (Figure 2.6). The triterpenoic acid hippospongic acid A 
was isolated from the sponge  Hippospongia sp.42, 43 The rhopaloic acids are a 
class of norsesterpenes that were isolated from both the marine sponge 
Rhopaloeides sp.42, 44 and from Hippospongia sp.45 Hippospongic acid A and the 
rhopaloic acids A and C all exhibit considerable activity for inhibiting 
gastrulation in starfish embryos. 
Figure 2.6: Examples of natural products that contain 2,5-disubstituted 
THP framework 
 
Interestingly, the synthesis of 2,5-disubstituted THP ring systems has not been 
intensively studied: only a few groups have developed methodologies for the 
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synthesis of 2,5-disubstituted THPs. In particular, there are no general 
approaches to those types of molecules. 
In 1990, Yamamoto and co-workers studied the reduction of acetals and found 
that depending on the nature of the solvent, the symmetrical bicyclic acetal 53 
could be reduced stereoselectively to give 2,5-disubstituted THPs cis-54 and 
trans-55 (Table 2.1). In a non-polar solvents such as toluene, the reaction gave 
predominately the 2,5-disubstituted THP trans-55 (entry 1), while in polar 
solvents such as THF and Et2O, the 2,5-disubsitituted THP cis-54 was the major 
product (entries 2 and 3). The optimum reaction conditions used 
dibromoaluminium hydride in Et2O and gave THP cis-54 in 72% yield and 97:3 
cis:trans selectivity (entry 3).  
Table 2.1: Reductions of acetal 53 
 
Entry Reagent Solvent Temp. 
(ºC) 
Time (h) Yield 
(%)a 
cis-54 : trans-55 
1 DIBAL-H toluene rt 20 38 17:83 
2 DIBAL-H THF rt 15 51 82:18 
3 Br2AlH Et2O _20 0.25 72 97:3 
a Yield of a mixture of cis and trans diastereoisomers after purification by chromatography. 
Two different mechanisms were proposed in order to explain the stereoselectivity 
of the reaction (Scheme 2.1). In a non-polar solvent, the oxonium ion forms a 
tight ion pair and the hydride attacks the cationic centre on the cis-face in an 
intramolecular fashion to give trans-55. In contrast, in a polar solvent, the ion 
pair can exist in an open conformation, and the hydride attacks the less sterically 
hindered face of the cationic centre to give cis-54. This study revealed that the 
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mechanism of the reductive cleavage of acetals may proceed differently 
depending on the nature of the solvent. Thus, cis-54 and trans-55 could be 
obtained selectively. However, this methodology was not sufficiently versatile to 
be used as a general route to 2,5-disubstituted THPs. 
Scheme 2.1: Proposed mechanism for the reduction of acetal 53 
 
Ohkata and co-workers have reported the synthesis of 2,5-disubsitituted THPs by 
an epoxide ring expansion process (Table 2.2).46 The epoxy bromide 56 was 
converted into tetrahydropyranylacrylate trans-58 on treatment with silver nitrate. 
The silver salt, which has a high halide affinity, eliminates the bromide ion to 
afford a bridged oxonium ion intermediate 57 via intramolecular nucleophilic 
attack of the epoxy group. Then, the nitrate ion attacks the intermediate to 
produce 2,5-disubstituted THP trans-58.  
The cis:trans diastereoselectivity was moderate and the use of CH2Cl2 as solvent 
resulted in an increase in yield (entry 2) compared with the Et2O-H2O solvent 
system (entry 1). Although this procedure allows access to the 2,5-disubstituted 
THP framework with a nitrate group on the 5-position of the THP, the formation 
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of key pyrans as a mixture of diastereoisomers is inefficient and gave a moderate 
cis:trans selectivity.  
Table 2.2: Synthesis of 2,5-disubstituted THP via ring expansion 
 
Entry Solvent Conditions Yield (%)a cis:transb 
1 Et2O-H2O (100:1) 25 ºC, 18 h 11 29:71 
2 CH2Cl2 25 ºC, 6 h 56 33:67 
a Yield of a mixture of cis and trans diastereoisomers after purification by chromatography. b 
Ratio of cis:trans determined from the 1H NMR spectrum of the crude product. 
More recently, Harrity’s group reported the synthesis of 2,5-disubsitituted THPs 
using epoxides and an organomagnesium reagent (Scheme 2.2).47 Furthermore, 
the methodology was then used to complete the total synthesis of rhopaloic acid 
A (Scheme 2.3).48  
Scheme 2.2: Synthesis of a 2,5-disubstituted THP usingan epoxide 
 
Methallyl alcohol 59 was first treated with an excess of n-BuLi in the presence of 
TMEDA followed by the addition of MgBr2 to afford the key allyl Grignard 
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reagent 60. Allyl Grignard reagent 60 was then reacted with epoxide 61 to 
provide the corresponding diol 62 in 74% yield. Treatment of diol 62 in a 
palladium-catalysed cyclisation gave THP 63 in high yield. A range of epoxides 
were employed in the reaction with allyl Grignard reagent 60, but lower yields 
for the cyclisations were obtained when the diol has a tertiary centre at one of the 
alcohols.  
To test the versatility of this methodology in stereoselective synthesis, the 
synthesis of rhopaloic acid A was explored (Scheme 2.3). The protected epoxy 
alcohol 64 was reacted with allyl Grignard reagent 60 and subsequent cyclisation 
gave the 2,5-disubstituted THP 65 in 54% yield.  
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Scheme 2.3: Stereoselective synthesis of rhopaloic acid A 
Treatment of 65 with Cp2Zr(H)Cl followed by iodine gave the desired iodide 
trans-66 in 23% yield with the undesired cis diastereoisomer in 58% yield. Then, 
alkylation of sulfone 67 with iodide trans-66 gave sulfone 68 with the farnesyl 
chain attached. Removal of the sulfone group followed by deprotection of the 
alcohol gave 69 in 69% yield. The primary alcohol 69 was then oxidised under 
Swern conditions to give the corresponding aldehyde, which was then reacted 
with dimethylmethylidene ammonium iodide under basic conditions to give 
unsaturated aldehyde 70 in 66% yield. Finally, oxidation of aldehyde 70 afforded 
rhopaloic acid A in 80% yield. Although a range of alcohols and pyrans could be 
synthesised utilising this procedure, it is hampered by the use of an excess 
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amount of Grignard reagent and the desired 2,5-disubstituted THP trans-66 was 
produced in low yield. 
The aluminium(III) triflate-catalysed cycloisomerisation of primary alcohols has 
been studied by Duñach and co-workers.49, 50 Such methodology was used for the 
construction of rose oxide trans-72 and cis-73 and its analogues trans-75/cis-76 
and trans-78/cis-79 (Scheme 2.4). The reaction involved the synthesis of primary 
alcohols 71, 74 and 77, followed by the aluminium(III) triflate-catalysed 
cycloisomerisation to afford disubstituted THPs both in high yield and high 
trans:cis diastereoselectivity. 
Scheme 2.4: Synthesis of 2,5-disubstituted THPs via cycloisomerisation 
 
A mechanism was proposed by Duñach in order to explain the stereoselectivity 
and the regioselectivity of the formation of the 6-membered ether ring in the 
cycloisomerisation step (Scheme 2.5). First, the lone pair of electrons on the 
oxygen attacks the aluminium(III) centre in the Lewis acid to give an oxonium 
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ion. One of the alkenes is now protonated by abstracting the proton from the 
alcohol. This gives a positively charged carbocation 80, which can be stabilised 
by resonance to give 81. The lone pair of electrons on the oxygen can now attack 
the carbocation to give the 6-membered THP trans-75 and cis-76.  
Scheme 2.5: Proposed mechanism for the cycloisomerisation 
 
The high trans:cis diasteroeselectivity ratio could be explained by the 
conformation of the intermediate species 82 (Figure 2.7).i The alkene group is in 
an equatorial position as a result of the free rotation about the CH2_CH bond and 
so as to avoid the sterically bulky aluminium triflate. Now, the lone pair of 
electrons from the oxygen can attack to form the THP. Therefore, the reaction 
gave a mixture of trans-75 and cis-76 from 74 in a trans:cis ratio of 90:10. 
                                                
i The assignment of the trans and cis isomers were found to be erroneous in the original paper. After 
correspondence with the author, the stereoisomers were agreed as shown in Scheme 2.4. 
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Figure 2.7: Formation of trans-75 
 
The limitation of this regiospecific cycloisomerisation is that, in order to afford 
exclusively the corresponding THPs, it requires a benzylic- or allylic-type cation 
intermediate to stablise, by conjugation, the positive charge formed in the 
presence of the metal triflate. Rose oxide analogues cis-75/trans-76 and 
cis-78/trans-79 were submitted for olfactory evaluations, and it is interesting to 
note that they all carry some fruity notes. 
A stereoselective alkoxymethyl radical cyclisation approach was developed by 
Rawal and co-workers to construct tetrahydrofurans and tetrahydropyrans 
(Scheme 2.6).51 The required cyclisation precursor 85 was prepared in two steps 
from the corresponding alcohol 83. Thus, alcohol 83 was treated with sodium 
hydride and (iodomethyl)tributylstannane in DMF to give the expected stannane 
84 in moderate yield. Stannane 84 was then transformed into the desired 
selenoacetal 85 by tin-lithium exchange and quenching with (PhSe)2. Under 
standard radical cyclisation conditions employing n-tributyltin hydride and AIBN, 
selenoacetal 85 gave an inseparable mixture of 6- and 7-membered cyclic ethers 
86 and 87. The yield of each compound was determined by GC. The major 
component in the 2,5-disubstituted THP 86 was the trans diastereoisomer. The 
5:1 diastereomeric ratio was determined by NMR spectroscopy. The potential 
by-product 88 resulting from reduction was observed as a very minor component 
(<2%) by NMR spectroscopy. The cyclisation reaction has a high efficiency and 
can be used to access the 2,5-disubstituted THP framework. However, the use of 
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an organotin compound and AIBN may restrict the synthetic utility of this 
methodology.  
Scheme 2.6: Synthesis of 2,5-disubstituted THPs via radical cyclisation 
Finally, a stereoselective synthesis of optically pure dihydrofurans and 
dihydropyrans in >99:1 er was reported by Tanyeli and co-workers.52 Their 
approach was first to construct racemic alcohols such as rac-89. Thus, 
nucleophilic addition of allyl magnesium bromide to furan-2-carbaldehyde 
resulted in alcohol rac-89. This was followed by enzyme-catalysed resolution to 
give enantiomerically enriched alcohol (S)-90 in >99:1 er (Scheme 2.7). 
Scheme 2.7: Enantioselective synthesis of alcohol (S)-90 
Diene (S)-91 was then synthesised from the enantioenriched alcohol (S)-90 by 
O-allylation. Use of sodium hydride and allyl bromide in the presence of TBAI 
in THF formed the diene (S)-91. Ring-closing metathesis using Grubbs’ 1st 
generation catalyst 4 afforded dihydropyran (S)-92 (Scheme 2.8). 
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Scheme 2.8: Formation of dihydropyran (S)-92 
 
In order to prepare dihydropyrans with 2,5-substitution, propargyl bromide was 
employed in the O-allylation step. Alcohol (S)-90 was reacted with sodium 
hydride together with propargyl bromide in the presence of TBAI in THF to 
afford enyne (S)-93. Under the same ring-closing metathesis conditions, 
2,5-disubstituted dihydropyran (S)-94 was synthesised in 70% yield. 
Scheme 2.9: Formation of 2,5-disubstituted dihydropyran (S)-94 
In summary, a number of strategies for the synthesis of the 2,5-disubstituted 
THPs have been developed. Harrity’s methodology allows access to the 
2,5-disubstituted THP framework in a few steps and the synthetic versatility was 
demonstrated by the synthesis of rhopaloic acid A. The aluminium triflate 
catalysed cycloisomerisation of primary alcohols afforded substituted THPs in 
good yield and high trans:cis diastereoselectivity. This procedure has been used 
in the synthesis of perfumery molecules such as rose oxide and its analogues. An 
enzyme-mediated stereoselective synthesis of dihydropyrans afforded 
unsaturated THPs in high ers. 
  
31 
 
2.3 Project Outline 
2,5-Disubstituted THPs are a unique class of molecules that are interesting from 
both biological and structural standpoints. Although there has been synthetic 
work aimed at rhopaloic acid A, a general route to the 2,5-disubstituted THP 
framework is still required. Furthermore, establishing a synthetic route to these 
target compounds could be valuable in the search for new perfumery molecules. 
Tanyeli’s methodology to the 2,5-disubstituted THPs is short and efficient, and 
one terminal alkene could serve as a synthetic handle for further manipulation. 
Therefore, we hoped that a similar procedure could be developed for the 
divergent synthesis of THPs. We would also like to apply the methodology 
developed to the synthesis of known perfumery compounds and some of the 
target molecules. Another aim of this part of the project is to develop the 
synthesis of enantioenriched homoallylic alcohols and 2,5-disubstituted THPs 
with high diastereoselectivity. 
This part of the thesis is an account of our attempt to design and develop new 
strategies for the 2,5-disubstituted THP framework and the synthesis of the 
newly designed potential perfumery compounds. 
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2.4 Synthesis of 2,5-Disubstituted Tetrahydropyrans via an 
Alkylation, Reduction and Cyclisation Route 
In this section, we focused our attention on developing two routes to 
2,5-disubstituted THPs, both of which utilise commercially available t-butyl 
propionate as the key building block. The first route starts with alkylation of 
t-butyl propionate using allyl bromide to give unsaturated ester 95. 
Hydroboration followed by oxidative work-up would then afford alcohol 96. 
Oxidation of the primary alcohol would provide aldehyde 97. Then, addition of 
Grignard reagents will provide the substituent at the 2-position in the final THP. 
Finally, mesylation or tosylation of the alcohol and reduction of the ester 
followed by cyclisation would afford the 2,5-disubstituted THPs 99 probably as a 
mixture of diastereoisomers (Scheme 2.10). 
Scheme 2.10: Proposed route to 2,5-disubstituted THPs 
 
The second proposed route starts with alkylation of t-butyl propionate with 
4-bromobut-1-ene to give unsaturated ester 100. Reduction of the ester followed 
by mesylation or tosylation would afford the activated alcohols 101 and 102. 
Oxidation using osmium tetraoxide and sodium periodate-mediated cleavage of 
the diol would give aldehydes 103 and 104. Finally, Grignard addition to the 
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aldehyde should give an alkoxide which hopefully would be nucleophilic enough 
to cyclise to form a mixture of diastereomeric 2,5-disubstituted THPs 99 
(Scheme 2.11). 
Scheme 2.11: Proposed route to 2,5-disubstituted THPs 
 
As outlined in Schemes 2.10 and 2.11, we envisaged that 2,5-disubstituted THPs 
99 could be synthesised from t-butyl propionate. In 2001, Heathcock and 
co-workers reported the development of a new polycyclisation route for the 
synthesis of a range of natural products belonging to the family of 
Daphniphyllum alkaloids.53 One of the reaction sequences described was found 
to be relevant to our project. Specifically, the synthesis of diol 107 began with 
sequential LDA-mediated alkylation of t-butyl propionate with an alkyl iodide 
and allyl bromide to provide ester 105 in excellent yield over two steps. Selective 
hydroboration of the less substituted alkene in ester 105 then afforded alcohol 
106. In the final step, reduction of the ester functionality in 106 efficiently 
provided the desired diol 107 in good yield (Scheme 2.12).  
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Scheme 2.12: Synthesis of alcohol 107 via sequential alkylation reactions 
 
Notably, when a less reactive electrophile such as 6-iodo-2-methylhex-2-ene was 
employed in the enolate alkylation step, DMPU was required during the trapping 
step in order to obtain a high yield of product. In contrast, the use of DMPU was 
not necessary when allyl bromide, a more reactive electrophile, was employed in 
the alkylation step. Presumably, DMPU coordinates to the lithium cation in the 
enolate, making it more reactive. This observation is significant to our project 
since alkylation of t-butyl propionate was also investigated using electrophiles of 
different reactivities. Thus, deprotonation of t-butyl propionate with LDA as base 
and trapping with allyl bromide gave ester 95 in 84% yield on a 1.5 g scale 
(Scheme 2.13).  
Scheme 2.13: Formation of ester 95 via alkylation 
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The use of DMPU was not necessary in this case, presumably due to the high 
reactivity of allyl bromide towards nucleophilic substitution. Curiously, the yield 
of product was in fact significantly lower with DMPU as additive. However, it 
should be noted that the reaction with DMPU was carried out on a small scale 
and ester 95 is volatile so that difficulties were experienced with handling the 
material. This could account for the lower yield from the reaction with DMPU. 
With gram quantities of alkylated ester 95 in hand, hydroboration of the terminal 
alkene in 95 was next explored (Table 2.3). Use of 1.2 equivalents of BH3·THF 
and a reaction time of 4 hours gave alcohol 96 in modest (42%) yield (entry 1), 
which was not improved with an extended reaction time (entry 2). 
Disappointingly, the yield of product was even lower when the amount of borane 
was increased (entries 3 and 4). We first suspected that instability of alcohol 96 
on silica gel could be the reason for the low isolated yields. Indeed, upon 
inspection of the 1H NMR spectrum of the crude product, good conversion to 
alcohol 96 was consistently observed, and it was the chromatography purification 
step which appeared to account for the low isolated yields. Alcohol 96 also 
decomposed after storage at room temperature over a period of time. This was 
shown by TLC analysis and inspection of the 1H NMR spectra.  
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Table 2.3: Hydroboration of ester 95 
 
Entry Eq. of borane Time (h) Yield (%)a 
1 1.2 4 42 
2 1.2 16 42 
3 3 3 30 
4 3 16 28 
a Yield of 96 after purification by chromatography. 
Despite the moderate isolated yield of alcohol 96, the reaction was readily scaled 
up and sufficient quantities of material were obtained. Thus, two methods for 
oxidation of alcohol 96 to aldehyde 97 were explored. First, alcohol 96 was 
treated with pyridinium chlorochromate.54 However, only a 20% yield of 
aldehyde 97 was obtained following a difficult purification by flash column 
chromatography (Scheme 2.14). Pleasingly, when Dess-Martin periodinane 
(DMP) was used as oxidant,55 aldehyde 97 was obtained in 93% yield and no 
purification difficulties were encountered. Therefore, oxidation using 
Dess-Martin periodinane was the preferred method.  
Scheme 2.14: Oxidation of alcohol 96 
 
Given the volatility issue with ester 95 and the purification difficulties we had 
encountered in the hydroboration step (despite apparent high conversion to 
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product), we attempted the alkylation, hydroboration and oxidation steps in a 
sequential reaction approach, where the crude product was used directly in the 
next steps. Unfortunately, the overall yield of aldehyde 97 over these three steps 
was only 14% after purification by flash column chromatography (Scheme 2.15). 
In contrast, a higher 33% overall yield was obtained where each of the individual 
intermediates had been isolated. Due to the low yield and difficulties experienced 
during the development of this approach, we decided to turn our attention to the 
alternative strategy. 
Scheme 2.15: Three-step sequential approach to aldehyde 97 
 
In our alternative strategy towards 2,5-disubstituted THPs, unsaturated ester 100 
was synthesised by alkylating t-butyl propionate via deprotonation with LDA and 
trapping with 4-bromobutene as the electrophile under different conditions 
(Table 2.4). More specifically, treatment of t-butyl propionate with LDA and 
4-bromobutene in the presence of DMPU furnished the desired product in 37% 
yield (entry 1). By increasing the amount of base and electrophile to 1.5 eq. and 
1.0 eq., respectively, and with 1.5 eq. of t-butyl propionate in the presence of 
DMPU, the yield of the reaction was improved to 62% based on 4-bromobutene 
as the limiting reagent (entry 2). From this reaction, β-keto ester 108 (14% yield) 
was also formed via a Claisen self-condensation reaction. This indicates the 
bulky t-butyl group has a small contribution, in this case, in preventing the 
self-condensation reaction. Since 4-bromobutene is not a very reactive 
electrophile in SN2 reactions, an identical reaction but in the absence of DMPU 
led, as expected, to a lower yield of product (entry 3).  
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Table 2.4: Alkylation of t-butyl propionate 
 
Entry Eq. of ester 
Eq. of 
LDA 
Eq. of 
electrophile 
Eq. of 
DMPU 
Yield (%)a 
1 1.0 0.95 0.7 2.0 37 
2 1.5 1.4 1.0 2.0 62b 
3 1.5 1.4 1.0 0 22 
a Yield of 100 after purification by chromatography. b β-keto ester 108 was also isolated in 14% 
yield. 
In order to broaden the substrate scope in our THP synthesis, we also studied the 
alkylation of t-butyl acetate (Scheme 2.16), as this would provide the opportunity 
to introduce a range of substituents in the 5-position of the THP. Thus, treatment 
of t-butyl acetate with LDA and trapping of the resulting enolate with 
4-bromobutene in the presence of DMPU afforded ester 109 in a respectable 55% 
yield. Alkylation of 109 with LDA and trapping with methyl iodide gave ester 
100 in 67% yield. Crucially, subsequent methylation of ester 109 not only 
provided an alternative means of obtaining ester 100, but it also suggested that 
through the use of alternative alkylation agents, access to differentially 
5-substituted THPs would be possible.  
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Scheme 2.16: Synthesis of ester 100 
 
A benzyl group was also introduced by deprotonation of t-butyl acetate using 
LDA followed by trapping with benzyl bromide (Scheme 2.17). This gave ester 
110 in 72% yield. Subsequent deprotonation and electrophilic trapping with 
4-bromobutene in the presence of DMPU afforded unsaturated ester 111 in only 
5% yield. The low yield was mainly due to the difficulties in purification by 
column chromatography. It was shown that ester 111 can be used as a crude 
product in later steps. For example, alkylation of ester 110 with 4-bromobutene 
gave crude ester 111 and subsequent reduction produced alcohol 112 in 40% 
yield over the two steps. 
Scheme 2.17: Synthesis of alcohol 112 
 
Reduction of ester 100 with LiAlH4 in THF furnished alcohol 113 in 66% yield 
(Scheme 2.18). Full conversion was established by analysis of the 1H NMR 
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spectrum of the crude product and we attributed the moderate yield of alcohol 
113 to its volatility. 
Scheme 2.18: Reduction of ester 100 
 
It was pleasing to find that mesylation of primary alcohol 113 afforded mesylate 
101 in excellent (96%) yield (Scheme 2.19). Oxidative cleavage of the terminal 
alkene in 101 with osmium tetraoxide and sodium periodate, using a procedure 
developed by Jin and co-workers,56 provided aldehyde 103 in 50% crude yield 
(Scheme 2.19). As aldehyde 103 proved to be unstable on silica, it was used in 
the next step without further purification. 
Scheme 2.19: Synthesis of aldehyde 103 
 
It was anticipated that, if aldehyde 103 was treated with i-propyl magnesium 
chloride, then upon chemoselective nucleophilic attack of the i-propyl group onto 
the aldehyde, the alkoxide anion thus formed in intermediate 114 would readily 
undergo an intramolecular cyclisation to provide the 2,5-disubstituted THPs 115 
in a single operation (Scheme 2.20).  
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Scheme 2.20: Proposed route to 2,5-disubstituted THP 115 
Based on the small quantity of the mesylate 103 obtained, we were only able to 
carry out the reaction once. Disappointingly, only a small amount of secondary 
alcohol 116 (15%) as a 50:50 mixture of diastereomers was obtained (Scheme 
2.21). The ratio was determined by integration of the signals due to the CHMe 
group: δH 1.01 (d, J = 7.0 Hz, 3H) and δH 1.00 (d, J = 7.0 Hz, 3H). The desired 
cyclised ether 115 was not observed in the 1H NMR spectrum of the crude 
product.  
Scheme 2.21: Formation of alcohol 116 via Grignard addition 
 
We encountered volatility issues during the isolation process of mesylate 101. 
Therefore, we decided to introduce a tosyl group as the activating group. By 
doing so, it increases the molecular weight of the molecule and could potentially 
overcome the volatility issue. The tosylate would also serve a second purpose: it 
is a better leaving group than a mesylate and this could facilitate the final 
cyclisation step of the alkoxide into the desired THP 115. Thus, alcohol 113 was 
treated with tosyl chloride in pyridine to give tosylate 102 in 71% yield. Under 
osmium tetraoxide and sodium periodate conditions, we were pleased to find that 
aldehyde 104 was isolated in an excellent 88% yield after purification. Finally, 
nucleophilic addition of i-propyl magnesium chloride gave secondary alcohol 
117 (as a ~50:50 mixture of diastereoisomers as revealed by 13C NMR 
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spectroscopy) in 88% yield (Scheme 2.22). This was a significant improvement 
compared to the addition to mesylate 103, but cyclisation to the diastereomeric 
THPs 115 was still not observed. 
Scheme 2.22: Synthesis of alcohol 117 
 
With alcohol 117 in hand, cyclisation of the secondary alcohol to the final THP 
115 in a separate step was next explored. Three sets of reaction conditions were 
investigated (Scheme 2.23). Following a literature procedure,57 alcohol 117 was 
first treated with potassium carbonate in methanol at rt and stirred for 16 h. 
However, only starting material was observed in the 1H NMR spectrum of the 
crude product. We then decided to increase the reaction temperature. Thus, 
alcohol 117 was refluxed with potassium carbonate in methanol for 16 h. 
However, no desired product was observed and only starting material was 
recovered. Next, a stronger base, sodium hydride, was used and the reaction 
mixture was refluxed for 16 h. Disappointingly, the resulting 1H NMR spectrum 
of the crude product showed a complex mixture with no sign of either product or 
starting material. We presume that competing β-elimination process may be 
responsible for the unsuccessful outcome of this reaction. Unfortunately, at this 
stage, our initial attempts to carry out the cyclisation reaction were unsuccessful 
and we were unable to continue due to lack of material.  
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Scheme 2.23: Attempted synthesis of 2,5-disubstituted THP 115 
 
Thus far, our efforts on the alkylation, reduction and cyclisation route were not 
successful, and the route was rather long. A short strategy to directly access the 
2,5-disubstituted THP framework would be more attractive. Hence, we focused 
our attention on an entirely different approach.  
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2.5 Synthesis of 2,5-Disubstituted Tetrahydropyrans via 
Grignard Addition, O-Alkylation, Ring-Closing Metathesis 
and Hydrogenation  
In this section, an alternative synthesis of 2,5-disubstituted THPs will be 
discussed. In this context, ready access to THPs of type 99 could be available in 
just four well-established steps from aldehydes 118 (Scheme 2.24). Specifically, 
allyl Grignard addition to aldehydes 118 would afford alcohols 119 which upon 
deprotonation and reaction with an allylic halide would generate dienes 120. The 
strategically placed alkenes in 120 would then be ready for a ring-closing 
metathesis reaction to furnish the cyclic dihydropyrans 121. In the final step, 
2,5-disubstituted THPs 99 would be obtained by hydrogenation of the alkene in 
121, conceivably with induction of 2,5-diastereocontrol.  
Scheme 2.24: Proposed route to 2,5-disubstituted THPs 
 
Seven aldehydes were chosen for this study and the reaction sequence towards 
THPs 99 outlined above proved to be efficient in all cases. Grignard addition 
using 1.2 eq. of allyl magnesium bromide to all seven aldehydes in THF at _78 ºC 
produced homoallylic alcohols 122-128 in 51-98% yield and in multi-gram 
quantities (Scheme 2.25).  
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Scheme 2.25: Synthesis of alcohols via Grignard addition 
 
O-Alkylation with sodium hydride as a base and 3-bromo-2-methylpropene as an 
electrophile afforded the terminal dienes 12 and 129-134 in excellent yields 
throughout (84-98%). At this stage, ring-closing metathesis using Grubbs 2nd 
generation catalyst 5 constructed the cyclic ether framework in dihydropyrans 13 
and 135-140 in excellent yield. This represents a very efficient route to 
dihydropyrans. The ring-closing metathesis route to such compounds has also 
been carried out previously by Grubbs12 and Schmidt.16, 17  
Scheme 2.26: Synthesis of 2,5-disubstituted dihydropyrans via O-alkylation 
and ring-closing metathesis 
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Finally, hydrogenation using 10 mol% palladium on carbon in methanol at rt for 
3 h efficiently provided the desired 2,5-disubstituted THPs 78, 79 and 141-152. 
These reactions were carried out several times in order to isolate the products 
with reasonable yields. This is due to the volatility issues of such low molecular 
weight molecules. The highest yielding results are presented in Tables 2.5 and 
2.6. The yield was generally moderate for all seven examples (57-80%). We 
were pleased to discover that a good level of cis-diastereoselectivity was induced 
in the hydrogenation process for the non-aromatic substituents (Table 2.5). The 
cis:trans diastereomeric ratio was determined from the 1H NMR spectrum of the 
products (both crude and isolated). The assignment of the relative 
stereochemistry is discussed in detail later. In general, an 83:17-89:11 ratio of cis 
and trans diastereomers was obtained for the alkyl substituted THPs (141-150). 
The slight decrease in the cis:trans diastereoisomeric ratio for cyclic ethers 147 
and 148 from the crude product to the isolated product (entry 4) is probably due 
to some loss of the major diastereoisomer, cis-147, during the purification by 
chromatography. 
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Table 2.5: Hydrogenation of 2,5-disubstituted dihydropyrans 135-139 
 
Entry Compound R Product 
cis:trans 
cis:trans 
(crude)a 
Yield 
(%)b 
cis:trans 
(isolated)c 
1 135 i-Bu 141 142 83:17 23 83:17 
2 136 t-Bu 143 144 89:11 77 89:11 
3 137 n-C4H9 145 146 88:12 23 88:12 
4 138 n-C5H11 147 148 88:12 86 83:17 
5 139 c-C6H11 149 150 87:13 57 87:13 
a Diastereomeric ratio determined from the 1H NMR spectrum of the crude product. b Yield of 
cis/trans-mixture after purification by chromatography. c Diastereomeric ratio determined from 
the 1H NMR spectrum of the purified product. 
In the case of tetrahydropyrans 13 and 140, a lower level of 
cis-diastereoselectivity was observed. A cis:trans ratio of 55:45 was obtained for 
cyclic ethers 79 and 78 (Table 2.6, entry 1), and a slightly higher cis:trans ratio 
of 65:35 for cyclic ethers 151 and 152 was found (entry 2). When the phenyl 
group is directly attached to the carbon bearing the oxygen as in 13, palladium on 
carbon reaction conditions not only resulted in hydrogenation to afford 
2,5-disubstituted THPs trans-78 and cis-79, but a small amount (13%) of alcohol 
153 was also isolated (entry 1). This observation is due to the benzylic C_O bond 
being cleaved under these conditions. 
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Table 2.6: Hydrogenation of dihydropyrans 13 and 140 
 
Entry Compound R Product cis:trans 
(crude)a 
Yield 
(%)b 
cis:trans 
(isolated)
c 1 13 Ph 79 78 55:45 57d 52:48 
2 140 PhCH2CH
2 
151 152 65:35 80 65:35 
a Diastereomeric ratio determined from the 1H NMR spectrum of the crude product. b Yield of 
cis/trans-mixture after purification by chromatography. c Diastereomeric ratio determined from 
the 1H NMR spectrum of the purified product. d 13% of 2-methyl-5-phenylpentan-1-ol 153 was 
also isolated. 
We then decided to investigate the competitive reactions between hydrogenation 
of dihydropyran 13 and the breaking of the benzylic C-O bond in the molecule. 
By submitting the compound to identical hydrogenation conditions with a shorter 
reaction time, the ratio of the two products would then give information on the 
rate of the two reactions. Thus, dihydropyran 13 was hydrogenated with 
palladium on carbon in methanol for 5 min to give the crude mixture (Scheme 
2.27). A 60% conversion from dihydropyran 13 to tetrahydropyrans cis-79 and 
trans-78 was determined from the 1H NMR spectrum of the crude mixture, and a 
cis:trans ratio of 55:45 was calculated.  Interestingly, none of alcohol 153 was 
observed. This demonstrated that the rate of hydrogenation of dihydropyran 13 
was much faster than the breaking of the benzylic C_O bond. Despite this 
competing process, the cis:trans diastereoselectivity in the hydrogenation of 
phenyl-substituted dihydropyran 13 is clearly lower than the alkyl-substituted 
dihydropyrans 135-139. 
49 
 
Scheme 2.27: Hydrogenation of 2,5-disubstituted dihydropyrans 13 
 
The relative stereochemistry in THPs 78, 79 and 143-152 was assigned in the 
following way. In THP 143 and 144, since the interaction between an axial 
t-butyl group and the 1,3-diaxial hydrogen atom is so severe, the t-butyl group is 
locked in the equatorial position. Therefore, cyclic ether cis-143 would exist in 
conformer 154, and cyclic ether trans-144 would be preferred in conformer 155 
(Figure 2.8).  
Figure 2.8: Conformational analyses of cis-143 and trans-144 
 
The equatorial position of the t-butyl group was confirmed by analysis of the 
protons in the axial position on C2 in each diastereoisomer and is summarised in 
Figure 2.9. The protons in the axial position have a large 3J coupling (11.0 Hz) in 
both 154 (cis-143) and 155 (trans-144). This corresponds to the trans-diaxial 
interaction with the axial protons. The other coupling constants for the signal at 
δH 2.85 (2.0 Hz) in 154 and δH 2.80 (2.0 Hz) in 155 are due to axial-equatorial 3J 
coupling. Analysis of the 1H NMR spectrum for the diastereotopic protons on C6 
revealed that 154 was the major diastereoisomer from the hydrogenation. In 154, 
the axial proton at C6 is assigned at δH 3.71 ppm (dd, J = 11.0, 2.0 Hz). This is 
recognised due to a large 2J coupling constant (11.0 Hz) with the other 
diastereotopic proton and a small 3J axial-equatorial coupling constant (2.0 Hz) 
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with the proton in the equatorial position on C5. In the alternative configuration, 
the proton in the axial position on C6 should have a large 2J coupling constant as 
well as a large 3J trans-diaxial coupling constant with the proton in the axial 
position on C5. This could potentially give a triplet splitting pattern. The signal at 
δH 2.96 with a triplet splitting pattern and J values of 12.0 Hz was thus assigned 
to the proton in the axial position on C6 for 155.  
Figure 2.9: 1H NMR spectroscopic interpretation of 154 and 155 
The relative stereochemistry in cyclic ethers 141, 142 and 145-150, which do not 
possess a fully conformational locking group, was assigned in the following way. 
First, the conformations of cyclic ethers 141, 142 and 145-150 were predicted. 
Using cis-149 with a cyclohexyl group as an example, the two possible 
conformations are shown in Figure 2.10. In conformer 156, we placed the 
sterically bulky cyclohexyl group in the axial position. Hence, there is a 
1,3-diaxial clash between the cyclohexyl group and the two hydrogens as 
indicated by the bold bonds. In contrast, when the cyclohexyl group is in the 
equatorial position (conformer 157), there is only the steric hindrance between 
the methyl group and the hydrogen and the much smaller lone pair on the oxygen 
atom. Therefore, our analysis predicted that conformer 157 should have a lower 
energy than conformer 156.  
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Figure 2.10: Conformational analysis of cis-149 
 
In the case of trans-150 (Figure 2.11), with the cyclohexyl group in the axial 
position, as shown in conformer 158, there is not only a 1,3-diaxial clash 
between the cyclohexyl group and the hydrogens as indicated by the bold bonds, 
but as the methyl group is also in an axial position, there is a further 1,3-diaxial 
clash. In the ring-flipped conformer 159, both cyclohexyl and methyl groups are 
in equatorial positions, and the steric hindrance is reduced. Hence, conformer 
159 should be lower in energy than conformer 158. 
Figure 2.11: Conformational analysis of trans-150 
 
The relative stability of the conformations of diastereomeric THPs cis-149 and 
trans-150 was also studied using DFT calculations.58 All structures were 
optimised at the B3LYP/6-31G** and MP2/6-31G** levels of theory, under the 
Gaussin ‘VeryTight’ convergence criteria. The B3LYP calculations utilised the 
Gaussin ‘UltraFine’ denser integration grid. It was found that for cis-149, 
conformer 156 is 8 kJ mol-1 higher in energy than that of conformer 157 at both 
B3LYP/6-31G** and MP2/6-31G** level (Figure 2.12). In the case of trans-150, 
conformer 158 is 22 kJ mol-1 higher in energy than that of conformer 159 at 
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B3LYP/6-31G** level, and 16 kJ mol-1 higher at MP2/6-31G** level (Figure 
2.12). Therefore, the DFT calculations supported our prediction of the 
conformational analysis: cyclic ether cis-149 would exist in conformer 157 and 
trans-150 would exist in conformer 159. 
Figure 2.12: Energy minimized structures for cis-149 and trans-150 
                       
  
156                                      157 
B3LYP/6-31G** level: 8 kJ mol-1                                        0 kJ mol-1 
MP2/6-31G** level:    8 kJ mol-1                                       0 kJ mol-1 
                             
 
158                                      159 
B3LYP/6-31G** level:  22 kJ mol-1                                      0 kJ mol-1 
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MP2/6-31G** level:     16 kJ mol-1                                      0 kJ mol-1 
The conformation of cyclic ethers was ultimately established by 1H NMR 
spectroscopic analysis of the protons in the axial position on C2 in each 
diastereoisomer, as was carried out for THPs 149 and 150. Both protons in the 
axial position should have a large 3J coupling in both cis-149 and trans-150 to 
correspond to the trans-diaxial interaction with the axial positions (Figure 2.13). 
Although these protons in 157 (cis-149) and 159 (trans-150) all have a multiplet 
splitting pattern, the large 3J coupling values resulting from the trans-diaxial 
interactions were featured in the majority of cyclic ethers. Some of the key 1H 
NMR spectroscopic data are similar to that of cyclic ether cis-143 and trans-144, 
and the relative stereochemistry was assigned using the same analytical approach. 
For example, in 157, the axial proton at C6 is assigned at δH 3.56 ppm (J = 11.0, 
2.0 Hz). The double doublet splitting pattern is due to a large 2J coupling 
constant (11.0 Hz) with the diastereotopic proton and a small 3J axial-equatorial 
coupling constant (2.0 Hz) with the proton in the equatorial position on C5. In 
159, a double doublet splitting with large J values could not be observed. The 
signal at δH 2.94-2.89 ppm (m) which integrates for two protons is assigned to 
the protons on C6 for 159. The splitting pattern for the proton in the axial position 
should be a doublet of doublet, or a triplet with large J values. However, this 
splitting pattern was not observed clearly due to overlapping with other signals.  
Figure 2.13: 1H NMR spectroscopic interpretation of 157 and 158 
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It should also be noted that 2,5-tetrahydropyrans trans-78 and cis-79 are known 
compounds previously synthesised by Duñach and co-workers in their work on 
the synthesis of rose oxide and its analogues.49 Their aluminium triflate-catalysed 
cycloisomerisation approach afforded an 86:14 mixture of trans-78 and cis-79 in 
84% yield. Both the diastereoselectivity and the yield are higher than our result 
(55:45 dr, 66% yield). However, we believe that the 1H NMR spectroscopic 
assignment for trans-78 and cis-79 reported in their paper is erroneous.49 Our 
approach to the stereochemical assignment allowed us to identify the proton at 
3.20 ppm with a triplet splitting pattern to be the axial proton on C6 in trans-78. 
The triplet splitting was due to the 3J trans-diaxial interaction between the 
protons on C6 and C5 and the large 2J coupling with the diastereotopic proton on 
C6.  
Figure 2.14: 1H NMR spectroscopic interpretation of trans-78 and cis-79 
 
Cyclic ethers 135-139 which all have alkyl substituents at the 2-position gave 
good cis diastereoselectivity ranging from 75:25-98:11. Using dihydropyran 139 
as an example, hydrogenation employing palladium on carbon furnished cis-149 
and trans-150 with 87:13 dr (Scheme 2.28).  
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Scheme 2.28: Hydrogenation of 2,5-disubstituted dihydropyran 139 
 
The following is our attempt to rationalise the diastereoselectivity observed in 
the hydrogenation of cyclic ethers 135-139 with an alkyl substituent. First, the 
conformation of the dihydropyran needs to be considered. The two possible 
half-chair conformations for dihydropyran 135 are shown in Figure 2.15. On 
inspection, conformer 160 would be predicted to be the more stable conformation; 
conformer 161 is higher in energy due to the 1,3-diaxial interaction between the 
cyclohexyl group and the pseudo-axial hydrogen atom.  
Figure 2.15: Conformation of 2,5-disubstituted dihydropyran 160 
 
DFT calculations using both B3LYP/6-31G** and MP2/6-31G** levels of 
theory were carried out on the two conformations of dihydropyran 139 (Figure 
2.16). It was found that conformer 161 is 23 kJ mol-1 higher in energy than that 
of conformer 160 at the B3LYP/6-31G** level, and 17 kJ mol-1 higher in energy 
at the MP2/6-31G** level. DFT calculations for dihydropyran 139 in the 
half-boat conformations for either a pseudo-equatorial or pseudo-axial 
substituent were also attempted. However, those conformers were too high in 
energy and relaxed to the half-chair conformations. 
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Figure 2.16: Energy minimized structures for dihydropyran 139 
              
          160                                161 
B3LYP/6-31G**:  0 kJ mol-1                          23 kJ mol-1 
MP2/6-31G**:      0 kJ mol-1                          17 kJ mol-1 
In the hydrogenation process, provided both hydrogen atoms are added to the 
alkene in a syn fashion, the face of the attack on the alkene would determine the 
configuration of the product, i.e. when the hydrogen atoms are added opposite to 
the R group, it would result in cis-149, and when the hydrogen atoms are added 
from the same face as the R group, trans-150 is formed (Figure 2.17). This 
suggests that in the energetically more stable conformer 160, both cis and trans 
diastereoisomers are likely to be formed in approximately equal amounts. This is 
due to both the top and bottom face being equally accessible, since there is no 
distinguishable steric hindrance. This can also be seen in the calculated DFT 
conformer 160. Hence the hydrogen atoms on the catalyst surface could attack 
the double bond from either face. However, this is at odds with the results we 
observed (e.g. 87:13 mixture of cis-149 and trans-150). 
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Figure 2.17: Rationale for the stereoselective hydrogenation of 160 
 
In order to explain the observed cis selectivity, we suggest that the reaction could 
proceed via the less favorable conformation 161. In conformer 161, the 
pseudo-axial cyclohexyl group would block the top face, so the hydrogen atoms 
could only attack the alkene from the more accessible bottom face, which is 
opposite to the cyclohexyl group, to furnish cis-149 (Figure 2.18). Although 
conformer 161 is higher in energy, it could be more reactive in the hydrogenation 
process under the palladium on carbon conditions and the equilibrium of the 
dihydropyran conformers 160 and 161 will shift to facilitate the progression of 
the reaction. 
Figure 2.18: Rationale for the stereoselective hydrogenation of 161 
 
This could explain the cis diastereoselectivity observed from the hydrogenation 
reaction when the R groups are alkyl substituents. However, with a t-butyl 
substituent, this theory does not apply due to the locking effect of the bulky 
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group. At this time, we do not have a suitable explanation for the high cis 
diastereoselectivity observed in the formation of cis-143 and trans-144. 
In the hydrogenation of phenyl-substituted dihydropyran 13, a 55:45 
diastereomeric ratio of cis-79 and trans-78 was obtained. This could be explained 
by considering the potential coordination of the dihydropyran 13 to the catalyst 
surface. The two possible conformations for dihydropyran 13 are shown in 
Figure 2.19. The steric argument discussed earlier is also appropriate for 
conformer 162 which would provide the cis diastereoisomer (cis-79). In 
conformer 163, when the phenyl group is in the pseudo-equatorial position, the π 
system from the phenyl group could coordinate with the catalyst surface from 
either the bottom or the top face. However, when the molecule approaches the 
catalyst surface from the top, there is another potential favorable coordination 
arising from the axial oxygen lone pair. Therefore, we suggest that the hydrogen 
atoms are more likely to attack the alkene from the top face to give trans-78. As 
a result, approximately equal reactivity from conformers 162 and 163 could 
occur to give the 55:45 dr observed. 
Figure 2.19: Rationale for the stereoselective hydrogenation of 162 and 163 
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In dihydropyran 140, the phenyl group is further away from the oxygen atom, 
and there is flexibility in the alkyl chain. Therefore, the interaction of the π 
system from the phenyl group with the catalyst is less significant, the steric 
factors dominate and most of the reaction proceeds via the axial conformer. 
Therefore, the cis/trans diastereoselectivity for cyclic ether 140 (65:35 dr) is 
higher than for cyclic ether 13 (55:45 dr), but is lower than when the substituents 
are alkyl groups. 
Next, we decided to carry out hydrogenation using other catalysts to study their 
effect on the diastereoselectivity. To start with, hydrogenation of cyclic ether 138 
was performed using heterogeneous Adam’s catalyst (platinum(II) oxide) in 
methanol at rt for 1 h. A low conversion (35%) to a 55:45 mixture of cis-147 and 
trans-148 was calculated from the 1H NMR spectrum of the crude mixture. Thus, 
much lower diastereoselectivity with Adam’s catalyst was observed. When the 
same reaction conditions were used with phenyl-substituted ether 13, only a 
small amount (<10%) of the alcohol 153 resulting from benzylic ether cleavage 
was seen: no evidence for the formation of cyclic ether trans-78 or cis-79 was 
observed in the 1H NMR spectrum of the crude product. 
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Scheme 2.29: Hydrogenation of dihydropyrans 138 and 13 
In contrast, more interesting results were obtained using homogenous 
hydrogenation with Wilkinson’s catalyst [(PPh3)2RhCl]. The results are 
presented in Table 2.7. For example, with dihydropyran 138, a 70:30 mixture of 
cyclic ether trans-147 and cis-148 was generated (entry 2). A similar result was 
also obtained for cyclic ether 13 (entry 4).  
Table 2.7: Hydrogenation of dihydropyrans 138 and 13 
 
Entry Compound R Time (h) Conversion 
(%)a 
Product trans:cis 
(crude)b 
1 138 n-C5H11 1 10 148 147 n.dc 
2 138 n-C5H11 16 60 148 147 70:30 
3 13 Ph 1 10 78 79 n.d 
4 13 Ph 16 20 78 79 75:25 
a Conversion determined from the 1H NMR spectrum of the crude product. b Diastereomeric ratio 
determined from the 1H NMR spectrum of the crude product. c n.d. = Not determined. 
Although we have now identified reaction conditions for a complementary route 
to trans-148 and cis-147 and trans-78 and cis-79, the rate of hydrogenation using 
Wilkinson’s catalyst was considerably slower than with the two heterogeneous 
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catalysts (palladium on carbon and platinum oxide). For example, when the 
reaction mixture was stirred at rt for 1 h, only 10% conversion to cyclic ethers 
trans-148 and cis-147 and trans-78 and cis-79 was observed (entries 1 and 3). 
With a prolonged reaction time of 16 h, 60% conversion was calculated from the 
1H NMR spectrum of the crude product for cyclic ether trans-148 and cis-147 
(entry 2), but formation of cyclic ether trans-78 and cis-79 had only proceed to  
20% conversion (entry 4). 
There are precedents for the slow conversion of the trisubstituted alkene of 
dihydropyrans such as 138 and 13 towards hydrogenation with Wilkinson’s 
catalyst.59, 60 For example, when hydrogenation was carried out with Wilkinson’s 
catalyst, the trisubstituted alkene in 164 was unreactive at atmospheric pressure 
and rt, and even at 100 psi and 50 ºC (Scheme 2.30). The slow reaction was 
attributed to the steric hindrance of the trisubstituted double bond, which renders 
it less able to coordinate to the rhodium.  
Scheme 2.30: Hydrogenation of alcohol 164 
 
The same study also showed that when a metal alkoxide was employed together 
with 3.6 mol% of the rhodium catalyst, the reaction proceeded with 7-68% yield 
depending on the metal used (potassium > sodium > lithium) and afforded 
cis-165 exclusively. The proposed mechanism is shown in Scheme 2.31. The 
protonated alcohol in tricyclic compound 164 is not nucleophilic enough to 
displace the chloride ligand. However, formation of the potassium alkoxide 
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resulted in effective displacement of the chloride ligand. Therefore, the hydrogen 
atoms, alkene and the directing group are all associated to the rhodium, and 
hydrogen atoms were delivered from the same face to afford cis-165. 
Scheme 2.31: Hydrogenation of 166 
 
Methyl ethers have also been shown to effectively bind to cationic rhodium to 
give good levels of diastereoselectivity via metal-directed hydrogenation.61 For 
example, bicyclic methyl ether 168 was hydrogenated with a rhodium-based 
catalyst 171 to afford an 85:15 mixture of saturated ethers trans-169 and cis-170.  
Scheme 2.32: Stereoselective hydrogenation of ether 168 
 
Although no precedent was found for cyclic ethers as directing groups in 
hydrogenation reactions, we believe such an effect can explain the observed 
trans diastereoselectivity for formation of cyclic ethers trans-148 and cis-147 
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and trans-78 and cis-79. Treatment of dihydropyran 138 and 13 with Wilkinson’s 
catalyst under hydrogen at rt for 16 h furnished cyclic ethers trans-148 and 
cis-147 and trans-78 and cis-79 with 70:30 and 75:25 dr respectively, 
predominately as the trans product. The reaction intermediate for dihydropyran 
13 is proposed as shown in Figure 2.20. In conformer 172, the rhodium metal 
could coordinate with the oxygen atom as well as the alkene from the top face. 
Hence, hydrogen would be delivered from the top face which led the formation 
of trans-78. 
Figure 2.20: Rationale for the stereoselective hydrogenation of 172 
 
In conformer 173, there is also the potential of a favorable association between 
the π-system in the phenyl group and rhodium, which would also lead to the 
diastereoisomer trans-78. These are shown in Figure 2.21.  
Figure 2.21: Rationale for the stereoselective hydrogenation of 173 
 
Even though both conformations for dihydropyran 13 could coordinate to the 
rhodium, the hydrogen would be delivered from the top face in both cases to give 
trans-78. Hence, the stereochemistry for formation of cyclic ethers trans-78 and 
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cis-79 showed predominately trans diastereoselectivity using Wilkinson’s 
catalyst. 
Finally, since the overall aim of preparing 2,5-disubstituted THPs was to 
investigate their odour properties, cyclic ethers 78, 79 and 141-152 were 
submitted for olfactory evaluation at Givaudan. The odour profiles are presented 
in Table 2.8. It was interesting to see that some ethers possess a floral note, while 
the majority has citrus odour. Unfortunately, none of the compounds synthesised 
had sufficiently interesting odours for further exploration by Givaudan. 
Table 2.8: Olfactory evaluation of THPs 
Entry Cyclic ether Odour Profile 
1 cis-141 and 
trans-142 
floral, indolic 
2 cis-143 and 
trans-144 
chemical, woody, dusty 
3 cis-145 and 
trans-146 
citrus, zesty 
4 cis-147 and 
trans-148 
peachy, lactonic 
5 cis-149 and 
trans-150 
overwhelmingly citrus, zesty 
6 cis-79 a d trans-78 citrus, zesty, slightly minty 
7	   cis-151 and 
trans-152	  
citrus, chemical 
 
To summarise, we have developed a route for the synthesis of 2,5-disubstituted 
tetrahydropyrans in a racemic fashion via Grignard addition to aldehydes,  
O-alkylation, ring-closing metathesis and hydrogenation. This procedure 
generates products in good yield and generally gives good 
cis-diastereoselectivity from the hydrogenation reaction. A lower yielding route 
to trans-148 and trans-78 was also developed. 
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2.6 Attempted Synthesis of Oxa-Orange Flower Ether 
Having investigated the Grignard addition, O-alkylation and ring-closing 
metathesis route for the synthesis of 2,5-disubstituted THPs 78, 79 and 141-152, 
we then decided to apply the methodology to one of the target molecules, namely 
oxa-orange flower ether 52, which is closely related to the perfumery ingredient 
orange-flower ether (Figure 2.22).  
Figure 2.22: Design of oxa-orange flower ether 52 
 
The first part of the retrosynthetic analysis of oxa-orange flower ether 52 is 
shown in Scheme 2.33. Thus, it was envisaged that the methyl ether in 52 will be 
constructed by O-methylation of the tertiary alcohol 174, which would be 
obtained by hydrogenation of alkene 175.  
Scheme 2.33: Retrosynthetic analysis of oxa-orange flower ether 52 
 
The remainder of the retrosynthetic analysis is shown in Scheme 2.34. It was 
anticipated that treatment of vinyl bromide 176 with magesium would result in 
the formation of a Grignard reagent in situ, which could then be reacted with 
acetone to afford tertiary alcohol 175. The cyclic vinyl bromide 176 could be 
constructed by ring-closing metathesis from the terminal diene 177, which in turn 
would be obtained by O-alkylation of commercial pent-4-en-2-ol 178. 
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Importantly, vinyl bromide 176 is also a strategic point for the divergent 
synthesis of a variety of analogues of 175 using, for example, Pd-catalysed 
coupling processes. Alternatively, a different synthetic strategy for the 
preparation of oxa-orange flower ether 52 is also presented (Scheme 2.34). In 
this approach, the bromide in 177 is replaced with an ester functionality (180). 
Thus, tertiary alcohol 175 would be prepared by means of a double addition of 
methyl magnesium halide to ester 179. The diene-ester 180 itself would be 
synthesised from pent-4-en-2-ol 178. It was hoped that the electron-withdrawing 
nature of the ester moiety might aid the desired O-alkylation. 
Scheme 2.34: Retrosynthetic analysis of ether 175 
 
The attempted synthesis of oxa-orange flower ether 52 began with the 
O-alkylation of pent-4-en-2-ol 178 with 2,3-dibromopropene. Given the volatility 
of the product derived from addition to pent-4-en-2-ol 178, and the potential 
difficulties associated with its isolation, the less volatile 1-phenylbut-3-en-1-ol 
127 was also used as a starting material. Thus, secondary alcohols 127 and 178 
were each treated with sodium hydride and 2,3-dibromopropene and the mixtures 
refluxed for 16 h. On inspection of the 1H NMR spectrum of the crude products, 
no reaction had taken place (Table 2.9, entries 1 and 2). With an extended 
reaction time of 72 h, we were pleased to discover that the desired bromodiene 
181 was isolated in 33% yield (entry 3). However, in the case of alcohol 178, the 
reaction resulted in a complex mixture (entry 4).  
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Table 2.9: O-Alkylation of alcohols 127 and 178 
 
Entry Compound R Time (h) Product Yield (%)a 
1 127 Ph  16 181 0 
2 178 Me  16 177 0 
3 127 Ph  72 181 33 
4 178 Me  72 177 0 
a Yield after purification by chromatography. 
As the yield of 181 was only moderate and the O-alkylation of pent-4-en-2-ol 
178 was not successful, phase transfer catalysis conditions (based on literature 
precedent62) were investigated. Thus, homoallylic alcohols 127 and 178 were 
treated with 2,3-dibromopropene, in the presence of cetyltrimethylammonium 
bromide in a biphasic mixture of aqueous sodium hydroxide and 
dichloromethane (Table 2.10). 
Table 2.10: O-Alkylation of alcohols 127 and 178 
 
Entry Compound R Time (h) Product Yield (%)a 
1 127 Ph  1 181 19 
2 178 Me  1 177 0 
3 127 Ph  16 181 11 
4 178 Me  16 177 7 
a Yield after purification by chromatography. 
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In the case of alcohol 127, the desired bromodiene 181 was isolated in 19% yield 
from a 1 h reaction (entry 1), whereas under the same conditions, O-alkylation of 
alcohol 178 was unsuccessful (entry 2). With a prolonged reaction time of 16 h, 
the yield of bromodiene 181 was still low (11%, entry 3). However, we were 
pleased to find that bromodiene 177 could finally be isolated, albeit in a low (7%) 
yield (entry 4). As these results were not satisfactory, we turned our attention to 
the alternative route. 
Using a literature procedure,63 bromoester 184 was prepared from treatment of 
formaldehyde with triethylphosphonoacetate 182 to form the crude alcohol 183. 
Phosphorus tribromide was then added to give the crude product. Purification by 
Kügelrohr distillation afforded bromoacrylate 184 in 30% yield. 
Scheme 2.35: Synthesis of bromoacrylate 184 
 
We then carried out the O-alkylation of phenyl homoallylic alcohol 127 with 
sodium hydride and bromoacrylate 184 in THF at rt for 24 h.64 However, no 
conversion to product 185 could be detected. The O-alkylation with 
pent-4-en-2-ol 178 under the same reaction conditions was then performed, and 
the result was also disappointing: no desired product could be observed in the 1H 
NMR spectrum of the crude product. It was anticipated that a higher reaction 
temperature could in principle facilitate product formation. Thus, alcohol 127 
was treated with sodium hydride and bromide 184 in THF at reflux for 16 h. This 
69 
 
resulted in a mixture of unidentified compounds. The desired product 185 was 
also not detected using mass spectrometry on the crude product. 
Scheme 2.36: Attempted O-alkylations of alcohols 127 and 178 
 
When the same O-alkylation conditions using sodium hydride was performed on 
alcohol 125, a 24% yield of diene-ester 186 was obtained (Scheme 2.37). 
Following a literature procedure,65 we then carried out O-alkylation of alcohol 
125 using n-BuLi followed by trapping with bromide 184. Thus, alcohol 125 was 
deprotonated using n-BuLi in the presence of CuI in THF at _78 ºC, and the 
intermediate formed was then trapped with bromide 184. Diene 186 was isolated 
in 14% yield together with 58% recovered starting material 125. On comparison 
with the 24% yield obtained using sodium hydride and alcohol 125, neither the 
conversion or the isolated yield of the desired product was improved using this 
procedure. These results suggest the bromoacrylate 184 traps slowly under these 
reaction conditions so that the starting material was recovered. 
Scheme 2.37: Synthesis of diene 186 
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Although we were able to obtain diene-ester 186, the reaction was not robust 
enough to produce a large amount of material. Therefore, the synthesis of 
oxa-orange flower ether 52 was not pursued further. 
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2.7 Asymmetric Deprotonation and Ring Closing Metathesis 
Route to Enantioenriched Oxygen Heterocycles 
In this section, an investigation of a route for the synthesis of 2,5-disubstituted 
THPs via asymmetric deprotonation and ring closing metathesis is described 
(Scheme 2.38). Thus, the enantioenriched alcohols 188 would be synthesised 
from O-alkyl carbamates 187 via asymmetric deprotonation using s-BuLi and the 
chiral diamine (_)-sparteine. O-Alkylation using allyl bromides, ring closing 
metathesis and hydrogenation (as described in Section 2.5) would ultimately 
afford the enantioenriched 2,5-disubstituted THPs 189. 
Scheme 2.38: Proposed synthesis of THP 189 
 
2.7.1 Background Literature on Asymmetric Deprotonation of O-Alkyl 
Carbamates 
The asymmetric deprotonation of O-alkyl carbamates was first reported by 
Hoppe and co-workers in 1990.66 An example is shown in Scheme 2.39. In this 
reaction, a complex of s-BuLi and the chiral diamine (_)-sparteine is used to 
affect the lithiation of an O-alkyl carbamate such as 190. The reaction proceeds 
via preliminary complexation of the s-BuLi/(_)-sparteine complex to the 
carbamate oxygen. This brings the reactive complex into the correct arrangement 
to abstract an α proton to form the lithiated species 191. The lithiated species 191 
can then be trapped with CO2 to give carboxylic acid (R)-192 in 75% yield 
and >97:3 er (Scheme 2.39). 
72 
 
Scheme 2.39: Asymmetric lithiation/trapping of carbamate 190 
 
Hoppe has extensively studied this type of O-alkyl carbamate methodology.67 In 
2004, Hoppe and co-workers reported the application of the asymmetric 
lithiation of O-alkyl carbamates to the synthesis of enantioenriched alcohols 
(Scheme 2.40).68 For example, treatment of carbamate 193 with 
s-BuLi/(_)-sparteine in Et2O at _78 ºC for 5 h was followed by trapping with 
tri-i-propylborate.  
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Scheme 2.40: Asymmetric synthesis of alcohol (R)-196 
 
Then, transesterification took place by treating the crude organoboron compound 
with pinacol in the presence of p-toluenesulfonic acid and MgSO4. The boron 
ester (S)-194 was isolated in 90% yield with >97:3 er. Addition of a Grignard 
reagent followed by alkyl migration in an intermediate ‘ate’ complex furnished 
boronate (S)-195. Finally, oxidative work-up afforded alcohol (R)-196 in high 
yield (70%) and enantioselectivity (>97:3 er). 
Building on this work, Aggarwal and co-workers developed an iterative 
homologation of boronic esters using lithiated O-alkyl carbamates to build up a 
molecule bearing two adjacent stereocentres with high diastereo- and 
enantioselectivities (Scheme 2.41).69 First, O-alkyl carbamate 193 was 
deprotonated using s-BuLi/(_)-sparteine and then trapped with tri-i-propylborate. 
Transesterification gave boronate ester (S)-197. Then, asymmetric deprotonation 
of O-alkyl carbamate 198 was carried out with s-BuLi/(_)-sparteine to give the 
lithiated species, which was reacted with boronate ester (S)-197 as an 
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electrophile to form the ‘ate’ complex. This was then rearranged by migration of 
a ligand group from boron to an electron deficient carbon. The leaving group 
here is the carbamate group, which was replaced by the ligand group with 
inversion of configuration to give boronate (1R,2R)-199. After oxidative work-up, 
alcohol (1S,2R)-200 was obtained in 82% yield, >98:2 er and 96:4 dr. By using 
s-BuLi/(+)-sparteine surrogate 203 complex, diastereoisomeric alcohol 
(1S,2S)-202 was formed in 63% yield,  >98:2 er and 96:4 dr. 
Scheme 2.41: Diastereoselective synthesis of alcohols (1S,2R)-200 and 
(1S,2S)-202 
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2.7.2 Synthesis of Cyclic Ethers via Asymmetric Deprotonation 
Our plan was to use the Hoppe-Aggarwal methodology to synthesise some 
enantioenriched alcohols for conversion into THPs. To start with, O-alkyl 
carbamate 193 was prepared using a procedure developed by Hoppe et al.70  
Deprotonation of 3-phenylpropanol with sodium hydride followed by 
nucleophilic attack of the deprotonated alcohol on di-i-propylcarbamoyl chloride 
gave O-alkyl carbamate 193 in 83% yield after purification by flash column 
chromatography (Scheme 2.42). 
Scheme 2.42: Synthesis of carbamate 193 
 
As a test reaction, asymmetric lithiation was first carried out on carbamate 193 
using s-BuLi/(_)-sparteine. Trapping with benzaldehyde gave diastereomeric 
alcohols syn-(1R,2R)-204 and anti-(1R,2S)-205 in 73% yield as an inseparable 
mixture. A 70:30 mixture of alcohols syn-(1R,2R)-204 and anti-(1R,2S)-205 was 
observed (by 1H NMR spectroscopy). The ratio was determined by integration of 
the signals due to OCHPh: δH 5.12-5.08 (m) for anti-(1R,2S)-205 and δH 
5.06-5.01 (m) for syn-(1R,2R)-204. The relative stereochemistry was assigned 
based on other work carried out in the group.71  
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Scheme 2.43: Lithiation/trapping of carbamate 193 
 
Then, the asymmetric deprotonation/trapping with tri-i-propyl borate was 
investigated. Thus, carbamate 193 was lithiated using s-BuLi/(_)-sparteine and 
trapped with tri-i-propyl borate. Transesterification was achieved by treating the 
crude organoboron compound with pinacol in the presence of p-toluenesulfonic 
acid based on Hoppe’s procedure.68  Boron ester (S)-194 was isolated in 74% 
yield over these three steps after purification by column chromatography 
(Scheme 2.44). 
Scheme 2.44: Lithiation/trapping of carbamate 193 
 
With the enantioenriched boronate ester (S)-194 in hand, we were able to access 
the corresponding vinyl alcohol (R)-208 and allyl alcohol (R)-128 in 52% and 54% 
yield respectively, by treating boronate ester (S)-194 with vinyl and allyl 
Grignard reagents respectively, followed by oxidative work-up (Scheme 2.45). 
Using CSP-HPLC, alcohol (R)-128 was shown to be formed in 99:1 er, whereas 
alcohol (R)-208 had 91:9 er. The er of the alcohols should be the same as the er 
of the starting boronate ester (S)-194. It is therefore surprising that alcohols 
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(R)-208 and (R)-128 do not have the same er. It appears that 
addition-rearrangement of the vinyl Grignard reagent to the boronate ester 
(S)-194 proceeds with some loss of er. A slight erosion of enantioselectivity has 
also been reported for other carbamates and boronates, and is likely to be due to a 
lack of stereospecifity in the boronate rearrangement. 71-73 
Scheme 2.45: asymmetric synthesis of alcohols (R)-208 and (R)-128 
 
The enantioenriched alcohols (R)-208 and (R)-128 were then reacted with 
sodium hydride and allyl bromide to give (R)-209 and (R)-211 in 59% and 57% 
yield respectively.22 Ring-closing metathesis was carried out using Grubbs’ 1st 
generation catalyst 4 to give (R)-210 and (R)-212 in 59% and 60% yield.23 The er 
of (R)-210 and (R)-212 are assumed to be the same as in (R)-208 and (R)-128 
(Scheme 2.46).  
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Scheme 2.46: Synthesis of dihydropyrans (R)-210 and (R)-212 
 
We then decided to synthesise cyclic ether (S)-212, the enantiomer of the 
previously synthesised (R)-212. The (+)-sparteine surrogate 203 has shown 
particularly high enantioselectivity as a ligand for organolithium reagents and 
generates the opposite enantiomer to (_)-sparteine in a range of reactions.74-76 
Hence, the stereochemistry in (S)-212 could be introduced in the asymmetric 
lithiation step using diamine 203 in place of (_)-sparteine. However, the 
stereochemistry at the stereogenic centre could also be inverted using 
(_)-sparteine as the diamine ligand but reversing the addition order with 
carbamate 213 and Grignard reagent 215. Our plan is shown in Scheme 2.47. 
Thus, deprotonation of O-alkyl carbamate 213 using s-BuLi/(_)-sparteine and 
trapping with tri-i-propylborate followed by transesterification would give 
boronate ester (S)-214. Addition of Grignard reagent 215 and boronate 
rearrangement would then furnish alcohol (S)-128. Finally, alkylation with allyl 
bromide and subsequent ring closing metathesis would afford cyclic ether 
(S)-212.  
79 
 
Scheme 2.47: Proposed synthesis of dihydropyran (S)-212 
 
O-Alkyl carbamate 213 was synthesised in 90% yield from 3-butene-1-ol. Next, 
we studied the deprotonation of carbamate 213 using methyl chloroformate and 
benzaldehyde as electrophiles (Scheme 2.48).  
Scheme 2.48: Synthesis and lithiation/trapping of carbamate 213 
 
Unfortunately, neither reaction gave satisfactory results (Scheme 2.48). Ester 
(R)-216 was isolated in only 19% yield. With benzaldehyde, alcohol 217 was 
isolated in only 24% yield and starting carbamate 213 was recovered in 65% 
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yield. Due to the low yield, the er of each product (R)-216 and 217 was not 
determined. 
We believe that the problem with the lithiation-trapping of O-alkyl carbamate 
213 can be explained as follows. Treatment of carbamate 213 with s-BuLi could 
result in competitive allylic deprotonation to give 218 and subsequent 
β-elimination of the carbamate would then furnish butadiene (Scheme 2.49). 
Such a process has been suggested previously by Aggarwal et al.77 Since the 
deprotonation of carbamate 213 gave disappointing yields, trapping with 
tri-i-propyl borate and the synthesis of cyclic ether (S)-212 were not pursued 
further. 
Scheme 2.49: Proposed mechanism for the formation of butadiene 
 
An alternative strategy towards the synthesis of alcohol (S)-128 was also 
proposed. This involves sulfoxide → magnesium exchange on an α-alkoxy 
sulfoxide such as anti-219 to generate the chiral α-functionalised Grignard 
reagents 220 in ≥99:1 er. Subsequent trapping with allyl boronate and oxidative 
work-up of the boron intermediate would then furnish enantioenriched alcohol 
221 (Scheme 2.50). 
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Scheme 2.50: Proposed synthesis of alcohol 221 
 
The synthesis of enantioenriched sulfoxides such as anti-219 and the sulfoxide 
→ magnesium exchange procedure have been recently developed in our group71 
as a route to enantiomerically pure products derived from O-alkyl carbamates. 
For example, lithiation of carbamate 193 using s-BuLi/(_)-sparteine and trapping 
with Andersen’s sulfinate (Ss)-224 furnished sulfoxide anti-(S,Ss)-222 in 53% 
yield and 99:1 er, together with syn-(R,Ss)-223 (Scheme 2.51). This enhancement 
of enantiomeric ratio is due to the combination of two chiral species combining 
in the same reaction.69 Then, sulfoxide → magnesium exchange on sulfoxide 
anti-222 using i-propyl magnesium chloride followed by trapping with methyl 
chloroformate afforded ester (R)-225 in 73% yield and 99:1 er.  
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Scheme 2.51: Synthesis of ester (R)-225 via sulfoxide → magnesium 
exchange 
 
Although there has been much work on the use of α-alkoxy sulfoxides in our 
group, catalytic asymmetric deprotonation and trapping with Andersen’s 
sulfinate (Ss)-224 has not previously been carried out. In addition, we also 
planned to determine if the enantioselectivity could be maintained using a 
Grignard reagent with allylboronic pinacol ester as an electrophile, since there 
was some loss of er observed in the formation of (R)-128 from (S)-194. 
To evaluate the α-alkoxy sulfoxide approach, initial efforts were focussed on 
racemic reactions. Thus, carbamate 193 was treated with s-BuLi in the presence 
of TMEDA in Et2O at _78 ºC for 1 h. Addition of the reaction mixture to a 
solution of methyl p-toluenesulfinate in Et2O gave a 60:40 mixture of 
diastereomeric sulfoxides anti-rac-226 and syn-rac-227 (based on the 1H NMR 
spectrum of the crude product). After purification by column chromatography, 
sulfoxides anti-rac-226 and syn-rac-227 were isolated in 32% and 23% yield 
respectively (Scheme 2.52). 
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Scheme 2.52: Synthesis of sulfoxides anti-rac-226 and syn-rac-227 
 
Next, we attempted sulfoxide → magnesium exchange, boronate trapping and 
oxidation to give allylic alcohol 128. There is precedent in the group for the use 
of i-propyl magnesium chloride to facilitate the exchange reaction. Thus, 
treatment of anti-rac-226 with i-propyl magnesium chloride in THF at rt for 1 
min, followed by trapping with allylboronic pinacol ester afforded boronate 229 
via a 1,2-metalate rearrangement of the ate-complex 228. It was then further 
oxidised to the alcohol 128 using NaOH/H2O2. Initially, after sulfoxide → 
magnesium exchange, intermediate 228 was stirred at rt for 30 min before 
refluxing, and the subsequent oxidation of the boronate 229 was carried out over 
2 h. This gave alcohol 128 in a low 28% yield (Conditions A, Scheme 2.53). The 
reaction time was then prolonged from 2 h to 4 h after the addition of 
allylboronic pinacol ester, as well as a longer reaction time for the conversion to 
the alcohol. This led to an improved result and gave alcohol 128 in a respectable 
56% yield (Conditions C). 
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Scheme 2.53: Investigation of different rearrangement conditions 
 
Having established a suitable procedure for the racemic lithiation/trapping of 
O-alkyl carbamate 193 followed by sulfoxide → magnesium exchange, we then 
moved on to development of the asymmetric lithiation/trapping using catalytic 
asymmetric deprotonation. Our group has previously developed a two-ligand 
catalytic system, and this methodology has been applied to the asymmetric 
lithiation of N-Boc pyrrolidine and an O-alkyl carbamate.78 In both cases, the 
best enantioselectivity at a specific loading of the chiral diamine was obtained 
with diamine 203. Therefore, the use of (+)-sparteine surrogate 203 in 
sub-stoichiometric amounts was explored. Thus, carbamate 193 was lithiated 
with s-BuLi/achiral diamine 230 in the presence of just 0.2 eq. of diamine 203 
followed by trapping with Andersen’s sulfinate (Ss)-224. Encouragingly, 
sulfoxide anti-(S,Ss)-222 was obtained in 13% yield and 85:15 er, together with 
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syn-(R,Ss)-223 in 19% yield and 99:1 er (Scheme 2.54). The stereochemistry was 
assigned by comparison with other work in the group.71  
Scheme 2.54: Catalytic asymmetric lithiation/trapping of carbamate 193 
 
Before optimizing the lithiation-trapping further, the sulfoxide → magnesium 
exchange with syn-(R,Ss)-223 was investigated. Using the optimised condition 
previously developed, sulfoxide syn-(R,Ss)-223 was transformed into alcohol 
(S)-128 in 19% yield and 93:7 er (Scheme 2.55). Comparison with the product 
formed via the asymmetric lithiation approach (see Scheme 2.54) proved that the 
reaction proceeded with retention of configuration at carbon. There was a slight 
decrease in enantioselectivity for the 1,2-metelate rearrangement. Blakemore had 
shown that a higher enantioselectivity could be retained using Li-carbenoid 
instead of Mg-carbenoid, although the use of an allyl substituent as a migrating 
group was not studied.79, 80 However, there was insufficient time to optimise this 
reaction further. 
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Scheme 2.55: Synthesis of alcohol (S)-128 via sulfoxide → magnesium 
exchange 
 
To summarise, we have demonstrated that cyclic ethers (R)-210 and (R)-212 
could be synthesised in high yield and er via an asymmetric deprotonation, 
O-alkylation and ring-closing metathesis approach (Figure 2.22). The catalytic 
asymmetric lithiation of carbamate 193 and trapping with Andersen’s sulfinate 
(Ss)-224 was less successful. An approximately 50:50 mixture of sulfoxides 
anti-(S,Ss)-222 and syn-(R,Ss)-223 were furnished in low yield. Although the 
sulfoxide → magnesium exchange protocol to (S)-128 was developed, there was 
a loss of er in the rearrangement step. 
Figure 2.22 
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2.8 Conclusions and Future Work 
In conclusion, the synthesis of 2,5-disubstituted THPs via alkylation, reduction 
and cyclisation was investigated. Alcohols 116 and 117 were obtained using this 
route and we were able to broaden the reaction scope by introducing a benzyl 
group as one of the substituents via alkylation. However, cyclisation of these 
compounds was not successful. Therefore, we were unable to access the 
2.5-disubstituted THPs utilising this approach. 
In contrast, the Grignard addition, ring-closing metathesis and hydrogenation 
approach was identified as a route to 2,5-disubstituted tetrahydropyrans in a 
racemic fashion. Using this route, seven potential perfumery compounds were 
produced. Moreover, when the R group is an alkyl substituent, high cis 
selectivity in the range of 83:17 to 89:11 dr was observed from the 
hydrogenation reaction (Scheme 2.56). 
Scheme 2.56: Hydrogenation of THP 121 
 
Two other hydrogenation catalysts (Wilkinson’s catalyst and Adam’s catalyst) 
were tested and we were pleased to find a complementary diastereoselectivity in 
the hydrogenation step, i.e. the trans-diastereomer was the major product. In a 
key example, using Wilkinson’s catalyst [(PPh3)3RhCl], cyclic ethers trans-78 
and cis-79 were generated in 75:25 dr (Scheme 2.57). However, the rate of 
conversion to the cyclic ether was much slower. 
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Scheme 2.57: Hydrogenation of dihydropyran 13 
 
The synthesis of cyclic ethers (R)-210 and (R)-212 (Figure 2.23) via asymmetric 
deprotonation followed by ring-closing metathesis has also been developed. 
Chiral alcohols (R)-208 and (R)-128 were synthesised via asymmetric 
deprotonation in 52% and 54% yield respectively. Then, ring closing metathesis 
was used to form the 5- and 6-membered oxygen heterocycles (R)-219 and 
(R)-212 in 57% and 60% yield. 
Figure 2.23: Structures of dihydropyrans (R)-210 and (R)-212 
 
Enantioenriched sulfoxide syn-(R,Ss)-223 was synthesised in 19% yield and 99:1 
er by catalytic asymmetric deprotonation and trapping with Andersen’s sulfinate 
(Ss)-224. We have shown that treatment of sulfoxide syn-(R,Ss)-223 with 
i-propyl magnesium chloride at rt for 1 min, and trapping with allyl boronic 
pinacol ester followed by oxidative work-up proceeds mostly with retention of 
stereochemistry. Thus, alcohol (R)-128 was synthesised using this protocol in 19% 
yield and 93:7 er (Scheme 2.58). 
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Scheme 2.58: Synthesis of ester (S)-128 via sulfoxide → magnesium 
exchange 
Although O-alkylation with hetero-homoallyl substituents as electrophiles has 
proved difficult, future work on the synthesis of oxa-orange flower ether 52 
could involve a detailed study of the O-alkylation of alcohol 178. This should 
involve the use of using other electrophiles, e.g. 3-bromoprop-1-yne, to provide a 
synthetic handle (Scheme 2.59). 
Scheme 2.59: Proposed synthesis of oxa-orange flower ether 52 
Future work on the investigation of the loss of er from sulfoxide → magnesium 
exchange might involve the employment of an organolithium reagent to furnish a 
lithiated carbamate. In 2006, Blakemore and co-workers reported the use of 
enantioenriched α-chloroalkyllithium regents and trapping with boronic esters in 
good yields.80 Higher enantioselectivity was observed when lithium was 
compared to magnesium. We could also investigate whether use of a lithium 
carbamate could improve the enantioselectivity (Scheme 2.60). Furthermore, if 
the sulfoxide → lithium exchange and trapping with allyl boronic ester still 
proceeds with loss of er, this would indicate that the lack of stereospecifity is due 
to the use of an allyl migrating group. 
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Scheme 2.60: Proposed route to alcohol (S)-128 
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Chapter 3. Asymmetric Synthesis of Phosphine 
Heterocycles 
This part of the thesis contains the results of a project aimed at developing new 
methodology for the asymmetric synthesis of P-stereogenic phospholene boranes 
2 (Figure 3.1) via lithiation/trapping of phosphine boranes and ring-closing 
metathesis. Section 3.1 describes a brief overview of the utility of a 
commercially available racemic phosphine oxide rac-231 (Figure 3.1) in 
catalytic reactions. Then, the aims of this project are discussed. Section 3.2 starts 
with a literature summary of the asymmetric lithiation/trapping of phosphine 
boranes. Then, the synthesis of several diamine ligands is described, followed by 
the results of their use in the lithiation/trapping of phosphine borane 285. Two 
strategies to access P-stereogenic phospholene boranes are provided in Section 
3.3. Then, the synthesis of a cyclic phosphine borane in a racemic fashion is 
discussed. Finally, we focus on the asymmetric synthesis of P-stereogenic 
phospholene boranes via asymmetric lithiation/trapping and subsequent 
ring-closing metathesis. 
Figure 3.1: Structures of P-stereogenic phospholene boranes and rac-231 
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3.1 Introduction 
3.1.1 Literature Background  
Chiral phosphine compounds form one of the most important class of ligands for 
the development of efficient transition metal-catalysed reactions.81-83 A selection 
of chiral phosphine compounds is shown in Figure 3.2. For ligands such as 
BINAP84 and CHIRAPHOS,85 the chirality is in the carbon backbone connecting 
the two phosphine fragments. In contrast, DIPAMP86 and TangPhos87 are 
P-stereogenic compounds, with four different substituents attached to each 
phosphorus atom. 
Figure 3.2: Phosphine-containing ligands 
 
One of the most studied metal-catalysed reactions using chiral phosphines is 
asymmetric hydrogenation. Zhang and co-workers found that TangPhos gave 
high enantioselectivity in the rhodium-catalysed asymmetric hydrogenation of 
α-(acylamino)acrylic acid and its derivatives.87 For example, rhodium-catalysed 
hydrogenation of unsaturated acid 232 using TangPhos as a catalyst afforded 
amino acid (R)-233 in >99:1 er. 
Scheme 3.1: Asymmtric hydrogenation of unsaturated acid 232 
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Although there are numerous examples of P-stereogenic chiral phosphines in 
transition metal-catalysed reactions, there are fewer examples of organocatalytic 
reactions.83 Recently, phosphine heterocycles such as phosphine oxide rac-231 
has been used in two catalytic processes: (i) catalytic aza-Wittig reactions and (ii) 
catalytic Wittig reactions.  
Figure 3.3: Phosphine oxide rac-231 
 
In 2008, Marsden and co-workers reported an aza-Wittig cyclisation in the 
synthesis of heteroaromatics using phosphine oxide rac-231 as a catalyst.88 The 
synthesis of the phenanthridine system from a range of isocyanates was explored. 
For example, isocyanates 234-236 were treated with catalytic phosphine oxide 
rac-231 (1-25 mol%) in refluxing toluene to give phenanthridines 237-239 in 
good yield (Table 3.1). With a 1 mol% loading of the catalyst and an extended 
reaction time (88 h), phenanthridine 238 was formed in 80% yield (entry 2). In 
comparison, with amide 236, which has a less electrophilic carbonyl group, the 
formation of phenanthridine 239 required a high loading of phosphine oxide 
rac-231 (25 mol%) and the yield of 239 was significantly lower (entry 3). 
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Table 3.1: Catalytic aza-Wittig cyclisations: phenanthridine synthesis. 
 
Entry Compound Product X 231 conc 
(M) 
Time 
(h) 
Yield 
(%)a 
1 234 237 OMe 25 0.03 21 87 
2 235 238 OMe 1 0.1 88 59 
3 236 239 NEt2 25 0.03 23 48 
a Yield after purification by chromatography. 
As an extension of this methodology, the synthesis of azoles was also studied 
using phosphine oxide rac-231. It was found that a broad range of alkyl 
substituents and carboxyl substituents could be employed regardless of the nature 
of those groups. For example, reaction of isocyanate ester 240 with 5 mol% of 
phosphine oxide rac-231 in refluxing toluene gave benzoxazole 243 in 87% yield 
(Table 3.2, entry 1). With electron-donating groups attached to the aromatic ring 
and to the ester, isocyanate ester 241 provided benzoxazole 244 in 59% yield 
(entry 2), whereas with two electron-withdrawing groups as substituents, 
benzoxazole 245 was formed in 48% yield (entry 3). 
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Table 3.2: Catalytic aza-Wittig cyclisations: benzoxazole synthesis 
 
Entry Compound Product R1 R2 Yield (%)a 
1 240 243 H Ph 87 
2 241 244 7-MeO 4-MeOC6H4 59 
3 242 245 5-F 4-FC6H4 48 
a Yield after purification by chromatography. 
The self-condensation of isocyanates to give carbodiimides under phosphine 
oxide catalysis has been known since the 1960s.89, 90 A proposed catalytic cycle 
for the formation of phenanthridines and benzoxazoles via Marsden’s 
methodology is shown in Scheme 3.2. Campbell and co-workers suggested that 
nucleophilic attack of the oxygen in the polarised phosphorus-oxygen bond on 
the isocyanate in compound 246 would give an intermediate iminophosphorane 
247 together with carbon dioxide. The iminophosphorane 247 would then 
undergo intramolecular aza-Wittig reaction with the carbonyl group to furnish 
the desired carbodiimide 248, as well as regenerating the phosphine oxide 
rac-249 for the next reaction cycle. 
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Scheme 3.2: Proposed catalytic aza-Wittig cyclisation 
 
In seemingly unrelated work, O’Brien and co-workers reported the catalytic 
Wittig reaction of benzaldehyde with methyl bromoacetate in the presence of a 
2:1 mixture of diastereomeric phosphine oxides rac-250,91 which was obtained 
by hydrogenation from phosphine oxide rac-231. A typical example is shown in 
Scheme 3.3. Benzaldehyde was treated with methyl bromoacetate with 10 mol% 
of rac-250 in the presence of diphenylsilane and sodium bicarbonate at 100 ºC in 
toluene to furnish the desired alkene 251 in 75% yield and trans:cis ratio of > 
95:5. 
Scheme 3.3: Catalytic Wittig reaction 
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The catalytic cycle for this Wittig reaction is shown in Scheme 3.4. The reaction 
first involves the formation of the trialkylphosphine 252 by reduction of the 
phosphine oxide 249 precursor. The trialkylphosphine 252 then reacts with alkyl 
halide 253 to generate a phosphonium salt 254. On deprotonation of 
phosphonium salt 254, the resulting phosphonium ylide 255 reacts with aldehyde 
256 to afford alkene 257 and phosphine oxide 249, the latter of which can be 
reduced to trialkylphosphine 252. 
Scheme 3.4: Proposed catalytic Wittig reaction 
 
The optimum reducing agent for phosphine oxide rac-249 was found to be 
diphenylsilane and when triphenylphosphine oxide was used, the reaction was 
ineffective and only aldehyde 256 was recovered. Preliminary theoretical 
calculations were carried out to understand the difference in reactivity between 
phosphine oxide rac-231 and triphenylphosphine oxide. It was shown that the 
bond length of P=O and P-Ph and the bond angle of O=P-Ph in both compounds 
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are similar. Therefore, it was suggested that phosphine oxide rac-231 was 
reduced more easily in the reaction due to the release of ring strain. 
3.1.2 Project Outline 
Although commercially available phosphine oxide rac-231 was explored in both 
the catalytic aza-Wittig and Wittig reactions, we became interested in the 
synthesis of enantioenriched phosphine boranes (R)-258 or (R)-259 (Figure 3.4). 
These phosphine boranes could easily be transformed into phosphine oxide 
(S)-260 and other protected phosphines.  
Figure 3.4: P-Stereogenic phospholenes 
 
The reasons for the development of a synthetic route to phosphine boranes 
(R)-258 and (R)-259 are twofold. First, phosphine oxides derived from them 
could be used as potential catalysts for future developments of catalytic reactions. 
Although Marsden’s heterocycle syntheses generate achiral products, the group 
has also reported the enantioselective synthesis of β-quaternary azacycles via 
asymmetric aza-Wittig reactions.92 However, chiral phosphine oxide (S)-231 was 
not tested as its synthesis was unknown at the time. With the catalytic Wittig 
reaction, there could be possibilities to further improve the trans:cis 
stereoselectivity by using enantioenriched phosphine oxide such as (R)-260. 
Secondly, to the best of our knowledge, there are no previous reports on the 
asymmetric synthesis of P-stereogenic phospholenes such as (R)-258 and 
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(R)-259. Therefore, we felt that there was a need for the development of 
synthetic routes to chiral phosphine heterocycles such as (R)-258 and (R)-259. 
We envisioned that the enantioenriched phosphine boranes (R)-258 or (R)-259 
could be synthesised via asymmetric lithiation/trapping followed by ring-closing 
metathesis. The proposed synthetic plan is outlined in Scheme 3.5. The 
stereogenic centre at phosphorus could be created by asymmetric lithiation using 
s-BuLi and a chiral diamine (e.g. (_)-sparteine).93 Electrophilic trapping with an 
allyl bromide would put the first alkene in place, to give phosphine borane 
(S)-263. Then, regioselective lithiation (at the less hindered methyl group)94 and 
trapping with paraformaldehyde would give a hydroxy adduct, which could then 
be transformed into the second alkene, as shown in (S)-264, ready for the 
formation of the phosphine heterocycle. Finally, ring-closing metathesis33 using a 
Grubbs-type catalyst would furnish the desired vinylic phospholene boranes 
(R)-258. We anticipated that the route would be synthetically flexible as 
substituents other than phenyl and a range of R groups could be introduced. 
Scheme 3.5: Proposed route to P-stereogenic phospholene borane (R)-258 
 
Although the use of the (+)-sparteine surrogate in the asymmetric lithiation of 
phosphine boranes produces the opposite enantiomer to that obtained using 
(_)-sparteine, there is still a need to design and investigate alternative chiral 
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diamines that would allow access to both enantiomers. Therefore, before we 
started the development of the asymmetric synthesis of heterocyclic phosphine 
boranes, we decided to first synthesise and test alternative chiral diamines in the 
asymmetric lithiation of phosphine boranes. At the time when the project 
commenced, (_)-sparteine was not commercially available. This further 
demonstrated the need to develop alternative diamine ligands for the asymmetric 
lithiation chemistry. 
This part of the thesis reports our investigation of chiral diamine ligands for the 
asymmetric lithiation/trapping of phosphine boranes and the synthesis of 
enantioenriched vinylic phospholene boranes via asymmetric lithiation/trapping 
and subsequent ring-closing metathesis. 
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3.2 Asymmetric Lithiation-trapping of Phosphine Boranes 
3.2.1 Asymmetric Lithiation Approaches to P-Stereogenic Phosphines 
In 1985, Imamoto and co-workers reported the lithiation of phosphine borane 
265 using s-BuLi in THF followed by electrophilic trapping with ketones.95 Later, 
an extensive study of this reaction was carried out by the same group.96 
Phosphine borane 265 was lithiated and trapped with a variety of electrophiles to 
introduce a broad range of functionality. Some examples are shown in Table 3.3.  
Table 3.3: Lithiation/trapping with different electrophiles  
 
Electrophile E Yield (%)a 
Me3SiCl Me3Si 100 
Ph2CO Ph2C(OH) 94 
(MeO)2CO (MeO)CO 83 
C4H9Br C4H9 66 
a Yield of 266 after purification by chromatography. 
The most significant advance was the development of an asymmetric version of 
Imamoto’s reaction. In 1995, Evans and co-workers reported the asymmetric 
synthesis of phosphine boranes using an enantioselective deprotonation 
approach.93 Using the s-BuLi/(_)-sparteine complex, a range of dimethyl 
phosphines 261 and 267-269 was lithiated and subsequent electrophilic trapping 
with benzophenone gave hydroxy phosphine boranes (S)-270-273 in >89:11 er 
(Table 3.4). For example, lithiation/trapping of ortho-tolyldimethylphosphine 
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borane 268 gave hydroxy phosphine borane (S)-272 in 84% yield and 93.5:6.5 er 
(entry 3).  
Table 3.4: Asymmetric lithiation/trapping of dimethyl phosphine boranes 
 
Entry Compound Ar Product Yield (%) 
(%)a 
er (S:R)b 
1 261 Ph (S)-270 88 89.5:10.5 
2 267 o-MeOC6H4 (S)-271 81 91.5:8.5 
3 268 o-MeC6H4 (S)-272 84 93.5:6.5 
4 269 1-Naphthyl (S)-273 86 91:9 
a Yield of (S)-271-274 after purification by chromatography. b The er was determined by 
CSP-HPLC. 
Evans and co-workers also studied the asymmetric lithitation/trapping of 
dimethyl phosphine sulfides. In these cases, higher enantioselectivity was 
obtained using n-BuLi rather than s-BuLi. Using the n-BuLi/(_)-sparteine 
complex, hydroxy phosphine sulfides (R)-278-281 were isolated in 79-94% yield 
with up to 90:10 er (Table 3.5). Evans’ work suggested that the phosphine 
boranes were superior substrates to the analogous phosphine sulfides, generating 
products with higher enantioselectivity. For example, ortho-tolyldimethyl 
phosphine borane 268 gave hydroxy phosphine borane (S)-272 in 84% yield with 
93.5:6.5 er (Table 3.5, entry 3). In comparison, phosphine sulfide adduct (R)-280 
was obtained in 79% yield with a lower 89.5:10.5 er (Table 3.5, entry 3). 
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Table 3.5: Asymmetric lithiation/trapping of dimethyl phosphine sulfides 
 
Entry Compound Ar Product Yield (%)a er (R:S)b 
1 274 Ph (R)-278 94 89:11 
2 275 o-MeOC6H4 (R)-279 83 88:12 
3 276 o-MeC6H4 (R)-280 79 89.5:10.5 
4 277 1-Naphthyl (R)-281 80 80:20 
a Yield of (S)-278-281 after purification by chromatography. b The er was determined by 
CSP-HPLC. 
Evans and co-workers also investigated an oxidative coupling approach for the 
synthesis of bisphosphines. The original oxidative coupling method was 
developed by Mislow.97 Thus, lithiation of phosphine borane 261 using 
s-BuLi/(_)-sparteine, followed by coupling of two lithiated phosphine borane 
intermediates using a copper(II) salt resulted in the formation of bisphosphine 
borane (S,S)-282 in 72% yield with 99:1 er, together with some meso-282 
(Scheme 3.6). As shown in Table 3.4, the lithiation of phosphine borane 261 
using s-BuLi/(_)-sparteine gives 89.5:10.5 er (Table 3.4, entry 1). The 
enantioselectivity enhancement upon dimerisation to give (S,S)-282 in 99:1 er is 
due to most of the minor lithiated species being converted into meso-282. 
Scheme 3.6: Oxidative coupling of a lithiated phosphine borane 
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Following Evans’ pioneering work, Imamoto and co-workers applied the 
lithiation-dimerisation procedure to the synthesis of several ethylene-bridged 
diphosphines known as BISP* ligands.98,95 These exhibited excellent 
enantioselectivity in the asymmetric hydrogentaion of α-dehydroamino acid 
derivatives and other catalytic asymmetric reactions. For example, phosphine 
borane 283 was lithiated using s-BuLi/(_)-sparteine and then dimerised with 
CuCl2 to give the bisphosphine borane (S,S)-284 in 67% yield and >99:1 er 
together with a 13% yield of meso-284 (Scheme 3.7). Phospine borane (S,S)-284 
was then treated with excess amine to remove the borane group to give BisP*, a 
useful chiral bidentate ligand. 
Scheme 3.7: Synthesis of a BisP* precursor 
Imamoto has also designed and synthesised methylene-bridged diphosphines 
known as MiniPHOS ligands.99, 100 For example, phosphine borane 283 was 
lithiated using s-BuLi/(_)-sparteine and trapped with t-BuPCl2 to provide 
intermediate 285. Then, nucleophilic displacement of the other chlorine using 
methylmagnesium bromide and borane protection gave (R,R)-286 in 22% yield 
with 99:1 er after recrystallisation, together with meso-286 (Scheme 3.8). 
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Scheme 3.8: Synthesis of a MiniPHOS precursor 
 
The asymmetric lithiation of phosphine boranes and phosphine sulfides using 
s-BuLi/(_)-sparteine gives phosphines in only one enantiomeric series. Hence, 
Kann and co-workers investigated the use of other chiral diamine ligands, such 
as (+)-sparteine surrogate 203 and diamine 288, in the asymmetric lithiation 
reaction of phosphine boranes (Table 3.6).101 Diamine 203 (99:1 er) can be 
synthesised following a procedure developed by our group, from (_)-cytisine, 
which was isolated from the seeds of the Laburnum anagyroides tree.102  
Phenyldimethylphosphine borane 261 was lithiated using s-BuLi/diamine 203 
and trapped with benzophenone to give hydroxy phosphine borane (R)-270 in 89% 
yield with 84:16 er (Table 3.6, entry 3). In comparison, the corresponding 
reaction using (_)-sparteine gave (S)-270 in 87% yield with 89:11 er (entry 1). In 
a similar fashion, t-butyldimethylphosphine borane 283 and diamine 203 gave 
(R)-287 in 78% yield with 96:4 er (entry 4). When (_)-sparteine was used, 
hydroxy phosphine borane (S)-287 was isolated in 83% yield with 88:12 er (entry 
2). Diamine 288 was also synthesised and the enantioselectivity in the 
corresponding reactions were also measured (entries 5 and 6). It was proposed 
that increasing the steric bulk of the nitrogen substituent might provide a better 
mimic for (_)-sparteine, and thus increase the enantioselectivity. Use of 
s-BuLi/N-ethyl diamine 288 gave comparable results to that obtained with 
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(_)-sparteine. It can be concluded that diamine 203 is the best sparteine surrogate 
for the asymmetric lithiation of phosphine boranes. 
Table 3.6: Lithiation of phosphine boranes with different diamine ligands 
 
Entry Ligand R1 Yield (%)a er (S:R)b 
1 (_)-sparteine Ph 87 89:11 
2 (_)-sparteine t-Bu 83 88:12 
3 203 Ph 89 16:84 
4 203 t-Bu 78 4:96 
5 288 Ph 82 28.5:81.5 
6 288 t-Bu 72 12.5:87.5 
a Yield of (S)-270 and (S)-287 after purification by chromatography. b The er was determined by 
CSP-HPLC. 
Kann and co-workers also investigated a series of chiral diamines that are not 
derived from (_)-cytisine.101 Representative examples are shown in Table 3.7. 
Deprotonation of phosphine borane 261 in the presence of s-BuLi/diamine 
(R,R)-289 followed by electrophilic trapping with benzophenone gave hydroxy 
phosphine borane (R)-270 in 58.5:41.5 er (Table 3.7, entry 1). In the case of 
diamine (R,R)-290, hydroxy phosphine borane (R)-270 was obtained in 76.5:23.5 
er with a modest 42% yield (entry 2). This is the best result for a 
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non-cytisine-derived diamine ligand. In comparison, the related diamine 
(R,R)-291 gave neither high yield nor high enantioselectivity (entry 3). 
Table 3.7: Lithiation of phenyl phosphine borane with different diamine 
ligands 
 
Entry Ligand Yield (%)a er (R:S)b 
1 (R,R)-289 69 58.5:41.5 
2 (R,R)-290 42 76.5:23.5 
3 (R,R)-291 28 52.5:47.5 
a Yield of (S)-270 after purification by chromatography. b The er was determined by CSP-HPLC. 
Our group has synthesised a number of cyclohexyl-derived diamines and 
(R,R)-292 was tested in the asymmetric lithiation-trapping of phosphine borane 
283.103 Thus, phosphine borane 283 was lithiated using s-BuLi/(R,R)-292 in Et2O 
at _78 ºC for 3 h. The intermediate was then trapped with benzophenone to 
furnish hydroxyl adduct (R)-287 in 99% yield with 60:40 er (Scheme 3.9). Thus, 
diamine (R,R)-292 gives lower enantioselectivity than Kann’s best diamine 
(R,R)-290. 
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Scheme 3.9: Lithiation/trapping of t-butyl phosphine borane 
 
Our group has also investigated the catalytic asymmetric desymmetrisation of 
phosphine borane 283 and phosphine sulfide 294 as a route to P-stereogenic 
compounds.104 In this study, the catalytic performance of (_)-sparteine was 
investigated. A selection of results is shown in Table 3.8. Under stoichiometric 
conditions, using s-BuLi and (_)-sparteine (1.2 eq.) and trapping with 
phenyldimethylsilyl chloride, silyl phosphine borane (R)-283 was formed in 92:8 
er (entry 1). This is a higher enantioselectivity than silyl phosphine sulfide 
(S)-295 which was formed in 84:16 er (entry 2). Under catalytic conditions (0.2 
equiv. of diamine), there is a reduction in enantioselectivity for silyl phosphine 
borane (R)-293 (entry 3). In contrast, a significant decrease in enantioselectivity 
for silyl phosphine sulfide (S)-295 (60:40 er) was observed compared to using 
the stoichiometric conditions (entry 4). 
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Table 3.8: Deprotonation with different alkyllithum/(_)-sparteine bases 
 
Entry RLi Equiv.  
(_)-sparteine 
Product Yield (%)a erb 
1 s-BuLi 1.2 (R)-293 74 92:8 
2 s-BuLi 1.2 (S)-295 74 84:16 
3 s-BuLi 0.2 (R)-293 76 74:26 
4 s-BuLi 0.2 (S)-295 75 60:40 
5 n-BuLi 1.2 (R)-293 76 89:11 
6 n-BuLi 1.2 (S)-295 88 88:12 
7 n-BuLi 0.2 (R)-293 21 84:16 
8 n-BuLi 0.2 (S)-295 82 83:17 
a Yield of (R)-293 and (S)-295 after purification by chromatography. b The er was determined by 
CSP-HPLC. 
When the less basic base n-BuLi was used under stoichiometric conditions, both 
phosphine borane 283 and phosphine sulfide 294 were deprotonated and trapped 
to give products with high yield and good enantioselectivity: (R)-293 (76% yield, 
89:11 er, entry 5) and (S)-295 (88% yield, 88:12 er, entry 6) respectively. In the 
corresponding catalytic reaction, silyl adduct (R)-293 was isolated in similar er, 
but the yield was significantly lower (entry 7), indicating there was no catalytic 
turn-over. In contrast, silyl phosphine sulfide (S)-295 was obtained in an 
impressive 82% yield and 83:17 er in the catalytic reaction (entry 8). 
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In 2009, our group studied the regioselective lithiation of silyl phosphine 
sulfides.94 This methodology allows access to P-stereogenic compounds with the 
opposite configuration to that obtained by direct lithiation-trapping using 
organolithium reagents and (_)-sparteine. The synthetic utility was demonstrated 
by the synthesis of (R,R)-300, a Mini-PHOS precursor. First, enantioenriched 
silyl adduct (S)-296 was prepared using the procedure reported previously.104 
Treatment of phosphine sulfide 294 with n-BuLi/(_)-sparteine and subsequent 
trapping with trimethylsilyl chloride afforded silyl phosphine sulfide (S)-296 in  
56% yield and 99:1 er after recrystallization (Scheme 3.10). Next, regioselective 
lithiation of phosphine sulfide (S)-296 on the less hindered methyl group with 
s-BuLi/PMEDA 297 and subsequent trapping with t-butylphosphine dichloride 
was carried out. Then, displacement of the remaining chloride substituent by 
addition of methylmagnesium bromide and phosphorus protection with sulfur 
provided silyl phosphine sulfide (R,R)-299. Finally, TBAF-mediated silyl 
deprotection yielded (R,R)-300 in 46% yield and 99:1 er. Meso-300 was not 
formed which contrasts with Imamoto’s synthesis of the phosphine borane 
Mini-PHOS precursor.98, 100 
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Scheme 3.10: Regioselective lithiation/trapping of silyl phosphine sulfide 
 
Recently, our group has also developed an alternative one-ligand catalytic 
asymmetric deprotonation procedure as a route to P-steroegenic bisphosphine 
ligands.105 This protocol involves using a substoichiometric amount of diamine 
ligands with sequential additions of s-BuLi (Table 3.9). For example, phosphine 
borane 283 was added to a premixed solution of 0.2 eq. of s-BuLi/(_)-sparteine 
(in Et2O at _78 ºC). After 36 min, two portions of 0.4 eq. of s-BuLi were added at 
72 min intervals, which makes up to a total 3 h lithiation time before trapping 
with Ph2CO. Hydroxy adduct (S)-287 was isolated in 94% yield and 86:14 er 
(entry 3), which is comparable to the stoichiometric result (entry 1). A related 
protocol with 0.3 eq. of ligand gave the same enantioselectivity but a lower yield 
(entry 4). 
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Table 3.9: Asymmetric lithiation/trapping of phosphine borane 283 
 
Conditions: A: 1.1 eq. s-BuLi, 1.0 eq. diamines, Et2O, _78 ºC, 3 h 
B: 1.1 eq. s-BuLi, 0.2 eq. diamines, Et2O, _78 ºC, 3 h 
C: (i) 0.2 eq. s-BuLi, 0.2 eq. diamines, Et2O, _78 ºC, 36 min; (ii) 0.4 
eq. s-BuLi, _78 ºC, 72 min; (iii) 0.4 eq. s-BuLi, _78 ºC, 72 min 
D: (i) 0.3 eq. s-BuLi, 0.3 eq. diamines, Et2O, _78 ºC, 36 min; (ii) 
0.35 eq. s-BuLi, _78 ºC, 72 min; (iii) 0.35 eq. s-BuLi, _78 ºC, 72 
min 
Entry Diamine Equiv. of 
diamine 
Conditions Yield 
(%)a 
er (S:R)b 
1 (_)-sparteine 1.0 A 72 95:5 
2 (_)-sparteine 0.2 B 64 80:20 
3 (_)-sparteine 0.2 C 94 86:14 
4 (_)-sparteine 0.3 D 89 86:14 
5 Diamine 203 1.0 A 75 8:92 
6 Diamine 203 0.3 D 83 9:91 
a Yield of (S)-287 and (R)-287 after purification by chromatography. b The er was determined by 
CSP-HPLC. 
The reaction procedure was also performed with diamine 203. Since 
s-BuLi/diamine 203 deprotonates phosphine borane 283 faster than 
s-BuLi/(_)-sparteine,106 use of 0.3 eq. of diamine 203 with 0.3 eq. of s-BuLi, 
followed by sequential addition of two portions of 0.35 eq. of s-BuLi before 
trapping with benzophenone gave hydroxy adduct (R)-287 in 91:9 er (entry 6). 
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This is almost the same result as that obtained with a stoichiometric amount of 
diamine 203 (entry 5). 
Finally, the sequential catalytic lithiation-trapping procedure was applied to the 
synthesis of some P-stereogenic ligands. As an example, phosphine borane 283 
was lithiated using 0.4 eq. of s-BuLi/(_)-sparteine and sequential addition of 
s-BuLi, followed by trapping with di-t-butylphosphine chloride and then borane 
protection gave ‘trichickenfootphos’ precursor (R)-301 in 71% yield and an 
excellent 92:8 er (Scheme 3.11). In the same way, the opposite enantiomer 
(S)-301 was obtained in 71% yield and 93:7 er by using 0.3 eq. of diamine 203.  
Scheme 3.11: Syntheses of ‘trichikenfootphos’ precursors 
 
In summary, desymmetrisation followed by electrophilic trapping of tertiary 
dimethyl phosphines has been employed as a route to a range of P-stereogenic 
phosphines. Both (_)-sparteine and diamine 203 are efficient chiral diamine 
ligands and they facilitate access to P-stereogenic phosphines with opposite 
configuration. 
3.2.2 Selection and Synthesis of Suitable Chiral Diamines  
To study the asymmetric lithiation of phosphine boranes, three chiral diamine 
ligands were prepared. The cyclohexyl-derived diamine ligand, (S,S)-TMCDA 
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(S,S)-304, was chosen as one of the ligands because it is easily synthesised and 
its use in the lithiation-trapping of N-Boc pyrrolidine 302 is known.107 Although 
TMCDA (S,S)-304 resulted in racemic silyl product rac-303 when used in the 
lithiation of N-Boc pyrrolidine 302, it had not previously been tested in the 
asymmetric lithiation of phosphine boranes (Scheme 3.12). 
Scheme 3.12: Lithiation/trapping of N-Boc pyrrolidine 302 
 
Starting from racemic trans-cyclohexane-1,2-diamine 305, resolution using 
D-tartaric acid and acetic acid gave salt (S,S,S,S)-306, which was isolated in 38% 
yield (maximum 50%) by filtration. Then, Eshweiler-Clarke methylation of salt 
(S,S,S,S)-306 using formic acid and formaldehyde gave (S,S)-304 in 96% yield. 
In this way, 3 g of TMCDA (S,S)-304 was prepared in 36% yield over the two 
steps (Scheme 3.13). 
Scheme 3.1:3 Synthesis of diamine (S,S)-304 
 
The enantiomeric ratio of TMCDA (S,S)-304 was determined by chiral shift 1H 
NMR spectroscopy in the presence of 2,2,2-trifluoro-1-(9-anthryl)ethanol 
(Pirkle’s alcohol).103 This works by the formation of diastereomeric complexes 
115 
 
between the amine and the alcohol. As a result, two peaks in the 1H NMR 
spectrum are observed for the diastereomeric complexes. The key peak for chiral 
shift 1H NMR analysis of TMCDA is the NMe singlet observed at 2.22 ppm 
(major) and at 2.18 ppm (minor). Integration of the major and minor peaks gives 
a ratio which is indicative of the enantiomeric ratio of the product. In this way, 
the enantiomeric ratio of TMCDA (S,S)-304 with (R)-Pirkle’s alcohol was found 
to be 99:1 er (Figure 3.5).  
Figure 3.5: 1H NMR spectral analysis of (S,S)-304 
 
Bispidines contain the core diaza [3.3.1] ring system of (_)-sparteine and 
bispidines such as (S)-307 and (R)-308 derived from α-methylbenzylamine 
(Figure 3.6) were also an interesting class of ligands for our study in the 
asymmetric lithiation. It was hoped that the [3.3.1] ring structure would introduce 
rigidity and reduce the conformational variability in the transition state. The 
bispidine structure in (S)-307 and (R)-308 mimic the B and C rings in 
(_)-sparteine. Therefore, it was thought that this type of diamine ligand could also 
prove to be reactive and enantioselective when used in Evans’ procedure.  
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Figure 3.6: Structures of diamines (S)-307 and (R)-308 
 
Bispidine (S)-307 has previously been used in the lithiation of N-Boc pyrrolidine 
302 and high enantioselectivity of the product was obtained (Scheme 3.14).107 
Asymmetric deprotonation of N-Boc pyrrolidine 302 using s-BuLi/(S)-307 and 
subsequent trapping with tetramethylsilyl chloride afforded silyl adduct (R)-303 
in 55% yield and 87.5:12.5 er. It would be interesting to discover whether 
diamines (S)-307 and (R)-308 (previously unstudied) would introduce high 
enantioselectivity in the lithiation-trapping of phosphine boranes. Hence, 
diamines (S)-307 and (R)-308 became target ligands. 
Scheme 3.14: Lithiation/trapping of N-Boc pyrrolidine 302 
 
Following a procedure reported by Beak, a double Mannich reaction using 
freshly distilled N-Me-piperidone 309, (S)-α-methylbenzylamine and 
formaldehyde gave bispidone (S)-310 in 50% yield after Kugelrohr distillation 
(Scheme 3.15). A modified Wolff-Kishner reduction procedure was then used to 
produce bispidine (S)-307.108 Bispidone (S)-310 was refluxed with hydrazine 
monohydrate and 50% aqueous KOH solution in diethylene glycol to give 
bispidine (S)-307 in 47% yield (Scheme 3.15). During the work-up, it was 
important to note that the reaction mixture was cooled to ~60 ºC and then 
transferred to a separation funnel before water was added. This is because a 
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lower temperature results in a viscous reaction mixture which would be very 
difficult to handle when performing the work-up.  
Scheme 3.15: Synthesis of diamine (S)-307 
 
In the same way, the n-propyl analogue, bispidone (R)-312, was prepared in 50% 
yield from N-n-propyl-piperidone 311 and (R)-α-methylbenzylamine. Bispidine 
(R)-308 was then prepared in 41% yield by Wolff-Kishner reduction of bispidone 
(R)-312 (Scheme 3.16). 
Scheme 3.16: Synthesis of diamine (R)-308 
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3.2.3 Investigation of Chiral Diamines in the Lithiation-Trapping of a 
Phosphine Borane  
Since some of the best P-stereogenic ligands such as Mini-PHOS99, 109 and 
QuinoxP*110 contain t-Bu and Me groups on the phosphorus atom, 
t-butyldimethyl phosphine borane 283 was selected as a suitable substrate for an 
investigation of asymmetric lithiation using s-BuLi and new chiral diamines. 
t-Butyldimethyl phosphine borane 283 was synthesised using a method reported 
by Imamoto and co-workers.98 Sequential nucleophilic addition of t-butyl 
magnesium chloride and methyl magnesium bromide to phosphorus trichloride 
gave the crude trialkyl phosphine. Subsequent treatment with borane dimethyl 
sulfide complex gave phosphine borane 283 in 72% yield on a 5 g scale (Scheme 
3.17).  
Scheme 3.17: Synthesis of t-butyl phosphine borane 
 
To investigate the reactivity and enantioselectivity of the chiral diamine ligands 
in the s-BuLi/diamine-mediated lithiation/trapping of phosphine borane 283, it 
was first necessary to identify a suitable electrophile which would give a product 
that could be easily purified by column chromatography. In addition, the 
electrophile should also introduce a strong chromophore into the molecule which 
would facilitate the determination of er using chiral stationary phase HPLC 
(CSP-HPLC) equipped with a UV/Vis diode array detector.  
In Evans’ procedure, benzophenone was used as the electrophile to give hydroxy 
phosphine borane (S)-270 in 88% yield and 89.5:10.5 er (See Table 3.4, entry 1). 
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However, Kann and co-workers have found that benzophenone could also be 
reduced in the reaction to give benzhydrol, which cannot be easily separated 
from the desired products. It also co-elutes on CSP-HPLC with one of the 
enantiomers of hydroxy phosphine borane 270. Hence, determination of the 
enantioselectivity from lithiation/trapping with benzophenone by CSP-HPLC is 
potentially unreliable.101 We therefore decided not to use benzophenone for our 
studies. 
Indentification of the best electrophile was carried out using a racemic lithiation 
protocol. To start with, the lithiation/trapping of phosphine borane 283 using 
phenyl isocyanate, diphenyl disulfide, Weinreb amide 313 and 
dimethylphenylsilyl chloride were investigated. Thus, racemic lithiation of 
phosphine borane 283 was carried out using 1.1 eq. of s-BuLi in THF at 0 ºC for 
30 min. This was followed by trapping with different electrophiles (Table 3.10). 
Using phenyl isocyanate and diphenyl disulfide as electrophiles, none of the 
desired products rac-314 and rac-315 were formed (Table 3.10, entries 1 and 2). 
On inspection of the 1H NMR spectra of the crude products, both reactions 
resulted in decomposition. It was not clear why these electrophiles failed to give 
any product. 
Lithiation and trapping with Weinreb amide 313 gave phosphine ketone rac-316 
in 67% yield after purification by column chromatography (entry 3). The 
enantiomers of ketone rac-316 were successfully resolved on CSP-HPLC using 
chiral OD column. Dimethylphenylsilyl chloride was also used as an electrophile 
for the lithiation of phosphine borane 283 and silyl adduct rac-293 was isolated 
in 60% yield (entry 4). However, the separation of silyl phosphine borane 
rac-293 on CSP-HPLC was poor and the peaks overlapped. Therefore, Weinreb 
amide 313 was chosen as the electrophile. 
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Table 3.10: Lithiation/trapping with different electrophiles 
 
Entry Electrophile Product Yield (%)a 
1 PhNCO rac-314 -- 
2 PhSSPh rac-315 -- 
3 313 rac-316 67 
4 Me2PhSiCl rac-293 60 
a Yield after purification by chromatography. 
Having indentified a suitable electrophile for the racemic lithiation of phosphine 
borane 283 using s-BuLi in THF, we then investigated the asymmetric lithiation 
using different chiral diamines. Lithiation of phosphine borane 283 was carried 
out using 1.1 eq. of s-BuLi in the presence of 1.2 eq. of the chiral diamine 
ligands in Et2O at _78 ºC. In general, phosphine borane was lithiated for 3 h 
before electrophilic quenching with Weinreb amide 313. The crude product was 
purified by column chromatography and the enantiomer ratio of the product was 
determined by CSP-HPLC on chiral OD column. The results of this study are 
presented in Table 3.11. 
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Table 3.11: Lithiation/trapping with different diamine ligands 
 
Entry Diamine Yield (%)a er (R:S)b 
1 (_)-sparteine 56 9:91 
2 203 65 91:9 
3 (S,S)-304 50 78:22 
4 (S)-307 41 61:39 
5 (R)-308 33 45:55 
6 (S,S)-317c 67 45:55 
a Yield after purification by chromatography. b er determined by CSP-HPLC on Daicel Chiracel 
OD column. c (S,S)-317 was synthesised by a member of the group. 
Lithiation of phosphine borane 283 using s-BuLi/(_)-sparteine and trapping with 
Weinreb amide 313 gave ketone adduct (S)-316 in 56% yield and 91:9 er (Table 
3.11, entry 1). Similarly, with diamine 203 as a chiral ligand, ketone adduct 
(R)-316 was isolated in 65% yield and 91:9 er (entry 2). The asymmetric 
lithiation of phosphine borane 283 with (_)-sparteine and diamine 203 is 
well-studied and our ers are consistent with those previously reported.16,21 These 
two results provided the benchmark for the new chiral diamines investigated in 
this project. 
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In the corresponding reaction using s-BuLi/diamine (S,S)-304, phosphine borane 
283 was lithiated and trapped to furnish (R)-316 in 50% yield and 78:22 er (entry 
3). This reaction was repeated several times to show that it was reproducible. The 
er is slightly higher than that shown by Kann and co-workers with diamine 
(R,R)-290 (76.5:23.5 er), which is also a cyclohexyl-based diamine ligand and 
trapping with benzophenone (see Table 3.7, entry 2). In contrast, when 
s-BuLi/(S,S)-304 was used in the lithiation of N-Boc pyrrolidine 302, silyl adduct 
303 was formed with 90% conversion, but no enantioselectivity in the product 
was observed (See Scheme 3.12).107 
The deprotonation of phosphine borane 283 using N-Me bispidine (S)-307 
afforded phosphine ketone (R)-316 in 41% yield and 61:39 er (entry 4). In 
contrast, Beak showed that s-BuLi/(S)-307 provided silyl adduct (R)-303 in 
87.5:12.5 er (See Scheme 3.14).107 With N-Pr diamine (R)-308, both the yield 
and enantioselectivity were disappointing: 33% yield of (S)-316 with 55:45 er 
(entry 5). The enantiomeric induction of phosphine ketone (R)-316 is the same 
using (S,S)-317 as the chiral ligand, but with a higher yield (67%) compared with 
diamine (R)-308 (entry 6). 
In summary, it was shown that using (_)-sparteine or diamine 203 as a ligand in 
the asymmetric lithiation of phosphine borane 283, ketone adduct 316 can be 
accessed with high enantioselectivity (91:9 er) in both configurations. Diamine 
(S,S)-304 was found to function as an effective (+)-sparteine surrogate and 
lithiation of phosphine borane 283 using s-BuLi/diamine (S,S)-304 gave ketone 
adduct (R)-316 in 78:22 er, the best result of the non-sparteine-like ligands that 
were tested. Although diamine ligand (S,S)-304 provided substantial 
enantioselectivity in the lithiation of phosphine borane 283 and trapping with 
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Weinreb amide 313, (_)-sparteine or diamine 203 are still the best ligandsgiving 
both high yield and high enantioselectivity. 
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3.3 Asymmetric Lithiation and Ring-Closing Metathesis Route to 
P-Stereogenic Phosphine Heterocycles 
3.3.1 Strategies for the Synthesis of P-Stereogenic Vinyl Phosphine 
Heterocycles 
There are a number of methods for the synthesis of electronically and sterically 
diverse acyclic phosphine compounds.111, 112 However, the development of 
synthetic routes to P-stereogenic phosphine heterocycles is not well-studied. To 
the best of our knowledge, there are no previous reports on the asymmetric 
synthesis of P-stereogenic vinyl heterocycles such as (R)-258 and (R)-259 
(Figure 3.7).  
Figure 3.7: P-Stereogenic phospholene boranes 
 
There are a limited number of routes for the synthesis of vinylic phospholenes in 
a racemic fashion. For example, 1,3-diene 318 and phenylphosphorus dichloride 
underwent a McCormac reaction113 to provide cyclic phosphine intermediate 319. 
Then, hydrolysis of 319 furnished the desired vinyl phospholene rac-320 in 30% 
yield (Scheme 3.18).114 
Scheme 3.18: Example of McCormac reaction 
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Pietrusiewicz and co-workers studied cyclopentannulation and alkylation of 
phospholene derivatives which led to the formation of vinylic phospholenes.115, 
116 For example, deprotonation of phosphine oxide rac-321 (which could be 
made from diallylphenylphosphine oxide via ring-closing metathesis) using 2.0 
eq. of LDA followed by trapping with diiodopropane furnished bicyclic vinyl 
phospholene cis-322 in 74% yield (Scheme 3.19). Stereochemical assignment 
was made on the basis of nOe experiments and this indicated that the cis-fused 
ring system was formed exclusively.  
Scheme 3.19: Alkylation of phosphine oxide rac-321 
 
When 1,3-diiodobutane was used as the electrophile to diversify the substitution 
pattern of the annulated products, the reaction became less selective and 
monocyclic alkylated products were also observed (Scheme 3.20). With 
phosphine oxide rac-321, vinyl phospholene cis-323 was formed in 42% yield. 
Under the same reaction conditions, the desired phosphine borane cis-325 was 
formed in 32% yield, together with 11% of the dialkylated product rac-326. In 
addition, the bicyclic product could not be separated from the corresponding 
dialkylated derivatives by chromatography. 
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Scheme 3.20: Alkylations of phospholene derivatives 
 
During the course of investigating the alkylation of phospholene derivatives, 
Pietrusiewicz and co-workers found that when benzophenone was used as an 
electrophile for the lithiated species obtained from phosphine oxide rac-321, the 
trapping was directed to the 3-position. Thus, phosphine oxide rac-321 was 
treated with LDA and trapping with benzophenone afforded vinyl phospholene 
trans-327 in 74% yield (Scheme 3.21). The stereochemical assignment was 
carried out using nOe experiments, and it indicated that the electrophile was 
added trans to the P-Ph group. Although this approach provided the desired 
vinylic phospholene structure, it is limited by substrate scope since when alkyl 
halides were used, the trapping occurred  α to the phosphorus.  
Scheme 3.21: Alkylation of phosphine oxide rac-321 
 
The ligand TangPhos has been synthesised via the asymmetric lithiation of 
phospholene sulfide 328 and subsequent oxidative dimerisation using CuCl2.87 
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Our group investigated the dimerization process. On one single attempt, 
phospholene sulfide 328 was lithiated in a racemic fashion using 
s-BuLi/PMDETA at _78 ºC in Et2O for 5 h, followed by the addition of CuCl2 at 
_78 ºC. The reaction was allowed to warm to rt over 16 h. The desired dimerised 
product rac-330 was not observed, but a vinylic phosphine sulfide rac-329 was 
isolated in 55% yield (Scheme 3.22).117 It was suggested that the formation of 
phospholene rac-329 might arise from either an organocuprate-mediated process 
or a radical mechanism.  
Scheme 3.22: Attempted Cu(II)-mediated dimerisation 
 
There are two examples of the preparation of enantioenriched cyclic vinyl 
phosphines similar in structure to (R)-258 and (R)-259, both of which were 
reported by Pietrusiewicz and co-workers.118, 119 The first approach to obtain 
enantiomerically enriched bicyclic phospholene oxide used the classical 
resolution method.118 Vinyl phosphine oxide rac-322 was first synthesised using 
the pentannulation procedure described previously (See Scheme 3.19). Then, 
reduction of phosphine oxide cis-322 with phenylsilane gave vinyl phosphine 
rac-331 in quantitative yield (Scheme 3.23). 
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Scheme 3.23: Formation of phosphine heterocycle rac-331 via reduction 
 
For the resolution procedure, a solution of cyclic phosphine rac-331 in ethyl 
acetate was treated with a solution of (_)-menthyl bromoacetate (_)-332 in ethyl 
acetate to produce crystalline phosphonium bromides. Recrystallisation gave 
phosphonium bromide 333 as a single diastereoisomer. Phosphonium bromide 
333 was then hydrolysed using sodium hydroxide to give phosphine oxide 
(1R,3aS,6aS)-334 in 25% yield (out of a possible 50%) with >99:1 er. To access 
the enantiomer, phosphine oxide (1S,3aR,6aR)-334, the supernatant was 
hydrolysed to the phosphine oxide and reduced to the free phosphine. Resolution 
using (+)-menthyl bromoacetate gave phosphonium bromide ent-333 in 37% 
yield with >99:1 er. This resolution procedure for isolating enantioenriched 
phosphine oxides allows access to both enantiomers. However, the methodology 
is inefficient as a number of steps are required and the overall yield is moderate.  
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Scheme 3.24: Formation of enantiomeric phosphine oxide 334 via resolution 
 
Pietrusiewicz and co-workers also investigated the chiral base-promoted 
enantioselective rearrangement of organophosphorus epoxides as an asymmetric 
route to phosphine heterocycles.119 An extensive study of this reaction was 
carried out on phosphine oxide 321 and phosphine borane 338 using various 
chiral base systems such as s-BuLi/(_)sparteine and Cinchona alkaloids. It was 
found that the rearrangement generally afforded the desired hydroxy 
phospholene 336 or 339 in good yield but with moderate enantioselectivity. For 
130 
 
example, epoxide 335 was synthesised by diastereoselective epoxidation of 
phosphine oxide 321 using m-CPBA. Then, treatment of phosphine oxide 335 
with quinidine at 20 ºC for 90 days(!) gave hydroxy phospholene oxide 
(RP,SC)-336 in 41% yield, with 52% optical purity (Scheme 3.25).  
Scheme 3.25: Enantioselective rearrangement of a phosphine oxide 
The proposed reaction mechanism for the weak base-mediated epoxide 
rearrangement using quinidine is shown in Scheme 3.26. It was shown that the 
abstraction of the proton adjacent to phosphorus occurred syn to the oxygen of 
the phosphine oxide. In addition, the oxygen in a phosphine oxide is an efficient 
lone pair donor to protons and metal cations. Therefore, it was assumed the 
rearrangement process begins with the coordination of quinidine 337 to epoxide 
335 through hydrogen bonding. Then, the base abstracts the more accessible 
enantiotopic proton, which in this case is anti to the epoxide oxygen to give 
phosphine oxide (RP,SC)-336. 
Scheme 3.26: Proposed mechanism for epoxide rearrangement 
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With a strong organolithium base, the enantioselective rearrangement of 
phosphine borane 338 using s-BuLi/(_)-sparteine in Et2O at _78 ºC resulted in 
hydroxy phospholene borane (RP, SC)-339 in 72% yield with 77.5:22.5 er 
(Scheme 3.27). The rearrangement utilising s-BuLi/(_)-sparteine proceeds via a 
different reaction mechanism. The complex-induced proximity effect, in which 
coordination of the borane group to the lithium directs the incoming 
organolithium reagent, is shown in 340. Then, one of the enantiotopic protons is 
abstracted preferentially to afford phosphine oxide (RP, SC)-339. Although both 
procedures allow access to the enantioenriched hydroxy phospholenes, the 
methodology is hampered by a narrow substrate scope.  
Scheme 3.27: Enantioselective rearrangement of a phosphine borane 
 
 
To summarise, only two strategies have been developed for the synthesis of 
enantioenriched P-stereogenic phospholenes. The resolution approach suffers 
from multiple steps and low yield, while the desymmetrisation method is 
restricted in substrate scope and exhibits only moderate enantioselectivity. 
Therefore, the pursuit of an efficient and general approach to P-stereogenic 
phospholenes remains a significant and important synthetic challenge. 
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3.3.2 Synthesis of Enantioenriched Phospholenes 
As outlined in Section 3.1.2, we envisioned that the synthesis of cyclic phosphine 
compounds such as phosphine boranes (R)-258 or (R)-259 could be achieved 
using an asymmetric lithiation approach (Scheme 3.28). Thus, treatment of 
phosphine boranes 261 or 283 with s-BuLi/chiral diamine followed by trapping 
with allyl bromides 262 would afford alkene phosphine boranes (S)-263 and 
(S)-341. The employment of a chiral diamine ligand would set up the 
configuration at phosphorus. Then, regioselective lithiation and trapping with 
paraformaldehyde would give (S)-342 and (S)-343. Subsequent tosylation and 
elimination would then put in the second alkene in (S)-264 and (S)-344. Finally, 
ring-closing metathesis would deliver enantioenriched cyclic phosphine boranes 
(R)-258 and (R)-259. Notably, by varying the substituent in the dimethyl 
phosphine borane starting materials as well as in allyl bromides 262, we 
anticipated that a range of cyclic phosphine borane compounds could be 
synthesised. 
Scheme 3.28: Proposed route to P-stereogenic phospholene boranes 
First, the synthesis of cyclic phosphine compounds in a racemic fashion was 
investigated. We chose cyclic phosphine borane rac-258 as the target molecule 
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as it is the precursor of the ligand used in the catalytic Wittig reaction by O’Brien 
and co-workers.91 Phosphine borane 261 was synthesised using a known 
procedure (Scheme 3.29).98 Nucleophilic displacement of 
diphenylchlorophosphine with methylmagnesium bromide gave the crude trialkyl 
phosphine. Subsequent treatment with borane dimethyl sulfide complex gave 
phosphine borane 261 in 88% yield. 
Scheme 3.29: Synthesis of phenyl phosphine borane 
 
Then, phosphine borane 261 was lithiated using s-BuLi in THF at _ 78 °C. After 
1 h, methallyl bromide was added and the allylated phosphine borane rac-345 
was obtained in an excellent 90% yield after purification by column 
chromatography (Scheme 3.30). The 1H NMR spectrum of rac-345 showed a 
characteristic doublet at δH 1.58 (JPH = 10.5 Hz) corresponding to one of the 
methyl group and two sets of broad singlets at δH 4.73 and δH 4.69, assigned to 
the terminal alkene protons. 
Scheme 3.30: Lithiation/trapping of phosphine borane 261 
 
Next, the formation of the hydroxy adduct rac-346 was investigated (Scheme 
3.31). Phosphine borane rac-345 was lithiated using s-BuLi in THF at _78 ºC for 
30 min. Trapping the lithiated intermediate with paraformaldehyde gave hydroxy 
adduct rac-346 in 67% yield after purification by column chromatography. 
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However, this high isolated yield could not be reproduced despite several 
attempts. Hence, we prefer to quote a reproducible yield of 48% for this reaction. 
We speculate that the presence of the hydroxy group in rac-346 could increase 
the polarity of the molecule leading to a difficult purification by column 
chromatography, which could explain the variable yields obtained. There was no 
evidence of the other regioisomeric trapped product from this reaction on 
inspection of the 1H NMR spectrum of the crude product. Thus, this reaction 
showed complete regioselectivity for lithiation at the less sterically hindered 
methyl group compared to the methylene group. The 1H NMR spectrum of 
rac-346 revealed a multiplet at δH 3.96-3.78 with relative integration of 2H for 
the protons α to the hydroxy group. Crucially, there was no evidence for the 
P-methyl group in the 1H NMR spectrum of the crude product. 
Scheme 3.31: Lithiation/trapping with paraformaldehyde 
 
Next, we needed to develop a method for elimination of the hydroxy group. For 
this, we planned to use tosylation and base-mediated elimination. Thus, hydroxy 
adduct rac-346 was subjected to tosylation using tosyl chloride and pyridine 
(Scheme 3.32). Despite > 90% conversion on inspection of the 1H NMR 
spectrum of the crude mixture, we were only able to isolate tosylate rac-347 in 
32% yield after chromatography. We suspected that instability of tosylate 
rac-347 on silica gel could be the reason for the low isolated yield. Indeed, 
decomposition to an unknown by-product was shown by TLC analysis. 
Pleasingly, tosylate rac-347 was readily converted into diene rac-348 in 98% 
yield when treated with potassium t-butoxide in Et2O at rt for 2 h. The 1H NMR 
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spectrum of rac-348 showed the presence of three new alkene protons compared 
to rac-346. A 1H doublet of triplets at δH 6.40 (J = 18.0, 13.0 Hz) was assigned 
to the alkene proton α to the phosphorus. A multiplet at δH 6.27-6.14 was due to 
the two terminal alkene protons. 
Scheme 3.32: Tosylation and elimination of phosphine borane rac-346 
 
Since there were isolation issues with both hydroxy phosphine borane rac-346 
and tosylate rac-347, it was decided that the regioselective lithiation and trapping 
with paraformaldehyde, tosylation and elimination would be carried out using the 
crude mixture from the previous step without any purification. In this way, only 
diene rac-348 would be purified by chromatography. Using this telescoped 
procedure, diene rac-348 was obtained from allylated phosphine borane rac-345 
in 86% yield over 3 steps (Scheme 3.33). The impressive yield from this 
three-step process supports the idea that purification issues were the source of the 
problems in obtaining high yields of hydroxy adduct rac-346 and tosylate 
rac-347. 
Scheme 3.33: Telescoped procedure to diene rac-348 
 
With diene rac-348 in hand, the formation of cyclic phosphine borane rac-349 
was investigated using ring-closing metathesis and a range of Grubbs’ catalysts 
were evaluated. Although there are many examples of cyclic phosphine borane 
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synthesis using this approach (see Section 1.2), there are no reported examples of 
ring-closing metathesis approaches to vinylic phospholene boranes such as 
rac-349. Grubbs’ 1st generation catalyst 4 (2 mol %) was investigated first. None 
of the desired product rac-349 was detected in the 1H NMR spectrum of the 
crude mixture and only the starting material rac-348 was present (Table 3.12, 
entry 1). Hence, a more reactive Grubbs’ 2nd generation catalyst 5 (2 mol %), 
was employed.  
Table 3.12: Ring-closing metathesis using catalysts 4 and 5  
 
Entry Catalyst Solvent Temp Time (h) rac-348:rac-349a 
1 4 CH2Cl2 rt 16 100:0 
2 5 CH2Cl2 rt 72 77:23 
3 5 CH2Cl2 reflux 16  83:17b 
4 5 toluene reflux 16 78:22c 
a Ratio of rac-348:rac-349 determined from the 1H NMR spectrum of the crude product. b Crude 
product from entry 2 was used as starting material. c Crude product from entry 3 was used as 
starting material. 
After stirring at rt for 72 h, 23% conversion to diene rac-349 was observed (entry 
2). The conversion was identified by a signal at δH 5.70, which was assigned to 
the alkene proton in the product rac-349. Encouraged by this enhanced reactivity, 
the reaction temperature was then increased and the crude mixture from entry 2 
was refluxed with Grubbs’ 2nd generation catalyst 5 (2 mol %) in CH2Cl2 for 16 h. 
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However, a similar result was observed compared to stirring at rt: 17% 
conversion into phospholene rac-349 (entry 3). Disappointingly, when the crude 
mixture from entry 3 was heated to reflux in toluene for 16 h, no further 
conversion was observed (entry 4).  
Phosphine-free isopropoxy-chelated complexes, such as 350, a group of catalysts 
introduced by Hoveyda, show an expanded application with enhanced reactivity 
in ring-closing metathesis reactions.120 Therefore, such a catalyst was explored 
next. Ring-closing metathesis of diene rac-348 using Hoveyda-Grubbs 2nd 
generation catalyst 350 (2 mol %) in CH2Cl2 at rt for 16 h gave 13% conversion 
to phospholene rac-349 (Table 3.13, entry 1). Then, the catalyst loading was 
increased to 10 mol% and the crude mixture from entry 1 was stirred in CH2Cl2 
at rt for 16 h. On inspection of the 1H NMR spectrum of the crude mixture, 50% 
conversion into phospholene rac-349 was observed (entry 2). This is a 
significantly better result compared to Grubbs’ 2nd generation catalyst 5. 
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Table 3.13: Ring-closing metathesis using catalyst 350 
 
Entry Catalyst Solvent Temp Time (h) rac-348:rac-349a 
1 350b CH2Cl2 rt 16 87:13 
2 350c CH2Cl2 rt 16 50:50d 
3 350c CH2Cl2 rt 48 40:60d 
4 350c CH2Cl2 rt 72 40:60d 
5 350c CH2Cl2 reflux 16 n.d.e 
a Ratio of rac-348:rac-349 determined from the 1H NMR spectrum of the crude product. b 2 mol% 
of Hoveyda-Grubbs II 5 catalyst was used. c 10 mol% of Hoveyda-Grubbs II 350 catalyst was 
used. d Crude product from previous entry was used as starting material. e Ratio of 
rac-348:rac-349 could not be determined. 
The crude mixture from the previous ring-closing metathesis study was used for 
the following reactions. Satisfyingly, when the reaction time was extended to 48 
h, the conversion improved to 60% (entry 3). With a prolonged reaction time of 
72 h, no further improvement of conversion was observed (entry 4). Finally, 
increasing the reaction temperature to reflux in CH2Cl2 for 16 h with 
Hoveyda-Grubbs 2nd generation catalyst 350 (10 mol %) gave a complex mixture 
with only a trace of the desired product rac-349 presents (entry 5). It is possible 
that heating the reaction mixture with Hoveyda-Grubbs type catalyst could lead 
to product decomposition and/or a cross-metathesis side reaction. Thus, the 
ring-closing metathesis showed that the highest conversion of diene rac-348 into 
cyclic phosphine borane rac-349 was 60% after stirring at rt for 80 h in total. 
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Therefore, a separate reaction was carried out using 10 mol% of 
Hoveyda-Grubbs 2nd generation catalyst 350 at rt. After 48 h, the crude product 
was purified and rac-349 was isolated in 36% yield, together with 40% 
recovered diene rac-348 (Scheme 3.34). The 1H NMR spectrum of the desired 
product rac-349 showed a new signal at δH 5.70 (ddd, J = 32.0, 3.0, 1.5 Hz), 
corresponding to the alkene proton next to the phosphorus. A 3H singlet at δH 
2.09 is assigned to the methyl group. 
Scheme 3.34: Formation of phospholene borane rac-349 
 
The highest conversion for the transformation of rac-349 from rac-348 is 60% 
using 10 mol% of Hoveyda-Grubbs 2nd generation catalyst 350. This indicates 
that, in this case, the Hoveyda-Grubbs catalyst 350 is superior to the Grubbs-type 
catalysts.  Therefore, use of Hoveyda-Grubbs 2nd generation catalyst 350 (10 
mol %) in CH2Cl2 at rt for 48 h was our best conditions for formation of cyclic 
phosphine borane rac-349. Based on these results and more details discussed 
later, we conclude that the steric hindrance around the disubstituted alkene leads 
to inefficient ring-closing metathesis.  
Although the yield for the final ring-closing metathesis was low, a viable route 
for the synthesis of vinyl phospholene boranes has been developed. Therefore, 
we turned our attention to the asymmetric synthesis of cyclic phosphine boranes. 
Since (_)-sparteine and diamine 203 were the best diamine ligands amongst the 
six ligands tested in the lithiation of phosphine borane 283 (see Section 3.2.3), 
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we decided to investigate the synthesis of enantioenriched cyclic phosphine 
boranes using (_)-sparteine as the ligand. To demonstrate the versatility of this 
methodology, examples starting from t-butyl phosphine boranes were also 
synthesised. We also planned to vary the allyl bromide in order to show the 
synthetic utility of our proposed route. 
Lithiation of phosphine boranes 261 and 283 was carried out using 
s-BuLi/(_)-sparteine in Et2O at _78 ºC following the Evans’ procedure.93 After 
trapping with methallyl bromide, allylated phosphine (S)-345 was obtained in 73% 
yield and 89:11 er by CSP-HPLC (Table 3.14, entry 1). Using allyl bromide as 
an electrophile, allylated phosphine (S)-351 was isolated in 57% yield with a 
similar 88:12 er (entry 2).  
Table 3.14: Asymmetric lithiation/trapping of phosphine boranes 
 
Entry R1 R2 Product Yield (%)a er 
1 Ph Me (S)-345 73 89:11b 
2 Ph H (S)-351 57 88:12b 
3 t-Bu Me (S)-352 57 96:4c 
4 t-Bu H (S)-353 58 93:7c 
a Yield of (S)-345 and (S)-351-353 after purification by chromatography. b Enantiomeric ratio 
determined by CSP-HPLC and Daicel Chiracel AD-H column. c Enantiomeric ratio determined 
by CSP-HPLC of the corresponding phosphine sulfides on a Daicel Chiracel AD-H column. 
In contrast, the lithiation-alkylation of t-butyl phosphine borane 283 gave allyl 
phosphine adducts (S)-352 and (S)-353 in 57% yield with 96:4 er (entry 3) and 
58% yield with 93:7 er (entry 4) respectively. The enantioselectivity is generally 
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higher for the t-butyl phosphine borane than for the phenyl substituted analogue 
261. This may be due to the enhanced steric bulk between the t-butyl and methyl 
groups compared to the phenyl and methyl substituents.93, 98 
The enantiomeric ratios of (S)-345 and (S)-351 were determined directly by 
CSP-HPLC. However, there is no UV chromophore in phosphine boranes 
(S)-352 and (S)-353 that would allow the determination of er using CSP-HPLC. 
Thus, phosphine boranes (S)-352 and (S)-353 were transformed into phosphine 
sulfides (R)-354 and (R)-355 respectively for the determination of the 
enantioselectivity in the asymmetric lithiation step. It is known in our group that 
the P=S group provides a suitable UV chromophore. Phosphine borane (S)-352 
was treated with sulfur and DABCO in refluxing toluene for 16 h to afford 
phosphine sulfide (R)-354 in 87% yield (Scheme 3.35). The same procedure was 
also carried out on phosphine borane (S)-353 to obtain phosphine sulfide (R)-355 
in 80% yield. The ers of phosphine sulfides (R)-354 and (R)-355 were 
determined to be 96:4 and 93:7 respectively. 
Scheme 3.35: Formation of phosphine sulfides 
 
The preparation of dienes (R)-348 and (R)-356-358 was then performed from the 
enantioenriched allylated phosphine boranes (S)-345 and (S)-351-353 using the 
optimised telescoped procedure. The results are presented in Table 3.15. 
Regioselective lithiation of phenyl phosphine boranes (S)-345 and (S)-351 
followed by trapping with paraformaldehyde gave the crude hydroxy phosphine 
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boranes. The crude hydroxy adducts were then used in the tosylation and 
elimination reactions. Diene phenyl phosphine boranes (R)-348 and (R)-356 were 
obtained in 71% and 58% yield respectively after purification by column 
chromatography (entries 1 and 2). Under the same reaction conditions, t-butyl 
phosphine boranes (S)-352 and (S)-353 were transformed into dienes (R)-357 and 
(R)-358 and isolated in 56% and 60% yield respectively (entries 3 and 4). 
Table 3.15: Synthesis of phosphine dienes using the telescoped procedure 
 
Entry SM R1 R2 Product Yield (%)a 
1 (S)-345 Ph Me (R)-348 58 
2 (S)-351 Ph H (R)-356 71 
3 (S)-352 t-Bu Me (R)-357 56 
4 (S)-353 t-Bu H (R)-358 60 
a Yield of (R)-348 and (R)-356-358 after purification by chromatography. 
Finally, ring-closing metathesis was carried out on dienes (R)-348 and 
(R)-356-358 and the results are presented in Table 3.16. Using the optimised 
conditions (10 mol% Hoveyda-Grubbs 2nd generation catalyst 350 in CH2Cl2 at rt 
for 48 h), dienes (R)-348 and (R)-357 afforded the desired substituted cyclic 
phenyl phosphine borane (R)-349 and cyclic t-butyl phosphine borane (R)-360 in 
46% yield and 41% yield respectively (entries 1 and 3). Notably, a significantly 
higher yield of cyclic phosphine boranes (R)-359 and (R)-361 (71% and 85% 
respectively) were achieved using a low loading of 1 mol% of Hoveyda-Grubbs 
2nd generation catalyst 350 (entries 2 and 4).  
143 
 
When there is a methyl group attached to the alkene, the ring-closing metathesis 
gave moderate yield. With monosubstituted alkenes, the reaction proceeded 
smoothly and provided the desired products in high yield with low loading of the 
catalyst. This further indicates the steric effect of the methyl substituent which 
reduces the formation of the cyclic phosphine boranes. 
Table 3.16: P-Stereogenic phospholene boranes via ring-closing metathesis 
 
Entry SM R1 R2 Catalyst loading 
(mol%) 
Product Yield (%)a 
(%)a 
1 (R)-348 Ph Me 10 (R)-349 46 
2 (R)-356 Ph H 1 (R)-359 71 
3 (R)-357 t-Bu Me 10 (R)-360 41 
4 (R)-358 t-Bu H 1 (R)-361 85 
a Yield of (R)-349 and (R)-359-361 after purification by chromatography. 
To confirm that the enantiomeric ratio of phosphine borane (S)-351 (88:12 er) 
did not change throughout the reaction sequence, the enantioselectivity of cyclic 
phosphine borane (R)-359 was obtained using CSP-HPLC. The er of 87:13 for 
cyclic phosphine borane (R)-359 confirmed that the reactions proceeded without 
loss of enantiomer ratio.  
To demonstrate that the functional group at phosphorus can undergo 
transformation with retention of configuration, phosphine borane (R)-361 was 
converted into phosphine sulfide (R)-362 (Scheme 3.36). Thus, treating 
phosphine borane (R)-361 with sulfur and DABCO, phosphine sulfide (R)-362 
was isolated in 26% yield. The enantioselectivity of phosphine sulfide (R)-362 
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was determined to be 95:5 er using CSP-HPLC, while the enantiomer ratio of 
phosphine borane (R)-361 was presumed to be 93:7 er, as it was derived from 
phosphine borane (S)-353 of 93:7 er. These results confirmed the expected 
retention of configuration at phosphorus through the oxidation reaction. 
Scheme 3.36: Transformation of phosphine sulfide (R)-362 from phosphine 
borane (R)-361 
 
In order to synthesise an enantioenriched version of phosphine oxide 231 used in 
the catalytic Wittig and aza-Wittig reactions, described by O’Brien and Marsden 
respectively, the phosphine borane functional group would need to be converted 
into a phosphine oxide. As a test reaction, phosphine borane (R)-360 was treated 
with m-CPBA in CH2Cl2 at 0 ºC for 15 min (Scheme 3.37).121 Pleasingly, the 31P 
NMR spectrum of the crude product revealed that the phosphine borane (R)-360 
had fully converted into phosphine oxide (R)-363: the signal at δP 68.2 
corresponding to the phosphine borane (R)-360 had disappeared and a new siganl 
at δP 87.1 indicated the presence of phosphine oxide (R)-363. Unfortunately, it 
was extremely difficult to purify phosphine oxide (R)-363 by column 
chromatography probably due to its highly polar nature. Therefore, we were 
unable to isolate phosphine oxide (R)-363 as a pure compound. 
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Scheme 3.37: Attempted synthesis of phosphine oxide (R)-363 
 
Next, we wondered whether it would be possible to synthesise the enantiomeric 
cyclic phosphine borane, (S)-349, without employment of the (+)-sparteine 
surrogate 203. The opposite configuration at phosphorus would be obtained by 
reversing the order of two of the steps in the synthetic sequence. Our proposed 
plan is shown in Scheme 3.38. Thus, lithiation of phosphine borane 261 using 
s-BuLi/(_)-sparteine and trapping with paraformaldehyde would give hydroxyl 
adduct (S)-364. Tosylation followed by elimination would then provide vinyl 
phosphine borane (S)-365. Regioselective lithiation of vinyl phosphine borane 
(S)-365 would introduce the second alkene to give (S)-366. Finally, ring-closing 
metathesis using the Hoveyda-Grubbs 2nd generation catalyst 350 would furnish 
the desired cyclic phosphine borane (S)-349.  
Scheme 3.38: Proposed route to P-stereogenic phospholene borane (S)-349 
First, we started the synthesis by investigating the lithiation/trapping with 
phosphine borane 261 in a racemic fashion (Scheme 3.39). Thus, phosphine 
borane 261 was lithiated using s-BuLi in THF at _78 °C for 1 h followed by 
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trapping with paraformaldehyde. Pleasingly, hydroxy adduct rac-364 was 
isolated in 52% yield and a 24% yield of phosphine borane 261 was also 
recovered.  
Scheme 3.39: Lithiation/trapping with paraformaldehyde 
 
Next, hydroxy adduct rac-364 was transformed into tosylate rac-367 using tosyl 
chloride and pyridine (Scheme 3.40). After stirring at rt for 16 h, tosylate rac-367 
was formed with good conversion on inspection of the 1H NMR spectrum of the 
crude product. Since we experienced purification issues when isolating tosylate 
rac-347, tosylate rac-367 was used without any further purification. Vinylic 
phosphine borane rac-365 was prepared by the elimination of tosylate rac-367 
using potassium t-butoxide. After purification by column chromatography, vinyl 
phosphine borane rac-365 was isolated in 70% yield over two steps (Scheme 
3.40). 
Scheme 3.40: Tosylation and elimination of phosphine borane rac-364 
With vinyl phosphine borane rac-365 in hand, regioselective lithiation was next 
explored. Thus, vinyl phosphine borane rac-365 was treated with s-BuLi in THF 
at _78 ºC for 1 h. Then, allyl bromide was added (Scheme 3.41). On inspection of 
the 1H NMR spectrum of the crude product, diene rac-369 was not observed. 
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Instead, alkylated phosphine borane rac-368 was isolated in 8% yield after 
chromatography, along with some unidentified by-products.  
Scheme 3.41: Lithiation/trapping with allyl bromide 
 
On inspection of the 1H NMR spectrum of the isolated product, an s-butyl group 
was clearly incorporated since there were multiplet signals at δH 0.87-0.61 (6H) 
corresponding to the two methyl groups. There are three stereogenic centres in 
rac-368 which would result in four diastereoisomers. The 1H NMR spectrum 
revealed the presence of four diastereoisomers in approximately equal amounts. 
This is evident from the four sets of doublets at δH 1.59 (J = 10.0 Hz), 1.58 (J = 
10.0 Hz), 1.57 (J = 9.5 Hz) and 1.56 (J = 10.0 Hz), with equal integrations, 
corresponding to the methyl group α to the phosphorus. The mass spectrometry 
result further confirmed the molecular formula to be consistent with phosphine 
borane rac-368.  
A mechanism to account for the formation of rac-368 is shown in Scheme 3.42. 
Instead of reacting as a strong base and abstracting a proton from the methyl 
group in phosphine borane rac-365, s-BuLi attacks the terminal alkene as a 
nucleophile to afford the anion intermediate 370. On addition of allyl bromide, 
intermediate 370 undergoes nucleophilic substitution to give alkylated phosphine 
borane rac-368. 
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Scheme 3.42: Proposed mechanism for the formation of rac-368 
Unfortunately, at this stage, initial attempts to carry out the lithiation of 
phosphine borane rac-365 were unsuccessful, producing only a small amount of 
alkylated phosphine borane rac-368. Hence, we decided not to pursue the 
synthesis of phospholene (S)-349 with the other configuration any further. 
In summary, the first examples of asymmetric synthesis of P-stereogenic vinylic 
phospholene boranes such as (R)-349 and (R)-359-361 have been accomplished. 
The route involves asymmetric lithiation of dimethyl phosphine borane 261 and 
283, followed by electrophilc trapping with methyl allyl bromide and allyl 
bromide. Crucially, a telescoped regioselective deprotonation, paraformaldehyde 
trapping and hydroxy group elimination procedure was developed, to give 
enantioenriched alkylated phosphine boranes (R)-348 and (R)-356-358. Finally, 
ring-closing metathesis using Hoveyda-Grubbs 2nd generation catalyst 350 
afforded the desired phosphine heterocycles (R)-349 and (R)-359-361.  
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3.4 Conclusions and Future Work 
In conclusion, we have designed and synthesised three chiral diamine ligands and 
evaluated their utility in the asymmetric lithiation/trapping of phosphine borane 
283. (_)-Sparteine and diamine 203 remain the best ligands in the reaction, 
providing ketone adduct (R)-316 in 91:9 er and 9:91 er respectively, while 
diamine (S,S)-304 was found to function as an effective (+)-sparteine surrogate 
and gave ketone adduct (R)-316 in 78:22 er. 
In a separate study, we have developed a general route for the synthesis of 
enantioenriched vinyl phospholenes via asymmetric lithiation/trapping and 
ring-closing metathesis (Scheme 3.43). The s-BuLi/(_)-sparteine-mediated 
asymmetric lithiation-trapping of phenyl phosphine borane 261 gave alkylated 
products (S)-345 and (S)-351 in 73% yield with 89:11 er and 57% yield with 96:4 
er respectively. With t-butyl phosphine borane 283, alkylated phosphine boranes 
(S)-352 and (S)-353 were obtained in 57% yield with 96:4 er and 58% yield with 
93:7 er respectively. 
Scheme 3.43: P-Stereogenic phospholene boranes via asymmetric 
lithiation/trapping and ring-closing metathesis 
A telescoped procedure was developed for the synthesis of dienes (R)-348 and 
(R)-356-358. This includes regioselective lithiation of the phosphine boranes, 
trapping with paraformaldehyde to give hydroxy adducts, followed by tosylation 
and elimination. This three-step telescoped protocol allows access to 
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enantioenriched dienes (R)-348 and (R)-356-(R)-358 in 56-71% yield, with only 
chromatographic purification in the last step. Finally, ring-closing metathesis 
using Hoveyda-Grubbs 2nd generation catalyst 350 afforded the desired vinyl 
phospholenes (R)-349 and (R)-359-361 in moderate to good yield. This approach 
has been published.122 
Future work could study the regioselective addition of organocuprate reagents to 
phospholene oxide rac-371, which would need to be synthesised (Scheme 3.44). 
Since organocuprate reagents are soft nucleophiles, the reaction should take 
place via conjugate addition to give rac-372. The diastereoselectivity should also 
be investigated. This would provide an alternative route to the synthesis of cyclic 
phosphine oxides rac-372 and an understanding of the reactivity of cyclic 
phosphine oxide rac-371. 
Scheme 3.44: Regioselective addition to a phosphine oxide 
 
Future work could also include an asymmetric lithiation/trapping approach to the 
synthesis of cyclic phosphine sulfides such as (RP,RC)-373 (Scheme 3.45). By 
introducing a chiral centre α to the phosphine, this type of cyclic phosphorus 
compound could be used to explore the diastereoselectivity of the catalytic 
Wittig reactions. Initial investigations on the asymmetric lithiation/trapping of 
phospholene sulfide 328 have been carried out in our group.117 The 
stereoselective lithiation of phospholene sulfide 328 was explored by trapping 
with both fast-trapping electrophiles and less reactive electrophiles. For example, 
phospholene sulfide 328 was lithiated using n-BuLi/(_)-sparteine. Trapping with 
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benzophenone afforded (RP,RC)-373 in 80% and 78:22 er as a single 
diastereomeric product. In contrast, when the lithiated intermediate was trapped 
with a less reactive electrophile such as phenyldimethylsilyl chloride, two 
diastereomeric phosphine sulfides 374 and 375 were formed in similar 
enantioselectivity (Scheme 3.45). 
Scheme 3.45: Asymmetric lithiation/trapping of a cyclic phosphine sulfide 
 
In 2001, Kobayashi and co-workers reported the asymmetric lithiation and 
trapping with 5- and 6-membered cyclic phosphine boranes.123 An example is 
shown in Scheme 3.46. Cyclic phosphine borane 376 was treated with 
s-BuLi/(_)-sparteine followed by trapping with dry-ice to afford trans-377 in 41% 
yield and 96:4 er. Therefore, a more detailed study on the asymmetric lithiation 
of phosphine borane 376 could be carried out. Investigation on the 
stereoselectivity by trapping with various electrophiles and the temperature at 
which the electrophiles were added could be explored.  
Scheme 3.46: Asymmetric lithiation/trapping of a cyclic phosphine borane 
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Chapter 4. Experimental 
4.1 General  
All non-aqueous reactions were carried out under oxygen free Ar using 
flame-dried glassware. Et2O and THF were dried on a Pure Solv MD-7 solvent 
purification system or distilled from sodium and benzophenone. Alkyllithiums 
were titrated against N-benzylbenzamide before use.124 All diamines used in 
lithiations were distilled over CaH2 before use. Petrol refers to the fraction of 
petroleum ether boiling in the range of 40-60 ºC and was purchased in 
Winchester quantities. Brine refers to a saturated solution. Water is distilled 
water. 
Flash chromatography was carried out using Fluka Chemie GmbH silica 
(220-440 mesh). Thin layer chromatography was carried out using commercially 
available Merck F254 aluminium backed silica plates. Proton (400 MHz), carbon 
(100.6 MHz) and phosphine (109 MHz) NMR spectra were recorded in CDCl3, 
chemical shifts are quoted in parts per million relative to CHCl3 (δH 7.27) and 
CDCl3 (δC 77.0, central line of triplet). Carbon NMR spectra were recorded with 
broad band proton decoupling and assigned using DEPT experiments. Coupling 
constants (J) are quoted in Hertz. Infrared spectra were recorded on an ATI 
Mattson Genesis FT-IR spectrometer. Electrospray high and low resonance mass 
spectra were recorded at room temperature on a Jasco DIP-370 polarimeter 
(using sodium D line; 259 nm) and [α]D given in units of 10-1 deg cm3 g-1. Chiral 
stationary phase HPLC was performed on an Agilent 1200 series 
chromatography. 
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4.2 General Procedures  
General Procedure A: Addition of allyl magnesium bromide to aldehydes 
Allyl magnesium bromide (100 mL of 1 M solution in Et2O, 100.0 mmol, 1.1 eq.) 
was added dropwise to a stirred solution of the aldehyde (91.0 mmol, 1.0 eq.) in 
Et2O (100 mL) at 0 ºC under Ar. The resulting solution was stirred at 0 oC for 1 h 
and then stirred at rt for 1 h. Saturated NH4Cl(aq) (200 mL) was added and the 
layers were separated. The aqueous layer was extracted with Et2O (3 × 50 mL). 
The combined organic extracts were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. 
General Procedure B: O-Alkylation of homoallylic alcohols 
A solution of the alcohol (2.93 mmol, 1.0 eq) in THF (5 mL) was added 
dropwise to a stirred suspension of NaH (60% wt dispersion in mineral oil, 8.79 
mmol, pre-washed with Et2O (3 × 2 mL), 3.0 eq.) in THF (10 mL) at rt under Ar. 
The resulting mixture was stirred at rt for 15 min. Then, 
3-bromo-2-methylprop-1-ene (3.52 mmol, 1.2 eq.) was added and the resulting 
mixture was stirred and heated at reflux for 16 h. After being allowed to cool to 
rt, the solution was poured into saturated NH4Cl(aq) (15 mL) and extracted with 
Et2O (3 × 10 mL). The combined organic extracts were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. 
General Procedure C: Cyclic ether formation via ring-closing metathesis  
Grubbs’ 2nd generation catalyst 5 (0.06 mmol, 0.01 eq.) was added in one 
portion to a stirred solution of the diene (5.94 mmol, 1.0 eq.) in CH2Cl2 (50 mL) 
at rt. The resulting mixture was stirred at rt for 3 h. The solvent was evaporated 
under reduced pressure to give the crude product. 
General Procedure D: Hydrogenation using Pd/C  
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Pd/C (5% wt on carbon, 0.14 mmol, 0.1 eq.) was added to a stirred solution of 
the alkene (1.42 mmol, 1.0 eq.) in MeOH (5 mL) at rt under N2. The flask was 
evacuated and back-filled with N2 three times and finally evacuated and 
back-filled with H2. Then, the mixture was stirred at rt for 1 h. Et2O (10 mL) was 
added and the solids were removed by filtration through a pad of Celite® and the 
filter-cake was washed with Et2O (3 × 10 mL). The combined organic washings 
were evaporated under reduced pressure to give the crude product. 
General Procedure E: Asymmetric lithiation of phosphine borane 261 or 283 
and trapping with methyallyl bromide/allyl bromide 
s-BuLi (1.63 mL of a 1.3 M solution in hexane, 2.12 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of (_)-sparteine (2.32 mmol, 1.2 eq.) in Et2O (8 mL) 
at _78 ºC under Ar. After stirring for 15 min, a solution of phosphine borane 261 
or 283 (1.93 mmol, 1.0 eq.) in Et2O (2 mL) was added dropwise. The resulting 
solution was stirred at _78 ºC for 2 h. Then, methallyl bromide or allyl bromide 
(2.32 mmol, 1.2 eq.) was added dropwise and the mixture was allowed to warm 
to rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. 
General Procedure F: Lithiation and trapping with paraformaldehyde, 
tosylation and elimination 
s-BuLi (2.62 mL of a 1.3 M solution in hexane, 3.41 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of phosphine borane (S)-345 (2.84 mmol, 1.0 eq.) 
in THF (10 mL) at _78 ºC under Ar. The resulting mixture was stirred at _78 ºC 
for 2 h. Then, a solution of paraformaldehyde (3.41 mmol, 1.2 eq.) in THF (5 mL) 
was added dropwise and the mixture was allowed to warm to rt over 16 h. 
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Saturated NH4Cl(aq) (5 mL) was added and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic 
layers were washed with brine (5 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude hydroxy phosphine borane. A solution of 
p-toluenesulfonyl chloride (2.86 mmol, 1.5 eq.) in CH2Cl2 (5 mL) was added 
dropwise to a stirred solution of the crude hydroxy phosphine borane and 
pyridine (2.86 mmol) in CH2Cl2 (5 mL) at rt under Ar. The resulting mixture was 
stirred at rt for 16 h. 2 M HCl(aq) (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 5 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude tosylate. KOt-Bu (4.51 
mmol) was added in one portion to a stirred solution of the crude tosylate in Et2O 
(10 mL) at rt under Ar. The resulting mixture was stirred at rt for 2 h. Then, the 
solid was removed by filtration through Celite®. The solid was washed with Et2O 
(3 × 5 mL) and the combined organics were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. 
General Procedure G: Cyclic phosphine formation via ring-closing metathesis  
Grubbs-Hoveyda 2nd generation catalyst 350 (0.01-0.1 eq.) was added in one 
portion to a stirred solution of vinyl phosphine borane (R)-348 (0.23 mmol, 1.0 
eq.) in CH2Cl2 (2 mL) at rt. The resulting mixture was stirred at rt for 16 h. The 
solvent was evaporated under reduced pressure to give the crude product. 
General Procedure H: Formation of phosphine sulfide using DABCO 
A suspension of phosphine sulfide (S)-352 (0.11 mmol, 1.0 eq.), DABCO (0.24 
mmol, 2.2 eq.) and sulfur (0.54 mmol, 5.0 eq.) in toluene (5 mL) was stirred and 
heated at 80 ºC under Ar for 16 h. Then, 1 M HCl(aq) (10 mL) was added and the 
mixture was stirred for 30 min. The layers were separated and the aqueous layer 
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was extracted with Et2O (3 × 10 mL). The combined organic layers were washed 
with brine (5 mL), dried (MgSO4) and evaporated under reduced pressure to give 
the crude product. 
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4.3 Experimental for Chapter 2 
 
t-Butyl 2-methylpent-4-enoate 95 
LDA (5.8 mL of a 2 M solution in THF, 11.52 mmol, 1.0 eq.) was added 
dropwise to a stirred solution of t-butyl propionate (1.5 g, 11.52 mmol, 1.0 eq.) in 
THF (25 mL) at _78 ºC under Ar. After stirring at _78 ºC for 1 h, allyl bromide 
(1.0 mL, 11.52 mmol, 1.0 eq.) was added dropwise. The reaction mixture was 
allowed to warm to rt over 2 h and then stirred at rt for 16 h. Saturated NH4Cl(aq) 
(25 mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 10 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as 
eluent gave alkylated ester 95 (1.68 g, 84%) as a colourless oil, RF (95:5 
petrol-EtOAc) 0.4; 1H NMR (400 MHz, CDCl3) δ 5.75 (ddt, J = 14.0, 10.0, 7.0 
Hz, 1H, =CH), 5.09-5.01 (m, 2H, =CH2), 2.42-2.35 (m, 2H, CH), 2.20-2.12 (m, 
1H, CH), 1.45 (s, 9H, CMe3), 1.11 (d, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 
MHz, CDCl3) δ 175.6 (C=O), 135.9 (=CH), 116.6 (=CH2), 80.1 (OCMe3), 40.1 
(CH), 38.1 (CH2), 28.2 (CMe3), 16.7 (Me); MS (ESI) m/z 194 [(M + Na)+, 29], 
126 (100); HRMS (ESI) m/z calcd for C10H20O3 (M + Na)+ 193.1199, found 
193.9730 (_5.9 ppm error). Spectroscopic data consistent with those reported in 
the literature.125 Alkylated ester 95 is volatile and should be used immediately 
after purification. 
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t-Butyl 5-hydroxy-2-methylpentanoate 96 
BH3.THF complex (3.44 mL of a 1 M solution in THF, 3.44 mmol, 1.2 eq.) was 
added dropwise to a stirred solution of alkylated ester 95 (488 mg, 2.86 mmol, 1 
eq.) in THF (25 mL) at 0 ºC under Ar. The resulting solution was allowed to 
warm to rt and stirred at rt for 16 h. NaOH(aq) (2.15 mL of a 2 M solution, 4.30 
mmol, 1.5 eq.) and H2O2 (2.75 mL of a 35 wt% solution in water, 31.46 mmol, 
11.0 eq.) were added and the mixture was stirred for 3.5 h. Then, brine (5 mL) 
and water (10 mL) were added. The aqueous layer was extracted with EtOAc (3 
× 10 mL), dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 95:5 
CH2Cl2-EtOAc as eluent gave alcohol 96 (227 mg, 42%) as a colourless oil, RF 
(95:5 CH2Cl2-EtOAc) 0.7; IR (film) 3422 (OH), 2976, 2936, 2876, 1728 (C=O), 
1460, 1368, 1255, 1223, 1155, 1067, 734 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 3.60 (td, J = 6.0, 3.0 Hz, 2H, CH2OH), 2.37-2.28 (m, 1H, CH), 1.71-1.50 (m, 
4H, CH), 1.43 (s, 9H, CMe3), 1.10 (d, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 
MHz, CDCl3) δ 176.3 (C=O), 80.1 (OCMe3), 62.8 (CH2OH), 40.3 (CH), 30.5 
(CH2), 30.0 (CH2), 28.2 (CMe3), 17.5 (Me); MS (ESI) m/z 211 [(M + Na)+, 100], 
155 [(M _ OCMe3)+, 25]; HRMS (ESI) m/z calcd for C10H20O3 (M + Na)+ 
211.1305, found 211.1305 (0.0 ppm error). 
 
t-Butyl 2-methyl-5-oxopentanoate 97 
Dess-Martin periodinane (676 mg, 1.59 mmol, 1.2 eq.) was added in one portion 
to a stirred solution of alcohol 96 (250 mg, 1.33 mmol, 1.0 eq.) in CH2Cl2 (10 
mL) at rt under Ar. The resulting suspension was stirred at rt for 1 h. Then, a 
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solution of Na2S2O3·5H2O (3.2 g, 9.21 mmol, 8.0 eq.) in 5% NaHCO3(aq) (10 mL) 
was added. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product (229 mg, 93%) which was sufficiently pure for 
use in the next step.  
A solution of alcohol 96 (74 mg, 0.41 mmol, 1.0 eq.) in CH2Cl2 (1 mL) was 
added dropwise to a stirred solution of pyridinium chlorochromate (175 mg, 0.82 
mmol, 2.0 eq.) in CH2Cl2 (1 mL) at rt under Ar. The resulting mixture was stirred 
at rt for 1 h before Et2O (5 mL) was added and the solids were removed by 
filtration through Celite®. The filtrate was evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica 
with 4:1 petrol-EtOAc as eluent gave aldehyde 97 (14 mg, 20%) as a colourless 
oil, RF (4:1 petrol-EtOAc) 0.3; IR (film) 2976, 2936, 2878, 1727 (C=O), 1714 
(C=O), 1459, 1392, 1368, 1279, 1155, 1074, 1033, 987, 916, 848 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 9.78 (br t, J = 2.0 Hz, 1H, CHO), 2.51-2.46 (m, 2H, 
CH2CHO), 2.41-2.33 (m, 1H, CHMe), 1.96-1.87 (m, 1H, CHCH2), 1.80-1.71 (m, 
1H, CHCH2), 1.45 (s, 9H, CMe3), 1.14 (d, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 
MHz, CDCl3) δ 202.0 (C=O, CHO), 178.0 (C=O, ester), 80.4 (OCMe3), 41.6 
(CH2CHO), 39.6 (CH), 28.5 (CMe3), 25.8 (CH2), 17.2 (Me); MS (ESI) m/z 211 
[(M + Na)+, 100], 155 [(M _ t-BuO)+, 25]; HRMS (ESI) m/z calcd for C10H20O3 
(M + Na)+ 209.1148, found 209.1150 (_0.5 ppm error). 
LDA (5.2 mL of a 2 M solution in THF, 10.44 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of t-butyl propionate (1.2 g, 9.49 mmol, 1.0 eq.) in 
THF (25 mL) at _78 oC under Ar. After stirring at _78 oC for 1 h, allyl bromide 
(1.1 mL, 10.44 mmol, 1.1 eq.) was added dropwise. The reaction mixture was 
allowed to warm to rt over 2 h and then stirred at rt for 16 h. Saturated NH4Cl(aq) 
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(25 mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 10 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Then, 
the crude alkylated ester was dissolved in THF (25 mL) at 0 ºC under Ar and 
BH3.THF complex (10.71 mL of a 1 M solution in THF, 10.71 mmol, 1.2 eq.) 
was added dropwise. The resulting solution was allowed to warm to rt and stirred 
at rt for 4 h. NaOH(aq) (6.7 mL of a 2 M solution, 13.40 mmol, 1.5 eq.) and H2O2 
(8.72 mL of a 35 wt% solution in water, 99.55 mmol, 11.0 eq.) were added and 
the mixture was stirred for 30 min. Then, brine (15 mL) and water (20 mL) were 
added. The aqueous layer was extracted with EtOAc (3 × 10 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude alcohol. Then, the crude alcohol was dissolved in 
CH2Cl2 (40 mL) at rt under Ar. Dess-Martin periodinane (3.71 g, 8.76 mmol, 1.5 
eq.) was added in one portion. The resulting suspension was stirred at rt for 16 h. 
Then, a solution of Na2S2O3·5H2O (11.6 g, 46.72 mmol, 8.0 eq.) in 5% 
NaHCO3(aq) (50 mL) was added. The aqueous layer was extracted with CH2Cl2 (3 
x 10 mL) and the combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 9:1 EtOAc-petrol as eluent gave aldehyde 97 (241 
mg, 14%) as a colourless oil.  
 
t-Butyl 2-methylhex-5-enoate 100 
n-BuLi (12.0 mL of a 2.05 M solution in hexane, 24.71 mmol, 1.4 eq.) was added 
dropwise to a stirred solution of di-i-propylamine (2.5 g, 24.71 mmol, 1.4 eq.) in 
THF (35 mL) at _78 ºC under Ar. The resulting solution was warmed to 0 ºC for 
10 min and then cooled to _78 ºC. A solution of t-butyl propionate (3.5 g, 26.46 
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mmol, 1.5 eq.) in THF (5 mL) was added dropwise. After stirring at _78 ºC for 1 
h, 4-bromobutene (1.8 mL, 17.64 mmol, 1.0 eq.) was added dropwise followed 
by DMPU (4.0 mL, 33.28 mmol, 2.0 eq.). The reaction mixture was stirred  at 
_78 ºC for 1 h before allowed to warm to at _45 ºC and stirred for 1.5 h. Saturated 
NH4Cl(aq) (35 mL) and water (15 mL) were added at this temperature and the two 
layers were separated. The aqueous layer was extracted with Et2O (3 × 20 mL) 
and the combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 95:5 petrol-EtOAc as eluent gave alkylated ester 
100 (2.01 g, 62%) as a colourless oil, RF (95:5 petrol-EtOAc) 0.7; 1H NMR (400 
MHz, CDCl3) δ 5.89 (ddd, J = 17.0, 10.0, 7.0 Hz, 1H, =CH), 5.15 (dq, J = 17.0, 
2.0 Hz, 1H, =CH), 5.00-4.95 (m, 1H, =CH), 2.33 (sextet, J = 7.0 Hz, 1H, CH), 
2.09-2.04 (m, 2H, CH2CH=), 1.78-1.68 (m, 1H, CHAHBCHMe), 1.56-1.47 (m, 
1H, CHAHBCHMe), 1.45 (s, 9H, CMe3), 1.10 (d, J = 7.0 Hz, 3H, Me). 
Spectroscopic data consistent with those reported in the literature.126 
n-BuLi (0.79 mL of a 2.05 M solution in hexane, 1.62 mmol, 1.4 eq.) was added 
dropwise to a stirred solution of di-i-propylamine (164 mg, 1.62 mmol, 1.4 eq.) 
in THF (5 mL) at _78 ºC under Ar. The resulting solution was warmed to 0 ºC for 
10 min and then cooled to _78 ºC. A solution of ester 109 (200 mg, 1.18 mmol, 
1.0 eq.) in THF (1 mL) was added dropwise. After stirring at _78 ºC for 1 h, 
methyl iodide (0.14 mL, 2.21 mmol, 1.5 eq.) was added dropwise. The reaction 
mixture was allowed to warm to rt over 2 h and then stirred at rt for 16 h. 
Saturated NH4Cl(aq) (5 mL) was added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 10 mL) and the combined organic 
layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 95:5 
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petrol-EtOAc as eluent gave alkylated ester 100 (182 mg, 67%) as a colourless 
oil. 
 
t-Butyl hex-5-enoate 109  
n-BuLi (1.70 mL of a 2.05 M solution in hexane, 4.02 mmol, 1.4 eq.) was added 
dropwise to a stirred solution of di-i-propylamine (429 mg, 4.02 mmol, 1.4 eq.) 
in THF (5 mL) at _78 ºC under Ar. The resulting solution was warmed to 0 ºC for 
10 min and then cooled to _78 ºC. A solution of t-butyl acetate (500 mg, 4.30 
mmol, 1.5 eq.) in THF (1 mL) was added dropwise. After stirring at _78 ºC for 1 
h, 4-bromobutene (0.31 mL, 3.09 mmol, 1.0 eq.) was added dropwise followed 
by DMPU (2.5 mL, 20.68 mmol, 6.7 eq.). The reaction mixture was stirred  at 
_78 ºC for 1 h before being allowed to warm to _45 ºC and stirred for 1.5 h. 
Saturated NH4Cl(aq) (5 mL) and water (1 mL) were added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3 × 10 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography 
on silica with 95:5 petrol-EtOAc as eluent gave alkylated ester 109 (297 mg, 
55%) as a colourless oil, RF (95:5 petrol-EtOAc) 0.7; 1H NMR (400 MHz, CDCl3) 
δ 5.79 (ddd, J = 17.0, 10.0, 8.0 Hz, 1H, =CH), 5.09-5.01 (m, 2H, =CH2), 2.23 (t, 
J = 8.0 Hz, 2H, CH2CO), 2.08 (q, J = 8.0 Hz, 2H, CH2CH=), 1.69 (quintet, J = 
8.0 Hz, 2H, CH2CH2CO), 1.45 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) 
(one CH2 signal not resolved) δ 172.4 (C=O), 137.0 (=CH), 115.2 (=CH2), 80.2 
(OCMe3), 34.7 (CH2), 29.1 (CH2),  28.1 (CMe3). Spectroscopic data consistent 
with those reported in the literature.127 
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t-Butyl 3-phenylpropanoate 110 
n-BuLi (6.37 mL of a 2.5 M solution in hexane, 15.92 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of di-i-propylamine (1.46 g, 15.92 mmol, 1.2 eq.) 
in THF (30 mL) at _78 ºC under Ar. The resulting solution was warmed to 0 ºC 
for 10 min and then cooled to _78 ºC. A solution of t-butyl acetate (1.54 g, 13.26 
mmol, 1.0 eq.) in THF (5 mL) was added dropwise. After stirring at _78 ºC for 1 
h, benzyl bromide (3.40 g, 19.89 mmol, 1.5 eq.) was added dropwise. The 
reaction mixture was allowed to warmed to rt over 16 h. Saturated NH4Cl(aq) (40 
mL) and water (20 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 20 mL) and the combined organic 
layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 99:1 
petrol-Et2O as eluent gave alkylated ester 110 (1.96 g, 72%) as a colourless oil, 
RF (99:1 petrol-Et2O) 0.7; IR (film) 2979, 2932, 1730 (C=O), 1455, 1392, 1367, 
1297, 1255, 1148, 911, 735, 699 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.31-7.27 
(m, 2H, Ph), 7.22-7.20 (m, 3H, Ph), 2.92 (t, J = 8.0 Hz, 2H, CH2CO), 2.55 (t, J = 
8.0 Hz, 2H, CH2Ph), 1.43 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) δ 172.2 
(C=O), 140.7 (ipso-Ph), 128.4 (Ph), 128.3 (Ph), 126.1 (Ph), 80.2 (OCMe3), 37.0 
(CH2), 31.1 (CH2),  28.0 (CMe3); MS (ESI) m/z 229 [(M + Na)+, 100], 105 (96), 
151 (70), 133 (67); HRMS (ESI) m/z calcd for C13H18O2S (M + Na)+ 229.1199, 
found 229.1199 (_0.1 ppm error). Spectroscopic data consistent with those 
reported in the literature.128 
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t-Butyl 2-benzylhex-5-enoate 111 
n-BuLi (4.10 mL of a 2.5 M solution in hexane, 10.24 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of di-i-propylamine (1.04 g, 9.45 mmol, 1.2 eq.) in 
THF (50 mL) at _78 ºC under Ar. The resulting solution was warmed to 0 ºC for 
10 min and then cooled to _78 ºC. A solution of ester 110 (1.95 g, 9.45 mmol, 1.2 
eq.) in THF (15 mL) was added dropwise. After stirring at _78 ºC for 1 h, 
4-bromobutene (0.80 mL, 7.88 mmol, 1.0 eq.) was added dropwise followed by 
DMPU (5.0 mL, 11.82 mmol, 1.5 eq.). The reaction mixture was stirred  at _78 
ºC for 1 h before being allowed to warm to _45 ºC and stirred for 1.5 h. Saturated 
NH4Cl(aq) (50 mL) and water (15 mL) were added at _45 ºC and the mixture was 
allowed to warm to rt. The two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 50 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as 
eluent gave alkylated ester 111 (96 mg, 5%) as a colourless oil, RF (95:5 
petrol-EtOAc) 0.7; IR (film) 2978, 2930, 1726 (C=O), 1454, 1391, 1284, 1254, 
1228, 1150, 912, 848, 737, 700 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.29-7.25 
(m, 2H, Ph), 7.21-7.17 (m, 3H, Ph), 5.78 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, =CH), 
5.05-4.96 (m, 2H, =CH2), 2.88 (dd, J = 14.0, 9.0 Hz, 1H, PhCHAHB), 2.73 (dd, J 
= 14.0, 9.0 Hz, 1H, PhCHAHB), 2.62-2.55 (m, 1H, CHCO), 2.17-2.01 (m, 2H, 
CH), 1.79-1.70 (m, 1H, CH), 1.59-1.50 (m, 1H, CH), 1.34 (s, 9H, CMe3); 13C 
NMR (100.6 MHz, CDCl3) δ 174.7 (C=O), 139.4 (Ph), 137.9 (ipso-Ph), 129.0 
(Ph), 128.2 (Ph), 126.1 (=CH), 115.0 (=CH2), 80.2 (OCMe3), 47.6 (CH), 38.7 
(CH2), 31.5 (CH2), 31.4 (CH2),  28.0 (CMe3); MS (ESI) m/z 283 [(M + Na)+, 
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100]; HRMS (ESI) m/z calcd for C17H24O2S (M + Na)+ 283.1664, found 
283.1664 (+1.6 ppm error). 
 
2-Benzylhex-5-en-1-ol 112 
n-BuLi (3.73 mL of a 2.5 M solution in hexane, 8.09 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of di-i-propylamine (819 mg, 8.09 mmol, 1.2 eq.) 
in THF (40 mL) at _78 ºC under Ar. The resulting solution was warmed to 0 ºC 
for 10 min and then cooled to _78 ºC. A solution of ester 110 (1.53 g, 7.42 mmol, 
1.1 eq.) in THF (15 mL) was added dropwise. After stirring at _78 ºC for 1 h, 
4-bromobutene (0.68 mL, 6.74 mmol, 1.0 eq.) was added dropwise followed by 
DMPU (3.5 mL, 8.09 mmol, 1.2 eq.). The reaction mixture was stirred  at _78 
ºC for 1 h before being allowed to warm to _45 ºC and stirred for 1.5 h. Saturated 
NH4Cl(aq) (50 mL) and water (15 mL) were added at _45 ºC and the mixture was 
allowed to warm to rt. The two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 50 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. A 
solution of crude ester 111 (940 mg, 3.61 mmol, 1.0 eq.) in THF (20 mL) was 
added dropwise to a stirred suspension of LiAlH4 (686 mg, 18.05 mmol, 5.0 eq.) 
in THF (15 mL) at 0 ºC under Ar. The resulting mixture was stirred at 0 ºC for 1 
h and then stirred at rt for 1 h. 1 M NaOH(aq) (10 mL) was added dropwise and 
the solids were removed by filtration through Celite®. The filtrate was evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 4:1 petrol-Et2O as eluent gave alcohol 112 (447 
mg, 40%) as a colourless oil, RF (4:1 petrol-Et2O) 0.3; IR (film) 3367 (OH), 3027, 
2926, 1640 (C=C), 1495, 1453, 1030, 996, 910, 735, 700 cm-1; 1H NMR (400 
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MHz, CDCl3) δ 7.32-7.28 (m, 2H, Ph), 7.22-7.18 (m, 3H, Ph), 5.80 (ddt, J = 17.0, 
10.0, 7.0 Hz, 1H, =CH), 5.03 (dq, J = 17.0, 2.0 Hz, 1H, =CH), 4.98-4.96 (m, 1H, 
=CH), 3.59-3.51 (m, 2H, CH2OH), 2.66 (d, J = 7.0 Hz, 2H, CH2Ph), 2.17-2.11 
(m, 2H, CH2CH=), 1.90-1.80 (m, 1H, CH), 1.57-1.38 (m, 2H, CH2CH); 13C 
NMR (100.6 MHz, CDCl3) δ 140.5 (Ph), 138.6 (ipso-Ph), 129.1 (Ph), 128.2 (Ph), 
125.6 (=CH), 114.5 (=CH2), 64.3 (OCH2), 41.7 (CH), 37.4 (CH2), 31.0 (CH2), 
29.7 (CH2); MS (ESI) m/z 191 [M+, 90], 213 [(M + Na)+, 100], 191 (70); HRMS 
(ESI) m/z calcd for C13H19O M+ 191.1410, found 191.1433 (¯1.5 ppm error). 
 
2-Methylhex-5-en-1-ol 113 
A solution of ester 100 (540 mg, 2.96 mmol, 1.0 eq.) in THF (5 mL) was added 
dropwise to a stirred suspension of LiAlH4 (138 mg, 3.55 mmol, 1.5 eq.) in THF 
(5 mL) at 0 ºC under Ar. The resulting mixture was stirred at 0 ºC for 1 h and 
then stirred at rt for 1 h. 1 M NaOH(aq) (5 mL) was added dropwise and the solids 
were removed by filtration throught Celite®. The filtrate was evaporated under 
reduced pressure to give crude alcohol 113 (224 mg, 66%) as a colourless oil, 
which was sufficiently pure for use in the next step, 1H NMR (400 MHz, CDCl3) 
δ  5.82 (ddd, J = 17.0, 10.0, 7.0 Hz, 1H, =CH), 5.03 (dq, J = 17.0, 2.0 Hz, 1H, 
=CH), 4.97-4.95 (m, 1H, =CH), 3.52 (dd, J = 10.0, 6.0 Hz, 1H, CHAHBOH), 3.45 
(dd, J = 10.0, 6.0 Hz, 1H, CHAHBOH), 2.20-2.01 (m, 2H, CH2CH=), 1.72-1.61 
(m, 1H, OH), 1.57-1.49 (m, 1H, CHMe), 1.27-1.18 (m, 2H, CH2CH), 0.94 (d, J = 
7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) δ 138.9 (=CH), 114.4 (=CH2), 
68.2 (CH2OH), 35.2 (CH), 32.3 (CH2), 31.2 (CH2), 16.4 (Me). Spectroscopic 
data consistent with those reported in the literature.129 
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2-Methyl-5-oxopentyl methanesulfonate 101 
Et3N (0.37 mL, 2.48 mmol, 1.3 eq.) was added dropwise to a stirred solution of 
alcohol 113 (218 mg, 1.91 mmol, 1.0 eq.) in CH2Cl2 (5 mL) at 0 ºC under Ar. 
Methanesulfonyl chloride (0.15 mL, 1.91 mmol, 1.0 eq.) was added dropwise. 
The resulting mixture was stirred at 0 ºC for 1 h. Water (5 mL) was added and 
the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 
10 mL) and the combined organic layers were washed with 2 M HCl(aq) (5 mL), 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 4:1 petrol-EtOAc as 
eluent gave mesylate 101 (352 mg, 96%) as a colourless oil, RF (4:1 
petrol-EtOAc) 0.2; 1H NMR (400 MHz, CDCl3) δ  5.79 (ddt, J = 17.0, 10.0, 7.0 
Hz, 1H, =CH), 5.04 (dq, J = 17.0, 2.0 Hz, 1H, =CH), 5.02-4.98 (m, 1H, =CH), 
4.11 (dd, J = 10.0, 7.0 Hz, 1H, CHAHBO), 4.05 (dd, J = 10.0, 7.0 Hz, 1H, 
CHAHBO), 3.01 (s,  3H, MeSO2), 2.21-2.20 (m, 2H, CH2CH=), 1.98-1.89 (m, 
1H, CHMe), 1.60-1.51 (m, 1H, CHAHBCHMe), 1.35-1.26 (m, 1H, 
CHAHBCHMe), 1.00 (d, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) 
δ 138.0 (=CH), 115.0 (=CH2), 47.3 (OCH2), 37.2 (MeSO2), 32.4 (CH), 31.8 
(CH2), 30.8 (CH2), 16.3 (Me). 
 
2-Methyl-5-oxopentyl methanesulfonate 103 
OsO4 (0.21 mL of 2.5 %wt solution in t-butanol, 0.021 mmol, 0.02 eq.), NaIO4 
(890 mg, 4.16 mmol, 4.0 eq.) and 2,6-lutidine (0.24 mL, 2.08 mmol, 2.0 eq.) 
were added to a stirred solution of mesylate 101 (200 mg, 1.04 mmol, 1.0 eq.) in 
a 3:1 mixture of dioxane-water (8 mL) at rt. The resulting mixture was stirred at 
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rt for 1 h. Water (10 mL) and CH2Cl2 (20 mL) were added and the two layers 
were separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic layers were washed with brine (10 mL), dried (MgSO4) and 
evaporated under reduced pressure to give crude aldehyde 103 (100 mg, 50%)as 
a colourless oil which was sufficiently pure for use in the next step, 1H NMR 
(400 MHz, CDCl3) δ  9.80 (s, 1H, CHO), 4.09-4.07 (m, 2H, CH2O), 3.03 (s, 3H, 
Me), 2.62-2.47 (m, 2H, CH), 1.99-1.79 (m, 2H, CH2CH), 1.60-1.51 (m, 3H, CH), 
1.01 (d, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) δ 201.6 (C=O), 
73.7 (OCH2), 40.9 (CH2), 37.1 (MeSO2), 32.3 (CH), 24.7 (CH2), 16.0 (Me); MS 
(ESI) m/z 217 [(M + Na)+, 100]; HRMS (ESI) m/z calcd for C7H14NaO4 (M + 
Na)+ 217.0505, found 217.0504 (0.5 ppm error). 
 
5-Hydroxy-2,6-dimethylheptyl methanesulfonate 116 
i-PrMgCl (0.29 mL of a 2 M solution in THF, 0.29 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of aldehyde 103 (95 mg, 0.49 mmol, 1.0 eq.) in 
THF (5 mL) at 0 ºC under Ar. The resulting mixture was stirred at 0 ºC for 1 h 
and then stirred at rt for 3 h. Saturated NH4Cl(aq) (5 mL) was added and the two 
layers were separated. The aqueous layer was extracted with Et2O (3 × 10 mL) 
and the combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 9:1 Et2O-CH2Cl2 as eluent gave a 50:50 mixture 
(by 1H NMR spectroscopy) of alcohol 116 (18 mg, 15%) as a colourless oil, RF 
(9:1 Et2O-CH2Cl2) 0.7; 1H NMR (400 MHz, CDCl3) δ 4.13-4.02 (m, 4H, CH2O), 
3.36-3.32 (m, 2H, CHOH), 3.01 (s, 6H, MeSO2), 1.78-1.31 (m, 14H, CH, OH), 
1.01 (d, J = 7.0 Hz, 1.5H, Me), 1.00 (d, J = 7.0 Hz, 1.5H, Me), 0.90 (d, J = 7.0 
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Hz, 1.5H, Me), 0.89 (d, J = 7.0 Hz, 1.5H, Me), 0.88 (d, J = 7.0 Hz, 1.5H, Me), 
0.87 (d, J = 7.0 Hz, 1.5H, Me). 
 
2-Methylhex-5-enyl 4-methylbenzenesulfonate 102 
 p-Toluenesulfonyl chloride (864 mg, 4.54 mmol, 1.5 eq.) was added dropwise 
to a stirred solution of alcohol 113 (345 mg, 3.02 mmol, 1.0 eq.) in pyridine (10 
mL) at 0 ºC under Ar. The resulting mixture was stirred at rt for 16 h. Water (5 
mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 10 mL) and the combined organic layers were washed 
with 2 M HCl(aq) (80 mL), dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica 
with 4:1 petrol-EtOAc as eluent gave tosylate 102 (578 mg, 71%) as a colourless 
oil, RF (4:1 petrol-EtOAc) 0.3; IR (film) 2972, 2928, 2856, 1641 (C=C), 1599, 
1495, 1462, 1360, 1307, 1292, 1188, 1177, 970, 939, 734, 667 cm-1; 1H NMR 
(400 MHz, CDCl3) δ  7.78 (d, J = 8.0 Hz, 2H, o-C6H4SO2),  7.74 (d, J = 8.0 
Hz, 2H, m-C6H4SO2), 5.71 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, =CH), 4.97-4.90 (m, 
2H, =CH2), 3.89 (dd, J = 9.0, 6.0 Hz, 1H, CHAHBOSO2), 3.82 (dd, J = 9.0, 6.0 
Hz, 1H, CHAHBOSO2), 2.44 (s, 3H, MeC6H4), 2.05-1.90 (m, 2H, CH2CH=), 
1.84-1.76 (m, 1H, CH), 1.48-1.39 (m, 1H, CHAHBCH), 1.25-1.15 (m, 1H, 
CHAHBCH), 0.88 (d, J = 6.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) 
δ 144.6 (ipso-Ar), 138.0 (=CH), 132.9 (ipso-Ar), 129.7 (Ar), 127.8 (Ar), 114.7 
(=CH2), 74.8 (OCH2), 32.1 (CH), 31.6 (CH2), 30.6 (CH2), 21.5 (C6H4Me), 16.1 
(Me); MS (ESI) m/z 291 [(M + Na)+, 100]; HRMS (ESI) m/z calcd for C14H20O3S 
(M + Na)+ 291.1025, found 291.1032 (_2.0 ppm error). Spectroscopic data 
consistent with those reported in the literature.130 
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4-Methyl-5-(((4-methylbenzene)sulfonyl)oxy)pentanal 104 
OsO4 (0.56 mL of 2.5 %wt solution in t-butanol , 0.055 mmol, 0.02 eq.), NaIO4 
(2.34 g, 10.96 mmol, 4.0 eq.) and 2,6-lutidine (0.64 mL, 5.48 mmol, 2.0 eq.) 
were added to a stirred solution of tosylate 102 (568 mg, 1.65 mmol, 1.0 eq.) in a 
3:1 mixture of dioxane-water (16 mL) at rt. The resulting mixture was stirred at 
rt for 1 h. Water (20 mL) and CH2Cl2 (40 mL) were added and the two layers 
were separated. The aqueous layer was extracted with CH2Cl2 (6 × 10 mL). The 
combined organic layers were washed with brine (80 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 4:1 petrol-EtOAc as eluent gave 
aldehyde 104 (654 mg, 88%) as a colourless oil, RF (4:1 petrol-EtOAc) 0.3; IR 
(film) 2967, 2828, 1723 (C=O), 1598, 1463, 1358, 1188, 1176, 1098, 968, 816, 
792, 733, 667 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.74 (s, 1H, CHO), 7.79 (d, J 
= 8.0 Hz, 2H, o-C6H4SO2),  7.36 (d, J = 8.0 Hz, 2H, m-C6H4SO2), 3.88-3.86 (m, 
2H, CH2OSO2), 2.45 (s, 3H, MeC6H4), 2.45-2.40 (m, 2H, CH2CHO), 1.88-1.80 
(m, 1H, CH), 1.77-1.68 (m, 1H, CHAHBCH), 1.52-1.42 (m, 1H, CHAHBCH), 0.91 
(d, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) δ 201.6 (C=O), 144.8 
(Ar), 132.6 (ipso-Ar), 129.8 (Ar), 127.7 (Ar), 74.2 (OCH2), 40.8 (CH2), 32.1 
(CH), 24.6 (CH2), 21.5 (C6H4Me), 16.0 (Me); MS (ESI) m/z 293 [(M + Na)+, 41], 
288 (100); HRMS (ESI) m/z calcd for C13H18O4S (M + Na)+ 293.0818, found 
293.0824 (_2.2 ppm error). 
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5-Hydroxy-2,6-dimethylheptyl 4-methylbenzenesulfonate 117 
i-PrMgCl (1.30 mL of a 2 M solution in THF, 2.60 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of aldehyde 104 (585 mg, 2.16 mmol, 1.0 eq.) in 
THF (10 mL) at 0 ºC under Ar. The resulting mixture was stirred at 0 ºC for 1 h 
and then stirred at rt for 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two 
layers were separated. The aqueous layer was extracted with Et2O (3 × 10 mL) 
and the combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 4:1 petrol-Et2O as eluent gave a 50:50 mixture (by 
13C NMR spectroscopy) of alcohol 117 (596 mg, 88%) as a colourless oil, RF (4:1 
petrol-Et2O) 0.3; IR (film) 3566 (OH), 2962, 1465, 1359, 1176, 1121, 1098, 966, 
835, 815, 667, 555 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.0 Hz, 2H, 
o-C6H4SO2), 7.32 (d, J = 8.0 Hz, 2H, m-C6H4SO2), 3.88-3.76 (m, 2H, CH2OSO2), 
3.25-3.22 (m, 1H, CHOH), 2.41 (s, 3H, MeC6H4), 1.94 (s, 1H, OH), 1.80-1.01 (m, 
6H, CH), 0.88-0.83 (m, 9H, Me); 13C NMR (100.6 MHz, CDCl3) δ 144.6 
(ipso-Ar), 132.9 (ipso-Ar), 129.7 (Ar), 127.7 (Ar), 76.5 (CHOH), 76.3 (CHOH), 
74.9 (OCH2), 74.8 (OCH2), 32.4 (CH), 33.2 (CH), 32.8 (CH), 32.7 (CH), 30.9 
(CH2), 30.8 (CH2), 29.0 (CH2), 28.9 (CH2), 21.5 (C6H4Me), 18.7 (Me), 18.6 (Me), 
17.0 (Me), 16.8 (Me), 16.4 (Me), 16.2 (Me); MS (ESI) m/z 315 [(M +, 13], 332 
(100); HRMS (ESI) m/z calcd for C16H27O4S M + 315.1624, found 315.1624 
(+0.1 ppm error). 
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Attempted synthesis of 2-i-propyl-5-methyltetrahydro-2H-pyran 115 
K2CO3 (264 mg, 1.91 mmol, 3.0 eq.) was added to a stirred solution of alcohol 
117 (200 mg, 0.64 mmol, 1.0 eq.) in MeOH (5 mL) under Ar. The resulting 
mixture was stirred at rt for 16 h. H2O (10 mL) was added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. No evidence of the desired product was 
observed in the 1H NMR spectrum of the crude product. 
K2CO3 (264 mg, 1.91 mmol, 3.0 eq.) was added to a stirred solution of alcohol 
117 (200 mg, 0.64 mmol, 1.0 eq.) in MeOH (5 mL) under Ar. The resulting 
mixture was stirred and heated to reflux for 16 h. After being allowed to cool to 
rt, the solution was poured into saturated NH4Cl(aq) (10 mL) and the two layers 
were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. No evidence of the desired product was 
observed in the 1H NMR spectrum of the crude product and starting material 
alcohol 117 was still present. 
A solution of alcohol 117 (130 mg, 0.41 mmol, 1.0 eq.) in THF (2 mL) was 
added dropwise to a stirred suspension of NaH (33 mg of 60% wt dispersion in 
mineral oil, 0.82 mmol, pre-washed with Et2O (3 × 2 mL), 2.0 eq.) in THF (3 mL) 
under Ar. The resulting mixture was stirred and heated to reflux for 16 h. After 
being allowed to cool to rt, the solution was poured into saturated NH4Cl(aq) (10 
mL) and the two layers were separated. The aqueous layer was extracted with 
Et2O (3 × 5 mL) and the combined organic layers were dried (MgSO4) and 
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evaporated under reduced pressure to give the crude product. No evidence of the 
desired product was observed in the 1H NMR spectrum of the crude product. 
 
6-Methylhept-1-en-4-ol 122 
Using general procedure A, allyl magnesium bromide (100 mL of 1 M solution 
in Et2O, 100.0 mmol, 1.1 eq.) and 3-methylbutanal (7.8 g, 90.9 mmol, 1.0 eq.) in 
Et2O (100 mL) gave the crude product. Purification by flash column 
chromatography with 4:1 petrol-Et2O as eluent gave alcohol 122 (10.5 g, 90%) as 
a colourless oil, RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 
5.89-5.78 (m, 1H, =CH), 5.16-5.11 (m, 2H, =CH2), 3.76-3.70 (m, 1H, CHOH), 
2.32-2.26 (m, 1H, =CHCHAHB), 2.16-2.09 (m, 1H,=CHCHAHB), 1.83-1.76 (m, 
1H, CHMe2), 1.56 (br s, 1H, OH), 1.42 (ddd, J = 13.0, 9.0, 5.0 Hz, 1H, 
CHAHBCHOH), 1.25 (ddd, J = 13.0, 9.0, 5.0 Hz, 1H, CHAHBCHOH ), 0.93 (d, J 
= 7.0 Hz, 3H, Me), 0.91 (d, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) 
δ 134.9 (=CH), 118.1 (=CH2), 68.6 (CHO), 46.0 (CH2), 42.5 (CH2), 24.6 (CH), 
23.4 (Me), 22.1 (Me). Spectroscopic data consistent with those reported in the 
literature.131 
 
2,2-Dimethylhex-5-en-3-ol 123 
Using general procedure A, allyl magnesium bromide (100 mL of 1 M solution 
in Et2O, 100.0 mmol, 1.1 eq.) and pivalaldehyde (7.8 g, 90.9 mmol, 1.0 eq.) in 
Et2O (100 mL) gave the crude product. Purification by flash column 
chromatography with 4:1 petrol-Et2O as eluent gave alcohol 123 (6.5 g, 56%) as 
a colourless oil, RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 
5.90-5.80 (m, 1H, =CH), 5.15-5.11 (m, 2H, =CH2), 3.24 (dd, J = 11.0, 10.0 Hz, 
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1H, CHOH), 2.38-2.33 (m, 1H, =CHCHAHB), 2.01-1.93 (m, 1H, =CHCHAHB), 
1.67 (s, 1H, OH), 0.91 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) δ 136.6 
(=CH), 117.7 (=CH2), 78.1 (CHO), 36.5 (CH2), 34.5 (CMe3), 25.7 (CMe3). 
Spectroscopic data consistent with those reported in the literature. 132 
 
Oct-1-en-4-ol 124 
Using general procedure A, allyl magnesium bromide (100 mL of 1 M solution 
in Et2O, 100.0 mmol, 1.1 eq.) and pentanal (7.8 g, 90.9 mmol, 1.0 eq.) in Et2O 
(100 mL) gave the crude product. Purification by flash column chromatography 
with 4:1 petrol-Et2O as eluent gave alcohol 124 (11.0 g, 94%) as a colourless oil, 
RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 5.88-5.78 (m, 1H, =CH), 
5.15-5.11 (m, 2H, =CH2), 3.67-3.61 (m, 1H, CHOH), 2.33-2.09 (m, 2H, 
=CHCH2), 1.75 (s, 1H, OH), 1.49-1.30 (m, 6H, CH), 0.91 (t, J = 7.0 Hz, 3H, Me); 
13C NMR (100.6 MHz, CDCl3) δ 134.9 (=CH), 118.0 (=CH2), 70.6 (CHO), 41.9 
(CH2), 36.5 (CH2), 27.8 (CH2), 22.7 (CH2), 14.0 (Me). Spectroscopic data 
consistent with those reported in the literature.133 
 
Non-1-en-4-ol 125 
Using general procedure A, allyl magnesium bromide (100 mL of 1 M solution 
in Et2O, 100.0 mmol, 1.1 eq.) and hexanal (9.1 g, 90.9 mmol, 1.0 eq.) in Et2O 
(100 mL) gave the crude product. Purification by flash column chromatography 
with 4:1 petrol-Et2O as eluent gave alcohol 125 (12.2 g, 98%) as a colourless oil, 
RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 5.88-5.78 (m, 1H, =CH), 
5.15-5.11 (m, 2H, =CH2), 3.67-3.61 (m, 1H, CHOH), 2.33-2.27 (m, 1H, 
=CHCHAHB), 2.17-2.10 (m, 1H, =CHCHAHB), 1.72 (s, 1H, OH), 1.47-1.29 (m, 
8H, CH), 0.89 (t, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) δ 134.9 
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(=CH), 118.0 (=CH2), 70.8 (CHO), 42.0 (CH2), 36.9 (CH2), 31.8 (CH2), 25.4 
(CH2), 22.7 (CH2), 14.1 (Me). Spectroscopic data consistent with those reported 
in the literature.132 
 
1-Cyclohexylbut-3-en-1-ol 126 
Using general procedure A, allyl magnesium bromide (19.61 mL of 1 M solution 
in Et2O, 19.61 mmol, 1.1 eq.) and cyclohexanecarbaldehyde (2.0 g, 90.9 mmol, 
1.0 eq.) in Et2O (50 mL) gave the crude product. Purification by flash column 
chromatography with 4:1 petrol-Et2O as eluent gave alcohol 126 (2.3 g, 82%) as 
a colourless oil, RF (4:1 petrol-Et2O) 0.4; 1H NMR (400 MHz, CDCl3) δ 
5.90-5.78 (m, 1H, =CH), 5.17-5.13 (m, 2H, =CH2), 3.42-3.38 (m, 1H, CHOH), 
2.38-2.37 (m, 1H, =CHCHAHB), 2.32-2.09 (m, 1H, =CHCHAHB), 1.89-1.65 (m, 
5H), 1.56 (s, 1H, OH), 1.42-0.98 (m, 6H); 13C NMR (100.6 MHz, CDCl3) 
δ 135.5 (=CH), 118.0 (=CH2), 74.7 (CHO), 43.1 (CH), 38.8 (CH2), 29.1 (CH2), 
28.1 (CH2), 26.5 (CH2), 26.3 (CH2), 26.1 (CH2). Spectroscopic data consistent 
with those reported in the literature.132 
 
1-Phenylbut-3-en-1-ol 127 
Using general procedure A, allyl magnesium bromide (100 mL of 1 M solution 
in Et2O, 100.0 mmol, 1.1 eq.) and benzaldehyde (9.6 g, 90.9 mmol, 1.0 eq.) in 
Et2O (100 mL) gave the crude product. Purification by flash column 
chromatography with 4:1 petrol-Et2O as eluent gave alcohol 127 (11.0 g, 90%) as 
a colourless oil, RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 
7.38-7.34 (m, 5H, Ph), 5.88-5.78 (m, 1H, =CH), 5.21-5.15 (m, 2H, =CH2), 3.55 
(ddd, J = 8.0, 5.0, 3.0 Hz, 1H, CHOH), 2.59-2.47 (m, 2H, =CHCH2), 2.06-2.04 
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(m, 1H, OH); 13C NMR (100.6 MHz, CDCl3) δ 143.8 (ipso-Ph), 134.4 (Ph), 
128.4 (Ph), 127.5 (Ph), 125.8 (=CH), 118.3 (=CH2), 73.2 (CHO), 43.8 (CH2); MS 
(ESI) m/z 171 [(M + Na)+, 75], 131 (100); HRMS (ESI) m/z calcd for C10H12O 
(M + Na)+ 171.0786, found 171.0780 (¯3.5 ppm error). Spectroscopic data 
consistent with those reported in the literature.134 
 
1-Phenylhex-5-en-3-ol 128 
Using general procedure A, allyl magnesium bromide (41.0 mL of 1 M solution 
in Et2O, 41.0 mmol, 1.1 eq.) and 3-phenylpropanal (5.0 g, 37.23 mmol, 1.0 eq.) 
in Et2O (100 mL) gave the crude product. Purification by flash column 
chromatography with 4:1 petrol-Et2O as eluent gave alcohol 128 (3.4 g, 51%) as 
a colourless oil, RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 
7.32-7.28 (m, 2H, Ph), 7.23-7.18 (m, 3H, Ph), 5.88-5.78 (m, 1H, =CH), 5.18-5.14 
(m, 2H, =CH2), 3.72-3.66 (m 1H, CHOH), 2.86-2.79 (m, 1H, =CHCHAHB), 
2.74-2.67 (m, 1H, =CHCHAHB), 2.37-2.31 (m, 1H, CHAHBOH), 2.23-2.16 (m, 
1H, CHAHBOH), 1.83-1.77 (m, 2H, CH2), 1.62 (m, 1H, OH); 13C NMR (100.6 
MHz, CDCl3) δ 142.0 (ipso-Ph), 134.6 (Ph), 128.4 (Ph), 128.3 (Ph), 125.8 (=CH), 
118.4 (=CH2), 69.9 (CHO), 42.1 (CH2), 38.4 (CH2), 32.0 (CH2). Spectroscopic 
data consistent with those reported in the literature.135 
 
6-Methyl-4-(2-methylallyloxy)hept-1-ene 129 
Using general procedure B, alcohol 122 (3.0 g, 23.40 mmol, 1.0 eq.), NaH (3.4 g 
of 60% wt dispersion in mineral oil, 70.20 mmol, pre-washed with Et2O (3 × 10 
mL), 3.0 eq.) and 3-bromo-2-methylprop-1-ene (2.81 mL, 28.08 mmol, 1.2 eq.) 
in THF (60 mL) gave the crude product. Purification by flash column 
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chromatography with 99:1 petrol-Et2O as eluent gave ether 129 (3.9 g, 90%) as a 
colourless oil, RF (99:1 petrol-Et2O) 0.5; IR (film) 2956, 2926, 2869, 1464, 1368, 
1347, 1085, 992, 899, 735 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.84 (ddt, J = 
17.0, 10.0, 7.0 Hz, 1H, =CH), 5.10-5.04 (m, 2H, =CH2), 4.97-4.87 (m, 2H, 
=CH2), 3.95 (d, J = 12.0 Hz, 1H, OCHAHB), 3.83 (d, J = 12.0 Hz, 1H, OCHAHB), 
3.45-3.40 (m, 1H, CHO), 2.30-2.27 (m, 2H, =CHCH2), 1.83-1.78 (m, 1H, 
CHMe2), 1.76 (s, 3H, =CMe), 1.50 (ddd, J = 14.0, 8.0, 6.0 Hz, 1H, CHAHBCHO), 
1.24 (ddd, J = 14.0, 8.0, 6.0 Hz, 1H, CHAHBCHO ), 0.93 (d, J = 7.0 Hz, 3H, 
CHMe), 0.90 (d, J = 7.0 Hz, 3H, CHMe); 13C NMR (100.6 MHz, CDCl3) δ 142.8 
(=CMe), 135.0 (=CH), 116.8 (=CH2), 112.0 (=CH2), 76.6 (CHO), 72.9 (OCH2), 
43.4 (CH2), 38.5 (CH2), 24.5 (CH), 23.3 (Me), 22.3 (Me), 19.8 (Me); MS (APCI) 
m/z 183 [(M + H)+, 30], 179 (100); HRMS (APCI) m/z calcd for C12H22O (M + 
H)+ 183.1746, found 183.1743 (1.4 ppm error). 
 
5,5-Dimethyl-4-[(2-methylprop-2-en-1-yl)oxy]hex-1-ene 130 
Using general procedure B, alcohol 123 (3.0 g, 23.40 mmol, 1.0 eq.), NaH (3.4 g 
of 60% wt dispersion in mineral oil, 70.20 mmol, pre-washed with Et2O (3 × 10 
mL), 3.0 eq.) and 3-bromo-2-methylprop-1-ene (2.81 mL, 28.08 mmol, 1.2 eq.) 
in THF (60 mL) gave the crude product. Purification by flash column 
chromatography with 99:1 petrol-Et2O as eluent gave ether 130 (4.1 g, 94%) as a 
colourless oil, RF (99:1 petrol-Et2O) 0.5; IR (film) 2955, 2867, 1640 (C=C), 1480, 
1462, 1392, 1363, 1335, 1113, 1090, 1058, 987, 898 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 5.94 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, =CH), 5.12-5.06 (m, 1H, 
=CHAHB), 5.01-4.83 (m, 3H, =CH2, =CHAHB), 4.02 (d, J = 12.0 Hz, 1H, 
OCHAHB), 3.83 (d, J = 12.0 Hz, 1H, OCHAHB), 2.93 (dd, J = 8.5, 8.0 Hz, 1H, 
CHO), 2.37-2.30 (m, 1H, =CHCHAHB), 2.25-1.16 (m, 1H, =CHCHAHB), 1.75 (s, 
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3H, =CMe), 0.93 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) δ 142.9 (=CMe), 
137.5 (=CH), 115.8 (=CH2), 111.2 (=CH2), 87.9 (CHO), 76.3 (OCH2), 36.0 
(CMe3), 35.8 (CH2), 26.3 (CMe3), 19.9 (Me); MS (ESI) m/z 183 [(M + H)+, 90], 
61 (100), 126 (70); HRMS (ESI) m/z calcd for C12H22O (M + H)+ 183.1737, 
found 183.1743 (+3.4 ppm error). 
 
4-[(2-Methylprop-2-en-1-yl)oxy]oct-1-ene 131 
Using general procedure B, alcohol 124 (2.0 g, 23.40 mmol, 1.0 eq.), NaH (2.3 g 
of 60% wt dispersion in mineral oil, 70.20 mmol, pre-washed with Et2O (3 × 10 
mL), 3.0 eq.) and 3-bromo-2-methylprop-1-ene (1.87 mL, 18.72 mmol, 1.2 eq.) 
in THF (60 mL) gave the crude product. Purification by flash column 
chromatography with 99:1 petrol-Et2O as eluent gave ether 131 (2.8 g, 98%) as a 
colourless oil, RF (99:1 petrol-Et2O) 0.4; IR (film) 2957, 2928, 2859, 1456, 1375, 
1342, 1107, 992, 911, 735 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.82 (ddt, J = 
17.0, 10.0, 7.0 Hz, 1H, =CH), 5.10-5.04 (m, 2H, =CH2), 4.98-4.87 (m, 2H, 
=CH2), 3.93 (d, J = 12.0 Hz, 1H, OCHAHB), 3.86 (d, J = 12.0 Hz, 1H, OCHAHB), 
3.38-3.32 (m, 1H, CHO), 2.30-2.27 (m, 2H, =CHCH2), 1.76 (s, 3H, =CMe), 
1.53-1.26 (m, 6H, 6 × CH), 0.91 (t, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, 
CDCl3) δ 142.8 (=CMe), 135.1 (=CH), 116.6 (=CH2), 111.9 (=CH2), 78.4 (CHO), 
72.9 (OCH2), 38.2 (CH2), 33.4 (CH2), 27.5 (CH2), 22.8 (CH2), 19.7 (Me), 14.1 
(Me); MS (APCI) m/z 183 [(M + H)+, 100], 165 (80); HRMS was not obtained 
successfully by either ESI or APCI. 
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4-[(2-Methylprop-2-en-1-yl)oxy]non-1-ene 132 
Using general procedure B, alcohol 125 (2.0 g, 14.06 mmol, 1.0 eq.), NaH (2.0 g 
of 60% wt dispersion in mineral oil, 44.4 mmol, pre-washed with Et2O (3 × 10 
mL), 3.0 eq.) and 3-bromo-2-methylprop-1-ene (1.69 mL, 16.87 mmol, 1.2 eq.) 
in THF (60 mL) gave the crude product. Purification by flash column 
chromatography with 99:1 petrol-Et2O as eluent gave ether 132 (2.7 g, 98%) as a 
colourless oil, RF (99:1 petrol-Et2O) 0.5; IR (film) 2928, 2857, 1641, 1456, 1375, 
1343, 1086, 993, 910, 735 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.83 (ddt, J = 
17.0, 10.0, 7.0 Hz, 1H, =CH), 5.11-5.03 (m, 2H, =CH2), 4.98-4.85 (m, 2H, 
=CH2), 3.92 (d, J = 12.0 Hz, 1H, OCHAHB), 3.86 (d, J = 12.0 Hz, 1H, OCHAHB), 
3.38-3.32 (m, 1H, CHO), 2.34-2.23 (m, 2H, =CHCH2), 1.76 (s, 3H, =CMe), 
1.51-1.46 (m, 2H, CH2), 1.35-1.26 (m, 6H, CH), 0.89 (t, J = 7.0 Hz, 3H, Me); 13C 
NMR (100.6 MHz, CDCl3) δ 142.8 (=CMe), 135.1 (=CH), 116.6 (=CH2), 111.8 
(=CH2), 78.4 (CHO), 72.8 (OCH2), 38.2 (CH2), 33.7 (CH2), 32.0 (CH2), 25.0 
(CH2), 22.6 (CH2), 19.6 (Me), 14.0 (Me); MS (ESI) m/z 197 [(M + H)+, 20], 61 
(100), 126 (70), 83 (65); HRMS (ESI) m/z calcd for C13H24O (M + H)+ 197.1907, 
found 197.1900 (_3.5 ppm error). 
 
(1-(2-Methylallyloxy)but-3-enyl)cyclohexane 133  
Using general procedure B, alcohol 126 (5.0 g, 32.40 mmol, 1.0 eq.), NaH (4.7 g 
of 60% wt dispersion in mineral oil, 44.4 mmol, pre-washed with Et2O (3 × 10 
mL), 3.0 eq.) and 3-bromo-2-methylprop-1-ene (3.89 mL, 16.87 mmol, 1.2 eq.) 
in THF (80 mL) gave the crude product. Purification by flash column 
chromatography with 99:1 petrol-Et2O as eluent gave ether 133 (2.7 g, 98%) as a 
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colourless oil, RF (99:1 petrol-Et2O) 0.4; IR (film) 2880, 2809, 1427, 1352, 1324, 
1094, 1016, 983, 884 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.92-5.82 (m, 1H, 
=CH), 5.10-5.03 (m, 2H, =CH2), 4.98-4.86 (m, 2H, =CH2), 3.93 (d, J = 12.0 Hz, 
1H, OCHAHB), 3.82 (d, J = 12.0 Hz, 1H, OCHAHB), 3.12-3.08 (m, 1H, CHO), 
2.31-2.26 (m, 2H, =CHCH2), 1.76 (s, 3H, =CMe), 1.26-0.87 (m, 11H, CH); 13C 
NMR (100.6 MHz, CDCl3) δ 142.9 (=CMe), 135.7 (=CH), 116.4 (=CH2), 111.8 
(=CH2), 83.3 (CHO), 73.9 (OCH2), 41.0 (CH), 35.2 (CH2), 28.9 (CH2), 28.6 
(CH2), 26.6 (CH2), 26.4 (CH2), 26.3 (CH2), 19.8 (Me); MS (ESI) m/z 1231 [(M + 
Na)+, 30], 137 (100); HRMS (ESI) m/z calcd for C14H24O (M + Na)+ 231.1727, 
found 231.1719 (_2.7 ppm error). 
 
(1-(2-Methylprop-2-en-1-yloxy)but-3-en-1-yl)benzene 12 
Using general procedure B, alcohol 127 (1.4 g, 9.65 mmol, 1.0 eq.), NaH (463 
mg of 60% wt dispersion in mineral oil, 44.4 mmol, pre-washed with Et2O (3 × 
10 mL), 1.2 eq.) and 3-bromo-2-methylprop-1-ene (1.17 mL, 11.58 mmol, 1.2 
eq.) in THF (45 mL) gave the crude product. Purification by flash column 
chromatography with 9:1 petrol-Et2O as eluent gave ether 12 (1.8 g, 93%) as a 
colourless oil, RF (9:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.38-7.29 
(m, 5H, Ph), 5.80 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, =CH), 5.08-5.01 (m, 2H, 
=CH2), 4.95 (br s, 1H, =CHAHBCMe), 4.89 (br s, 1H, =CHAHBCMe), 4.32 (dd, J 
= 7.0, 6.0 Hz, 1H, CHOH), 3.83 (d, J = 12.0 Hz, 1H, OCHAHB), 3.66 (d, J = 12.0 
Hz, 1H, OCHAHB), 2.61 (dt, J = 14.0, 7.0 Hz, 1H, CHAHBCH), 2.42 (dt, J = 14.0, 
6.0 Hz, 1H, CHAHBCH), 1.74 (s, 3H, Me); 13C NMR (100.6 MHz, CDCl3) 
δ 142.2 (ipso-Ph), 141.9 (=CMe), 134.9 (Ph), 128.2 (Ph), 127.5 (Ph), 126.7 
(=CH), 116.8 (=CH2), 111.9 (=CH2), 80.8 (CHO), 72.2 (OCH2), 42.7 (CH2), 19.6 
(Me); MS (ESI) m/z 225 [(M + Na)+, 40], 131 (100), 222 (63); HRMS (ESI) m/z 
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calcd for C14H18O (M + Na)+ 225.1258, found 225.1250 (_3.8 ppm error). 
Spectroscopic data consistent with those reported in the literature.136 
 
(3-(2-Methylallyloxy)hex-5-enyl)benzene 134 
Using general procedure B, alcohol 128 (3.0 g, 17.03 mmol, 1.0 eq.), NaH (2.0 g 
of 60% wt dispersion in mineral oil, 51.09 mmol, pre-washed with Et2O (3 × 10 
mL), 3.0 eq.) and 3-bromo-2-methylprop-1-ene (1.87 mL, 18.73 mmol, 1.2 eq.) 
in THF (80 mL) gave the crude product. Purification by flash column 
chromatography with 99:1 petrol-Et2O as eluent gave ether 134 (3.4 g, 86%) as a 
colourless oil, RF (99:1 petrol-Et2O) 0.4; IR (film) 3029, 2980, 2930, 2875, 2816, 
1473, 1432, 1323, 1080, 888, 735, 688 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.31-7.27 (m, 2H, Ph), 7.21-7.17 (m, 3H, Ph), 5.84 (ddt, J = 17.0, 10.0, 7.0 Hz, 
1H, =CH), 5.12-5.06 (m, 2H, =CH2), 5.01 (br s, 1H, =CHAHBCMe), 4.90 (br s, 
1H, =CHAHBCMe), 3.96 (d, J = 12.0 Hz, 1H, OCHAHB), 3.87 (d, J = 12.0 Hz, 
1H, OCHAHB), 3.44-3.38 (m, 1H, CHO), 2.78 (ddd, J = 14.0, 10.0, 6.0 Hz, 1H, 
CHAHBCH), 2.64 (dt, J = 14.0, 10.0, 6.0 Hz, 1H, CHAHBCH), 2.40-2.28 (m, 2H, 
CH2), 1.87-1.82 (m, 2H, CH2), 1.80 (s, 3H, Me); 13C NMR (100.6 MHz, CDCl3) 
δ 142.7 (ipso-Ph), 142.4 (=CMe), 134.8 (Ph), 128.4 (Ph), 128.3 (Ph), 125.7 
(=CH2), 117.0 (=CH), 112.0 (=CH2), 76.7 (CHO), 72.9 (OCH2), 38.2 (CH2), 35.6 
(CH2), 31.7 (CH2), 19.8 (Me); MS (ESI) m/z 253 [(M + Na)+, 100]; HRMS (ESI) 
m/z calcd for C16H22O (M + Na)+ 253.1559, found 253.1563 (1.1 ppm error). 
 
2-i-Butyl-5-methyl-3,6-dihydro-2H-pyran 135 
Using general procedure C, Grubbs’ 2nd generation catalyst 5 (23 mg, 0.03 
mmol, 0.01 eq.) and diene 129 (500 mg, 2.74 mmol, 1.0 eq.) in CH2Cl2 (25 mL) 
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gave the crude product. Purification by flash column chromatography with 99:1 
petrol-Et2O as eluent gave cyclic ether 135 (347 mg, 82%) as a brown oil, RF 
(99:1 petrol-Et2O) 0.3; IR (film) 2956, 2919, 2832, 2808, 1467, 1449, 1379, 1367, 
1131, 1100, 1060, 979, 904, 800 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.48-5.47 
(m, 1H, =CH), 4.07-3.95 (m, 2H, CH2O), 3.52-3.40 (m, 1H, CHO), 1.95-1.92 (m, 
2H, =CHCH2), 1.83-1.76 (m, 1H, CHMe2), 1.59 (s, 3H, =CMe), 1.53-1.46 (m, 
1H, CHAHBCHO), 1.28-1.21 (m, 1H, CHAHBCHO), 0.91 (d, J = 7.0 Hz, 6H, 
CHMe2); 13C NMR (100.6 MHz, CDCl3) δ 133.0 (=CMe), 118.6 (=CH), 71.8 
(CHO), 69.2 (OCH2), 45.0 (CH2), 31.4 (CH2), 24.4 (CH), 23.1 (Me), 22.5 (Me), 
18.6 (Me); MS was not obtained successfully by either ESI or APCI. 
 
2-t-Butyl-5-methyl-3,6-dihydro-2H-pyran 136 
Using general procedure C, Grubbs’ 2nd generation catalyst 5 (2 mg, 0.003 
mmol, 0.01 eq.) and diene 130 (50 mg, 0.27 mmol, 1.0 eq.) in CH2Cl2 (1 mL) 
gave the crude product. Purification by flash column chromatography with 99:1 
petrol-Et2O as eluent gave cyclic ether 136 (34 mg, 80%) as a brown oil, RF (99:1 
petrol-Et2O) 0.3; IR (film) 2956, 2921, 2871, 2819, 1481, 1465, 1448, 1363, 
1108, 1083, 1049, 984, 903, 735 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.52-5.49 
(m, 1H, =CH), 4.04-4.03 (m, 2H, CH2O), 3.07 (dd, J = 8.5, 8.0 Hz, 1H, CHO), 
2.19-2.02 (m, 1H, =CHCHAHB), 1.90-1.85 (m, 1H, =CHCHAHB), 1.60 (s, 3H, 
=CMe), 0.92 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) δ  133.0 (=CMe), 
119.1 (=CH), 81.6 (CHO), 70.2 (OCH2), 33.7 (CMe3), 25.8 (CMe3), 25.4 (CH2), 
18.5 (Me); MS was not obtained successfully by either ESI or APCI. 
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2-Butyl-5-methyl-3,6-dihydro-2H-pyran 137 
Using general procedure C, Grubbs’ 2nd generation catalyst 5 (55 mg, 0.06 
mmol, 0.01 eq.) and diene 131 (1.18 g, 6.47 mmol, 1.0 eq.) in CH2Cl2 (50 mL) 
gave the crude product. Purification by flash column chromatography with 99:1 
petrol-Et2O as eluent gave cyclic ether 137 (970 mg, 97%) as a colourless oil, RF 
(99:1 petrol-Et2O) 0.3; IR (film) 2957, 2928, 2859, 1449, 1379, 1358, 1125, 1098, 
1068, 978, 909, 734 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.48-5.47 (m, 1H, 
=CH), 4.08-3.97 (m, 2H, CH2O), 3.44-3.38 (m, 1H, CHO), 1.97-1.94 (m, 2H, 
=CHCH2), 1.60 (s, 3H, =CMe), 1.56-1.30 (m, 6H, CH), 0.91 (t, J = 6.0 Hz, 3H, 
Me); 13C NMR (100.6 MHz, CDCl3) δ 132.9 (=CMe), 118.6 (=CH), 73.6 (CHO), 
69.2 (OCH2), 35.5 (CH2), 31.0 (CH2), 27.7 (CH2), 22.7 (CH2), 18.5 (Me), 14.0 
(Me); MS (ESI) m/z 155 [(M + H)+, 10], 317 (100); HRMS (ESI) m/z calcd for 
C10H18O (M + H)+ 155.1424, found 155.1430 (+3.4 ppm error). 
 
5-Methyl-2-pentyl-3,6-dihydro-2H-pyran 138 
Using general procedure C, Grubbs’ 2nd generation catalyst 5 (43 mg, 0.05 
mmol, 0.01 eq.) and diene 132 (1.1 g, 5.09 mmol, 1.0 eq.) in CH2Cl2 (50 mL) 
gave the crude product. Purification by flash column chromatography with 99:1 
petrol-Et2O as eluent gave cyclic ether 138 (820 mg, 96%) as a colourless oil, RF 
(99:1 petrol-Et2O) 0.3; IR (film) 2927, 2858, 1449, 1379, 1357, 1125, 1100, 1069, 
979, 901, 734 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.48-5.47 (m, 1H, =CH), 
4.08-3.97 (m, 2H, CH2O), 3.44-3.38 (m, 1H, CHO), 1.97-1.91 (m, 2H, =CHCH2), 
1.59 (s, 3H, =CMe), 1.57-1.30 (m, 8H, CH), 0.89 (t, J = 6.0 Hz, 3H, Me); 13C 
NMR (100.6 MHz, CDCl3) δ 132.9 (=CMe), 118.5 (=CH), 73.6 (CHO), 69.2 
(OCH2), 35.8 (CH2), 31.9 (CH2), 31.0 (CH2), 25.2 (CH2), 22.6 (CH2), 18.6 (Me), 
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14.1 (Me); MS (APCI) m/z 169 [(M + H)+, 20], 151 (100), 95 (70); HRMS 
(APCI) m/z calcd for C11H20O (M + H)+ 169.1579, found 169.1587 (4.5 ppm 
error). 
 
2-Cyclohexyl-5-methyl-3,6-dihydro-2H-pyran 139 
Using general procedure C, Grubbs’ 2nd generation catalyst 5 (2 mg, 0.003 
mmol, 0.01 eq.) and diene 133 (50 mg, 0.25 mmol, 1.0 eq.) in CH2Cl2 (1 mL) 
gave the crude product. Purification by flash column chromatography with 99:1 
petrol-Et2O as eluent gave cyclic ether 139 (39 mg, 89%) as a colourless oil, RF 
(99:1 petrol-Et2O) 0.5; IR (film) 2922, 2851, 1449, 1378, 1353, 1140, 1105, 1082, 
1068, 1027, 986, 906, 888, 823, 734 cm-1; 1H NMR (400 MHz, CDCl3) δ 
5.47-5.45 (m, 1H, =CH), 4.03-3.94 (m, 2H, CH2O), 3.14-3.09 (m, 1H, CHO), 
2.04-1.86 (m, 3H, CH), 1.74-1.63 (m, 4H, CH), 1.57 (s, 3H, =CMe), 1.41-1.32 
(m, 1H, CH), 1.28-1.01 (m, 3H, CH), 1.04-0.90 (m, 2H, CH); 13C NMR (100.6 
MHz, CDCl3) δ  132.9 (=CMe), 118.7 (=CH), 77.9 (CHO), 69.5 (OCH2), 42.6 
(CH), 29.2 (CH2), 28.4 (CH2), 28.0 (CH2), 26.6 (CH2), 26.1 (CH2), 26.0 (CH2), 
18.5 (Me); MS (APCI) m/z 181 [(M + H)+, 20], 163 (100), 179 (50); HRMS was 
not obtained successfully by either ESI or APCI. 
 
5-Methyl-2-phenyl-3,6-dihydro-2H-pyran 13 
Using general procedure C, Grubbs’ 2nd generation catalyst 5 (49 mg, 0.06 
mmol, 0.01 eq.) and diene 12 (0.6 g, 0.58 mmol, 1.0 eq.) in CH2Cl2 (50 mL) gave 
the crude product. Purification by flash column chromatography with 99:1 
petrol-Et2O as eluent gave cyclic ether 13 (502 mg, 98%) as a colourless oil, RF 
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(99:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.40-7.28 (m, 5H, Ph), 
5.62-5.61 (m, 1H, =CH), 4.51 (dd, J = 10.0, 4.0 Hz, 1H, CHO), 4.29-4.16 (m, 2H, 
OCH2), 2.38-2.21 (m, 2H, =CHCH2), 1.68 (s, 3H, Me); 13C NMR (100.6 MHz, 
CDCl3) δ 142.5 (ipso-Ph), 133.1 (=CMe), 128.3 (Ph), 127.4 (Ph), 125.8 (Ph), 
118.8 (=CH), 76.7 (CHO), 75.7 (OCH2), 32.8 (CH2), 18.5 (Me); MS (ESI) m/z 
173 [(M)+, 80], 171 (100); HRMS (ESI) m/z calcd for C12H13O M + 173.0961, 
found 173.0948 (1.2 ppm error). Spectroscopic data consistent with those 
reported in the literature.137  
 
5-Methyl-2-phenethyl-3,6-dihydro-2H-pyran 140 
Using general procedure C, Grubbs’ 2nd generation catalyst 5 (30 mg, 0.08 
mmol, 0.01 eq.) and diene 134 (1.0 g, 7.67 mmol, 1.0 eq.) in CH2Cl2 (20 mL) 
gave the crude product. Purification by flash column chromatography with 99:1 
petrol-Et2O as eluent gave cyclic ether 140 (1.38 g, 89%) as a colourless oil, RF 
(99:1 petrol-Et2O) 0.3; IR (film) 2980, 2879, 2815, 2789, 1429, 1093, 1050, 895, 
722, 689 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.31-7.27 (m, 2H, Ph), 7.22-7.17 
(m, 3H, Ph), 5.48-5.47 (m, 1H, =CH), 4.10-4.00 (m, 2H, OCH2), 3.42 (ddt, J = 
13.0, 9.0, 4.0 Hz, 1H, CHO), 2.85-2.78 (m, 1H, CHOCHAHB), 2.70 (ddd, J = 
14.0, 9.0, 7.0 Hz, 1H, CHOHAHB), 2.06-1.73 (m, 4H, CH2), 1.73 (s, 3H, Me); 13C 
NMR (100.6 MHz, CDCl3) δ 142.2 (ipso-Ph), 133.0 (=CMe), 128.5 (Ph), 128.3 
(Ph), 125.7 (Ph), 118.4 (=CH), 72.6 (CHO), 69.2 (OCH2), 37.4 (CH2), 31.8 
(CH2), 31.0 (CH2), 18.6 (Me); MS (ESI) m/z 225 [(M + Na)+, 60], 91(100); 
HRMS (ESI) m/z calcd for C14H18O (M + Na) + 225.1251, found 225.1250 (_1.0 
ppm error). 
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2-i-5-Methyltetrahydro-2H-pyran cis-141 and trans-142 
Using general procedure D, Pd/C (69 mg of 5% wt on carbon, 0.06 mmol, 0.1 eq.) 
and alkene 135 (100 mg, 0.65 mmol, 1.0 eq.) in MeOH (2.5 mL) gave the crude 
product (24 mg, 23%) as a colourless oil, which contained an 83:17 mixture (by 
1H NMR spectroscopy) of cyclic ethers cis-141 and trans-142, RF (9:1 
petrol-Et2O) 0.3; IR (film) 2910, 2886, 2800, 1445, 1346, 1186, 1120, 1105, 
1069, 1024, 972, 894, 725 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.86 (ddd, J = 
11.0, 4.0, 2.0 Hz, 0.17H, C6HeqOtrans), 3.63 (dt, J = 11.0, 2.0 Hz, 0.83H, 
C6HeqOcis), 3.58 (dd, J = 11.0, 3.0 Hz, 0.83H, C6HaxOcis), 3.38-3.32 (m, 0.83H, 
C2Haxcis), 3.27-3.18 (m, 0.17H, C2Haxtrans), 2.98 (t, J = 11.0 Hz, 0.17H, C6Haxtrans), 
1.80-1.69 (m, 3H, CH), 1.52-1.37 (m, 4H, CH), 1.18-1.12 (m, 1H, CH), 1.07 (d, 
J = 7.0 Hz, 2.49H, CHMecis), 0.90 (d, J = 7.0 Hz, 6H, CHMe2), 0.78 (d, J = 7.0 
Hz, 0.51H, CHMetrans); 13C NMR (100.6 MHz, CDCl3) δ for cis-141 75.7 (CHO), 
72.5 (OCH2), 44.9 (CH2), 29.0 (CH2), 28.4 (CH), 27.4 (CH2), 24.2 (CH), 23.3 
(Me), 22.3 (Me), 16.7 (Me); δ  for trans-142 75.5, 74.8, 45.5, 32.5, 32.3, 31.4, 
31.0, 25.9, 24.3, 17.3; MS was not obtained successfully by either ESI or APCI. 
 
 2-t-Butyl-5-methyltetrahydro-2H-pyran cis-143 and trans-144 
Using general procedure D, Pd/C (69 mg of 5% wt on carbon, 0.06 mmol, 0.1 eq.) 
and alkene 136 (100 mg, 0.65 mmol, 1.0 eq.) in MeOH (2.5 mL) gave the crude 
product (76 mg, 77%), which contained an 89:11 mixture (by 1H NMR 
spectroscopy) of cyclic ethers cis-143 and trans-144. IR (film) 2908, 2883, 2811, 
1442, 1341, 1189, 1120, 1105, 1059, 1028, 971, 894, 724 cm-1; 1H NMR (400 
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MHz, CDCl3) δ 3.88 (ddd, J = 11.0, 4.0, 2.0 Hz, 0.11H, C6HeqOtrans), 3.71 (br dd, 
J = 11.0, 2.0 Hz, 0.89H, C6HeqOcis), 3.56 (dd, J = 11.0, 2.0 Hz, 0.89H, C6HaxOcis), 
2.96 (t, J = 11.0 Hz, 0.11H, C6Haxtrans), 2.85 (dd, J = 11.0, 2.0 Hz, 0.89H, 
C2Haxcis), 2.80 (dd, J = 11.0, 2.0 Hz, 0.11H, C2Haxtrans), 1.75-1.48 (m, 5H, CH), 
1.08 (d, J = 7.0 Hz, 2.67H, CHMecis), 0.90 (s, 8.01H, CMe3cis), 0.89 (s, 0.99H, 
CMe3trans), 0.76 (d, J = 7.0 Hz, 0.33H, CHMetrans); 13C NMR (100.6 MHz, CDCl3) 
δ for cis-143 86.3 (CHO), 73.5 (OCH2), 34.1 (CMe3), 29.7 (CH2), 28.1 (CH), 
26.0 (CMe3), 20.4 (CH2), 16.5 (Me); δ for trans-144 85.7 (CHO), 75.3 (OCH2), 
32.9, 31.1, 29.7, 26.2, 22.7, 17.2; MS was not obtained successfully by either ESI 
or APCI. 
 
2-Butyl-5-methyltetrahydro-2H-pyran cis-145 and trans-146 
Using general procedure D, Pd/C (69 mg of 5% wt on carbon, 0.06 mmol, 0.1 eq.) 
and alkene 137 (100 mg, 0.65 mmol, 1.0 eq.) in MeOH (2.5 mL) gave the crude 
product, which contained an 88:12 mixture (by 1H NMR spectroscopy) of cyclic 
ethers cis-145 and trans-146. Purification by flash column chromatography with 
95:5 petrol-Et2O as eluent gave an 88:12 mixture (by 1H NMR spectroscopy) of 
cyclic ethers cis-145 and trans-146 (23 mg, 23%) as a colourless oil, RF (95:5 
petrol-Et2O) 0.4; IR (film) 2887, 2813, 1441, 1363, 1119, 1078, 1060, 1020, 972, 
906, 723 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.86 (ddd, J = 11.0, 4.0, 2.0 Hz, 
0.12H, C6HeqOtrans), 3.63 (dt, J = 11.0, 2.0 Hz, 0.88H, C6HeqOcis), 3.58 (dd, J = 
11.0, 3.0 Hz, 0.88H, C6HaxOcis), 3.30-3.24 (m, 0.88H, C2Haxcis), 3.19-3.12 (m, 
0.12H, C2Haxtrans), 2.98 (t, J = 11.0 Hz, 0.12H, C6Haxtrans), 1.83-1.28 (m, 11H, 
CH), 1.06 (d, J = 7.0 Hz, 2.64H, CHMecis), 0.92 (t, J = 7.0 Hz, 3H, Mecis+trans), 
0.78 (d, J = 7.0 Hz, 0.36H, CHMetrans); 13C NMR (100.6 MHz, CDCl3) δ for 
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cis-145 77.7 (CHO), 72.5 (OCH2), 35.5 (CH2), 28.9 (CH2), 28.4 (CH), 27.8 
(CH2), 26.9 (CH2), 22.8 (CH2), 16.7 (Me), 14.1 (Me); δ for trans-146 (one CH, 
one CH2 and one Me signals are not resolved) 77.5 (CHO), 74.8 (OCH2), 36.1 
(CH2), 32.5 (CH2), 31.8 (CH2), 31.0 (CH2), 17.3 (Me); MS was not obtained 
successfully by either ESI or APCI. 
 
5-Methyl-2-pentyltetrahydro-2H-pyran cis-147 and trans-148 
Using general procedure D, Pd/C (63 mg of 5% wt on carbon, 0.06 mmol, 0.1 eq.) 
and alkene 138 (100 mg, 0.59 mmol, 1.0 eq.) in MeOH (2.5 mL) gave the crude 
product, which contained an 88:12 mixture (by 1H NMR spectroscopy) of cyclic 
ethers cis-147 and trans-148. Purification by flash column chromatography with 
95:5 petrol-Et2O as eluent gave an 83:17 mixture (by 1H NMR spectroscopy) of 
cyclic ethers cis-147 and trans-148 (87 mg, 86%) as a colourless oil, RF (95:5 
petrol-Et2O) 0.4; IR (film) 2886, 2812, 1441, 1363, 1119, 1054, 972, 895, 853, 
723 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.86 (ddd, J = 11.0, 4.0, 2.0 Hz, 0.17H, 
C6HeqOtrans), 3.63 (dt, J = 11.0, 2.0 Hz, 0.83H, C6HeqOcis), 3.58 (dd, J = 11.0, 3.0 
Hz, 0.83H, C6HaxOcis), 3.30-3.24 (m, 0.83H, C2HaxOtrans), 3.20-3.12 (m, 0.17H, 
C2Haxcis), 2.98 (t, J = 11.0 Hz, 0.17H, C6Haxtrans), 1.84-1.63 (m, 2H, CH), 
1.55-1.26 (m, 11H, CH), 1.07 (d, J = 7.0 Hz, 2.49H, CHMecis), 0.89 (t, J = 7.0 Hz, 
3H, Mecis+trans), 0.78 (d, J = 7.0 Hz, 0.52H, CHMetrans); 13C NMR (100.6 MHz, 
CDCl3) δ for cis-147 77.7 (CHO), 72.5 (OCH2), 35.8 (CH2), 32.0 (CH2), 28.9 
(CH2), 28.4 (CH), 26.9 (CH2), 25.3 (CH2), 22.7 (CH2), 16.7 (Me), 14.1 (Me); 
δ for trans-148 (two CH2 and one Me signals are not resolved) 77.5 (CHO), 74.8 
(OCH2), 36.4 (CH2), 32.5 (CH2), 31.8 (CH2), 31.0 (CH), 22.6 (CH2), 17.3 (Me); 
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MS (ESI) m/z 171 [(M + H)+, 30], 169 (100); HRMS (ESI) m/z calcd for C11H22O 
(M + H)+ 171.1743, found 171.1743 (0.7 ppm error). 
PtO2 (13.5 mg, 0.06 mmol, 0.1 eq.) was added to a stirred solution of the ether 
138 (100 mg, 0.59 mmol, 1.0 eq.) in MeOH (2 mL) at rt under N2. The flask was 
evacuated and back-filled with N2 three times and finally evacuated and 
back-filled with H2. Then, the mixture was stirred at rt for 1 h. Et2O (10 mL) was 
added and the solids were removed by filtration through a pad of Celite® and the 
filter-cake was washed with Et2O (3 × 10 mL). The combined organic washings 
were evaporated under reduced pressure to give the crude product, which 
contained a 55:45 mixture (by 1H NMR spectroscopy) of cyclic ether cis-147 and 
trans-148. 
RhCl(PPh3)3 (55 mg, 0.06 mmol, 0.1 eq.) was added to a stirred solution of the 
ether 138 (100 mg, 0.59 mmol, 1.0 eq.) in MeOH (2 mL) at rt under N2. The 
flask was evacuated and back-filled with N2 three times and finally evacuated 
and back-filled with H2. Then, the mixture was stirred at rt for 16 h. Et2O (10 mL) 
was added and the solids were removed by filtration through a pad of Celite® and 
the filter-cake was washed with Et2O (3 × 10 mL). The combined organic 
washings were evaporated under reduced pressure to give the crude product (60% 
conversion), which contained a 70:30 mixture (by 1H NMR spectroscopy) of 
cyclic ether trans-148 and cis-147. 
 
2-Cyclohexyl-5-methyltetrahydro-2H-pyran cis-149 and trans-150 
Using general procedure D, Pd/C (59 mg of 5% wt on carbon, 0.06 mmol, 0.1 eq.) 
and alkene 139 (100 mg, 0.56 mmol, 1.0 eq.) in MeOH (2.5 mL) gave the crude 
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product, which contained an 87:13 mixture (by 1H NMR spectroscopy) of cyclic 
ethers cis-149 and trans-150. Purification by flash column chromatography with 
95:5 petrol-Et2O as eluent gave an 87:13 mixture (by 1H NMR spectroscopy) of 
cyclic ethers cis-149 and trans-150 (58 mg, 57%) as a colourless oil, RF (95:5 
petrol-Et2O) 0.3; IR (film) 2879, 2808, 1427, 1197, 1057, 1019, 975, 872, 723 
cm-1; 1H NMR (400 MHz, CDCl3) δ 3.87 (ddd, J = 11.0, 4.0, 2.0 Hz, 0.13H, 
C6HeqOtrans), 3.64 (dt, J = 11.0, 2.0 Hz, 0.87H, C6HeqOcis), 3.56 (dd, J = 11.0, 3.0 
Hz, 0.87H, C6HaxOcis), 3.02-2.97 (m, 0.87H, C2Haxcis), 2.94-2.89 (m, 0.26H, 
C2Haxtrans, C6Haxtrans), 1.94-1.13 (m, 14H, CH), 1.06 (d, J = 7.0 Hz, 2.61H, Mecis), 
1.01-0.83 (m, 2H, CH), 0.78 (d, J = 7.0 Hz, 0.39H, Metrans); 13C NMR (100.6 
MHz, CDCl3) δ for cis-149 82.3 (CHO), 72.8 (OCH2), 42.4 (CH), 29.1 (CH2), 
29.0 (CH2), 28.7 (CH2), 28.4 (CH), 26.2 (CH2), 26.3 (CH2), 26.2 (CH2), 23.4 
(CH2), 16.6 (Me); δ for trans-150 (two CH2 signals are not resolved) 82.0 (CHO), 
75.0 (OCH2), 43.1 (CH), 32.6 (CH2), 31.2 (CH), 29.2 (CH2), 28.6 (CH2), 28.5 
(CH2), 26.2 (CH2), 17.2 (Me); MS (APCI) m/z 183 [(M + H)+, 100], 165 (70); 
HRMS (APCI) m/z calcd for C12H22O (M + H)+ 183.1743, found 831.1743 (1.9 
ppm error). 
 
5-Methyl-2-phenyltetrahydro-2H-pyran cis-79 and trans-78 
Using general procedure D, Pd/C (122 mg of 10% wt on carbon, 0.11 mmol, 0.1 
eq.) and alkene 13 (200 mg, 1.15 mmol, 1.0 eq.) in MeOH (5 mL) gave the crude 
product, which contained a 60:40 mixture (by 1H NMR spectroscopy) of cyclic 
ethers cis-79 and trans-78. Purification by flash column chromatography with 
99:1 petrol-Et2O as eluent gave a 55:45 mixture (by 1H NMR spectroscopy) of 
cyclic ethers cis-79 and trans-78 (116 mg, 57%) as a colourless oil, RF (99:1 
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petrol-Et2O) 0.2; IR (film) 2930, 2871, 2850, 1452, 1091, 1072, 1057, 1021, 992, 
910, 734, 699, 648 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.40-7.25 (m, 5H, Ph), 
4.38-4.35 (m, 0.6H, CHPhcis), 4.27 (dd, J = 11.0, 2.0 Hz, 0.4H, CHPhtrans), 4.04 
(ddd, J = 11.0, 4.0, 2.0 Hz, 0.4H, CHeqOtrans), 3.83-3.76 (m, 1.2H, CH2Ocis), 3.20 
(t, J = 11.0 Hz, 0.4H, C6HaxOtrans), 1.98-1.56 (m, 4.6H, CH), 1.36-1.26 (m, 0.4H, 
CH), 1.17 (d, J = 7.0 Hz, 1.8H, Me), 0.86 (d, J = 7.0 Hz, 1.2H, Me); 13C NMR 
(100.6 MHz, CDCl3) δ  143.1 (ipso-Ph), 143.0 (ipso-Ph), 128.2 (Ph), 127.2 (Ph), 
127.1 (Ph), 125.8 (Ph), 79.8 (CHO), 79.7 (CHO), 75.2 (OCH2), 73.0 (OCH2), 
34.0 (CH2), 32.8 (CH2), 30.7 (CH), 29.4 (CH2), 28.7 (CH2), 28.0 (CH), 17.2 (Me), 
16.2 (Me); 13C NMR (100.6 MHz, CDCl3) δ  143.1 (ipso-Ph), 143.0 (ipso-Ph), 
128.2 (Ph), 127.2 (Ph), 127.1 (Ph), 125.8 (Ph), 79.8 (CHO), 79.7 (CHO), 75.2 
(OCH2), 73.0 (OCH2), 34.0 (CH2), 32.8 (CH2), 30.7 (CH), 29.4 (CH2), 28.7 
(CH2), 28.0 (CH), 17.2 (Me), 16.2 (Me). Spectroscopic data not consistent with 
those reported in the literature.49 We believe that the stereochemical assignment 
made by Duñach and co-workers is incorrect. 
RhCl(PPh3)3 (55 mg, 0.06 mmol, 0.1 eq.) was added to a stirred solution of the 
ether 13 (100 mg, 0.57 mmol, 1.0 eq.) in MeOH (2 mL) at rt under N2. The flask 
was evacuated and back-filled with N2 three times and finally evacuated and 
back-filled with H2. Then, the mixture was stirred at rt for 16 h. Et2O (10 mL) 
was added and the solids were removed by filtration through a pad of Celite® and 
the filter-cake was washed with Et2O (3 × 10 mL). The combined organic 
washings were evaporated under reduced pressure to give the crude product (20% 
conversion), which contained a 75:25 mixture (by 1H NMR spectroscopy) of 
cyclic ether trans-78 and cis-79. 
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5-Methyl-2-phenethyltetrahydro-2H-pyran cis-151 and trans-152 
Using general procedure D, Pd/C (100 mg of 10% wt on carbon, 0.09 mmol, 0.1 
eq.) and alkene 140 (200 mg, 0.99 mmol, 1.0 eq.) in MeOH (5 mL) gave the 
crude product, which contained a 65:35 mixture (by 1H NMR spectroscopy) of 
cyclic ethers cis-151 and trans-152. Purification by flash column 
chromatography with 99:1 petrol-Et2O as eluent gave a 65:35 mixture (by 1H 
NMR spectroscopy) of cyclic ethers cis-151 and trans-152 (164 mg, 80%) as a 
colourless oil, RF (99:1 petrol-Et2O) 0.3; IR (film) 2980, 2884, 2806, 1472, 1433, 
1363, 1121, 1074, 1055, 1017, 895, 723, 688 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.31-7.17 (m, 5H, Ph), 3.90 (ddd, J = 12.0, 4.0, 2.0 Hz, 0.35H, C6HeqOtrans), 
3.67 (dt, J = 11.0, 2.0 Hz, 0.65H, C6HeqOcis), 3.62 (dd, J = 11.0, 3.0 Hz, 0.65H, 
C6HaxOcis), 3.33-3.27 (m, 0.65H, C2Haxcis), 3.23-3.15 (m, 0.35H, C2Haxtrans), 2.99 
(t, J = 12.0 Hz, 0.35H, C6Haxtrans), 2.82-2.75 (m, 1H, CHOCHAHB), 2.70-2.63 (m, 
1H, CHOCHAHB), 1.95-1.23 (m, 7H, CH), 1.08 (d, J = 7.0 Hz, 1.95H, CHMecis), 
0.79 (d, J = 7.0 Hz, 1.05H, CHMetrans); 13C NMR (100.6 MHz, CDCl3) (one CH2 
signal not resolved) δ  142.4 (ipso-Ph), 128.5 (Ph), 128.3 (Ph), 125.6 (Ph), 77.2 
(CHO), 76.5 (CHO), 74.8 (OCH2), 72.4 (OCH2), 38.0 (CH2), 37.4 (CH2), 32.4 
(CH2), 31.9 (CH2), 31.8 (CH2), 31.0 (CH), 28.9 (CH2), 28.4 (CH), 27.0 (CH2), 
17.2 (Me), 16.7 (Me); MS (ESI) m/z 205 [(M + H)+, 100]; HRMS (ESI) m/z calcd 
for C14H21O (M + H)+ 205.1590, found 205.1587 (_1.8 ppm error). 
 
(1-[(2-Bromoprop-2-en-1-yl)oxy]but-3-en-1-yl)benzene 181 
A solution of alcohol 127 (500 mg, 3.37 mmol, 1.0 eq.) in THF (10 mL) was 
added dropwise to a stirred suspension of NaH (162 mg of 60% wt dispersion in 
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mineral oil, 4.05 mmol, pre-washed with Et2O (3 × 2 mL), 1.2 eq.) in THF (25 
mL) at rt under Ar. The resulting mixture was stirred for 15 min. 
2,3-Dibromoprop-1-ene (0.49 mL, 4.05 mmol, 1.2 eq.) was added and the 
resulting mixture was stirred and heated at reflux for 72 h. After being allowed to 
cool to rt, the solution was poured into saturated NH4Cl(aq) (60 mL) and extracted 
with Et2O (3 × 20 mL). The combined organic extracts were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave ether 181 
(294 mg, 33%) as a colourless oil, RF (95:5 petrol-Et2O) 0.6; IR (NaCl) 3076, 
2977, 2906, 2856, 1640 (C=C), 1453, 1161, 1088, 1026, 997, 913, 760, 701 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.39-7.29 (m, 5H, Ph), 5.91 (dd, J = 3.0, 1.5 Hz, 
1H, BrC=CHAHB) 5.82 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, =CH), 5.61-5.60 (m, 1H, 
BrC=CHAHB),  5.10-5.03 (m, 2H, CH=CH2), 5.39 (dd, J = 8.0, 6.0 Hz, 1H, 
CHO), 4.04 (dt, J = 14.0, 1.5 Hz, 1H, OCHAHB), 3.86 (dt, J = 14.0, 1.5 Hz, 1H, 
OCHAHB), 2.67-2.60 (m, 1H, CHAHBCH), 2.48-2.42 (m, 1H, CHAHBCH); 13C 
NMR (100.6 MHz, CDCl3) δ 141.1 (ipso-Ph), 134.5 (Ph), 129.5 (=CBr), 128.5 
(Ph), 127.9 (=CH), 126.8 (Ph), 117.5 (=CH2), 117.2 (=CH2), 81.2 (CHO), 72.4 
(OCH2), 42.5 (CH2); MS (ESI) m/z 289 [(79M + Na)+, 45], 126 (100), 91 (70), 
159 (65), 301 (45); HRMS (ESI) m/z calcd for C13H1579BrO (M + Na) + 289.0198, 
found 289.0196 (0.8 ppm error). 
A solution of alcohol 127 (500 mg, 3.37 mmol, 1.0 eq.) in CH2Cl2 (10 mL) was 
added dropwise to a stirred suspension of cetyltrimethylammonium bromide (184 
mg, 0.51 mmol, 0.15 eq.) in 50% NaOH(aq) (10 mL) at rt. The resulting mixture 
was stirred for 15 min. 2,3-Dibromoprop-1-ene (0.41 mL, 3.37 mmol, 1.0 eq.) 
was added and the resulting mixture was stirred at rt for 1 h. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic extracts were dried (MgSO4) and evaporated under reduced 
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pressure to give the crude product. Purification by flash column chromatography 
with 95:5 petrol-Et2O as eluent gave ether 181 (173 mg, 19%) as a colourless oil. 
 
2-((2-Bromoprop-2-en-1-yl)oxy)pentane 177 
A solution of alcohol 178 (500 mg, 5.81 mmol, 1.0 eq.) in THF (10 mL) was 
added dropwise to a stirred suspension of NaH (279 mg of 60% wt dispersion in 
mineral oil, 6.97 mmol, pre-washed with Et2O (3 × 5 mL), 1.2 eq.) in THF (25 
mL) at rt under Ar. The resulting mixture was stirred for 15 min. 
2,3-Dibromoprop-1-ene (0.85 mL, 6.97 mmol, 1.2 eq.) was added and the 
resulting mixture was stirred and heated at reflux for 72 h. After being allowed to 
cool to rt, the solution was poured into saturated NH4Cl(aq) (60 mL) and extracted 
with Et2O (3 × 20 mL). The combined organic extracts were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. No evidence of the 
desired product was observed in the 1H NMR spectrum of the crude product and 
starting material pent-4-en-2-ol was still present.  
A solution of alcohol 178 (500 mg, 5.81 mmol, 1.0 eq.) in CH2Cl2 (10 mL) was 
added dropwise to a stirred suspension of cetyltrimethylammonium bromide (318 
mg, 0.87 mmol, 0.15 eq.) in 50% NaOH(aq) (10 mL) at rt. The resulting mixture 
was stirred for 15 min. 2,3-Dibromoprop-1-ene (0.71 mL, 5.81 mmol, 1.0 eq.) 
was added and the resulting mixture was stirred at rt for 16 h. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic extracts were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography 
with 9:1 petrol-CH2Cl2 as eluent gave ether 177 (89 mg, 7%) as a colourless oil, 
RF (95:5 petrol-Et2O) 0.4; IR (NaCl) 2925, 1639 (C=C), 1457, 1092, 895 cm-1; 
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1H NMR (400 MHz, CDCl3) δ 5.95 (br s, 1H, C=CHAHB), 5.84 (ddd, J = 17.0, 
10.0, 7.0 Hz, 1H, =CH), 5.61-5.59 (br s, 1H, C=CHAHB), 5.12-5.06 (m, 2H, 
=CH2), 4.16-4.07 (m, 2H, CH2O), 3.58 (sext, J = 6.0 Hz, 1H, CHO), 2.39-2.19 
(m, 2H, CH2=CH), 1.18 (d, J = 6.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) 
δ 134.6 (=CH), 130.1 (=CBr), 117.1 (=CH2), 116.9 (=CH2), 75.1 (CHO), 72.5 
(OCH2), 40.9 (CH2), 19.4 (Me). 
 
Ethyl (α-bromomethyl)acrylate 184 
A solution of K2CO3 (3.0 g, 21.71 mmol, 1.2 eq.) in water (3.5 mL) was added to 
a stirred solution of triethylphosphonoacetate (3.59 mL, 18.09 mmol, 1.0 eq.) and 
37% formaldehyde(aq) (2.3 g, 72.35 mmol, 4.0 eq.) at rt. The resulting solution 
was stirred at rt for 15 min. Then a 1:1 mixture of Et2O and brine (40 mL) was 
added and the layers were separated. The aqueous layer was extracted with Et2O 
(3 × 10 mL) and the combined organic layers were washed with water (40 mL), 
dried (MgSO4) and evaporated under reduced pressure to give the crude alcohol. 
Phosphorus tribromide (1.03 mL, 10.86 mmol, 0.6 eq.) was added to a stirred 
solution of the crude alcohol in Et2O (25 mL) at 0 ºC. The resulting solution was 
stirred at rt for 16 h. Then, water (25 mL) was added and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 25 mL) and the 
combined organic layers were washed with water (40 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
Kügelrohr distillation gave acrylate 184 (590 mg, 30%) as a colourless oil, bp 
88-90 ºC/2.0 mmHg;138 1H NMR (400 MHz, CDCl3) δ 6.32 (d, J = 1.0 Hz, 1H, 
=CHAHB), 5.93 (d, J = 1.0 Hz, 1H, =CHAHB), 4.26 (q, J = 7.0 Hz, 2H, OCH2Me), 
4.18 (s, 2H, BrCH2), 1.32 (t, J = 7.0 Hz, 3H, Me). Spectroscopic data consistent 
with those reported in the literature.138 
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Attempted synthesis of ethyl 
2-(((1-phenylbut-3-en-1-yl)oxy)methyl)prop-2-enoate 185 
A solution of alcohol 127 (200 mg, 1.35 mmol, 1.0 eq.) in THF (10 mL) was 
added dropwise to a stirred suspension of NaH (81 mg of 60% wt dispersion in 
mineral oil, 2.03 mmol, pre-washed with Et2O (3 × 5 mL), 1.5 eq.) in THF (15 
mL) at 0 ºC under Ar. The resulting mixture was stirred for 30 min. Acrylate 184 
(390 mg, 2.03 mmol, 1.5 eq.) was added and the resulting mixture was stirred at 
0 ºC and allowed to warm to rt and stirred at rt for 16 h. Then, the solution was 
poured into saturated NH4Cl(aq) (30 mL) and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 20 mL) and the combined organic 
extracts were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. No evidence of the desired product was observed in the 1H NMR 
spectrum of the crude product. 
 
Attempted synthesis of ethyl 2-((pent-4-en-2-yloxy)methyl)acrylate 180 
A solution of alcohol 178 (200 mg, 2.32 mmol, 1.0 eq.) in THF (10 mL) was 
added dropwise to a stirred suspension of NaH (139 mg of 60% wt dispersion in 
mineral oil, 3.48 mmol, pre-washed with Et2O (3 × 5 mL), 1.5 eq.) in THF (15 
mL) at 0 ºC under Ar. The resulting mixture was stirred for 30 min. Acrylate 184 
(672 mg, 3.48 mmol, 1.5 eq.) was added and the resulting mixture was stirred at 
0 ºC and allowed to warm to rt and stirred at rt for 16 h. Then, the solution was 
poured into saturated NH4Cl(aq) (30 mL) and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 20 mL) and the combined organic 
extracts were dried (MgSO4) and evaporated under reduced pressure to give the 
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crude product. No evidence of the desired product was observed in the 1H NMR 
spectrum of the crude product. 
 
Ethyl 2-((non-1-en-4-yloxy)methyl)acrylate 186 
A solution of alcohol 125 (200 mg, 1.41 mmol, 1.0 eq.) in THF (10 mL) was 
added dropwise to a stirred suspension of NaH (85 mg of 60% wt dispersion in 
mineral oil, 2.12 mmol, pre-washed with Et2O (3 × 5 mL), 1.5 eq.) in THF (15 
mL) at 0 ºC under Ar. The resulting mixture was stirred for 30 min. Then, 
acrylate 184 (409 mg, 2.12 mmol, 1.5 eq.) was added and the resulting mixture 
was stirred at 0 ºC and allowed to warm to rt and stirred at rt for 16 h. Then the 
solution was poured into saturated NH4Cl(aq) (30 mL) and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 20 mL) and the 
combined organic extracts were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography 
on silica with 9:1 petrol-Et2O as eluent gave carbamate 186 (114 mg, 24%) as a 
colourless oil, RF (4:1 petrol-Et2O) 0.3; IR (NaCl) 2888, 2816, 1690 (C=O), 1616 
(C=C), 1439, 1348, 1329, 1285, 1252, 1157, 1079, 1014, 935, 900 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 6.28 (dd, J = 3.0, 1.0 Hz, 1H, =CHAHBCCO2Et), 5.90 
(q, J = 2.0 Hz, 1H, =CHAHBCCO2Et), 5.83 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H, 
=CH), 5.11-5.04 (m, 2H, =CH2), 4.26-4.15 (m, 4H, OCH2Me, OCH2), 3.44-3.38 
(m, 1H, CHO), 2.32-2.28 (m, 2H, =CHCH2), 1.58-1.23 (m, 8H, 4 × CH2), 1.31 (t, 
J = 7.0 Hz, 3H, Me), 0.89 (t, J = 7.0 Hz, 3H, Me); 13C NMR (100.6 MHz, CDCl3) 
δ  166.0 (C=O), 138.0 (C=CH2), 135.0 (=CH), 125.4 (=CH2), 116.8 (=CH2), 79.4 
(CHO), 67.1 (OCH2Me), 60.6 (OCH2), 38.3 (CH2), 33.7 (CH2), 31.9 (CH2), 25.0 
(CH2), 22.6 (CH2), 14.2 (Me), 14.0 (Me); MS (ESI) m/z 277 [(M + Na) +, 100]; 
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HRMS (ESI) m/z calcd for C15H26O3 (M + Na) + 277.1779, found 277.1774 (_1.7 
ppm error). 
n-BuLi (2.5 M in hexane, 0.68 mL, 1.69 mmol, 1.2 eq.) was added dropwise to a 
stirred solution of alcohol 125 (200 mg, 1.41 mmol, 1.0 eq.) in THF (15 mL) at 
_78 ºC under Ar. The resulting solution was stirred at _78 ºC for 15 min before it 
was transferred to CuI (404 mg, 2.11 mmol, 1.5 eq.). The resulting mixture was 
stirred for 30 min at _78 ºC. Then, acrylate 184 (407 mg, 2.11 mmol, 1.5 eq.) was 
added dropwise and the resulting solution was warmed to rt over 16 h. 1 M 
HCl(aq) (15 mL) was added and the layers were separated. The aqueous layer was 
extracted with Et2O (3 × 10 mL). The combined organic extracts were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 9:1 petrol-Et2O as 
eluent gave carbamate 186 (50 mg, 14%) as a colourless oil. 
 
3-Phenylpropyl N,N-di-i-propylcarbamate 193 
A solution of 3-phenyl-1-propanol (2.0 mL, 15.40 mmol, 1.2 eq.) in Et2O (20 mL) 
was added dropwise over 10 min to a stirred solution of NaH (0.78 g of 60% wt 
dispersion in mineral oil, 17.90 mmol, pre-washed with Et2O (3 × 10 mL), 1.3 
eq.) and a solution of di-i-propylcarbamoyl chloride (2.10 g, 13.30 mmol, 1.0 eq.) 
in Et2O (30 mL) at rt under Ar. The resulting mixture was stirred at rt for 16 h. 
Then, 2 M HCl(aq) (20 mL) was added and the resulting mixture was stirred 
vigorously for 5 min. The layers were separated and the aqueous layer was 
extracted with Et2O (3 × 10 mL). The combined organic layers were dried (2:1 
Na2SO4-NaHCO3) and evaporated under reduced pressure to give the crude 
product as a yellow oil. Purification by flash column chromatography on silica 
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with 4:1 petrol-Et2O as eluent gave carbamate 193 (2.90 g, 83%) as a colourless 
oil, RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.30-7.28 (m, 2H, 
Ph), 7.20-7.19 (m, 3H, Ph), 4.11 (t, J = 6.0 Hz, 2H, CH2O), 3.81 (br s, 2H, CHN), 
2.71 (t, J = 8.0 Hz, 2H, CH2Ph), 2.01-1.94 (m, 2H, CH), 1.21 (d, J = 7.0 Hz, 12H, 
CHMe); 13C NMR (100.6 MHz, CDCl3) δ 155.9 (C=O), 141.7 (ipso-Ph), 128.5 
(Ph), 128.4 (Ph), 126.0 (Ph), 64.1 (OCH2), 42.0 (NCH), 32.7 (CH2), 31.0 (Me), 
21.2 (CH2). Spectroscopic data consistent with those reported in the literature.68  
 
1-Hydroxy-1,4-diphenylbutan-2-yl di-iso-propylcarbamate syn-204 and 
anti-205 
s-BuLi (0.90 mL of a 1.3 M solution in hexane, 0.91 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of (_)-sparteine (260 mg, 0.91 mmol, 1.2 eq.) in 
Et2O (3 mL) at _78 ºC under Ar. After stirring at _78 oC for 15 min, a solution of 
O-alkyl carbamate 193 (227 mg, 0.76 mmol, 1.0 eq.) in Et2O (2 mL) was added 
dropwise. The resulting solution was stirred at _78 ºC for 3 h. Then, 
benzaldehyde (0.15 mL, 1.52 mmol, 2.0 eq.) was added and the resulting solution 
was warmed to rt over 16 h. 1 M HCl(aq) (2 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 4:1 petrol-Et2O as eluent gave a 
70:30 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols of syn-204 
and anti-205 (205 mg, 73%) as a colourless oil, RF (4:1 petrol-Et2O) 0.6; 1H 
NMR (400 MHz, CDCl3) δ 7.39-7.05 (m, 10H, Ph), 5.12-5.09 (m, 0.3H, OCH), 
5.06-5.01 (m, 0.7H, OCH), 4.88 (dd, J = 5.0, 3.0 Hz, 0.3H, CHOH), 4.72 (dd, J = 
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7.0, 5.0 Hz, 0.7H, CHOH), 4.71 (d, J = 5.0 Hz, 0.7 Hz, OH), 4.10 (d, J = 5.0 Hz, 
0.3H, OH), 3.97 (br s, 2H, CHN), 2.77-2.53 (m, 2H, CH), 1.94-1.70 (m, 2H, CH), 
1.26 (d, J = 7.0 Hz, 6H, Me), 1.25 (d, J = 7.0 Hz, 6H, Me). 
 
(S)-3-Phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl 
di-i-propylcarbamate (S)-194 
s-BuLi (8.0  mL of 1.3 M solution in hexane, 10.50 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of (_)-sparteine (2.45 g, 10.50 mmol, 1.2 eq.) in 
Et2O (15 mL) at _78 ºC under Ar.  After stirring at _78 ºC for 15 min, a solution 
of O-alkyl carbamate 193 (2.30 g, 8.71 mmol, 1.0 eq.) in Et2O (5 mL) was added 
dropwise. The resulting solution was stirred at _78 oC for 3 h. Then, tri-i-propyl 
borate (3.0 mL, 13.07 mmol, 1.5 eq.) was added dropwise and the resulting 
solution was warmed to rt over 16 h. 1 M HCl(aq) (15 mL) was added and the 
layers were separated. The aqueous layer was extracted with Et2O (3 × 10 mL). 
The combined organic extracts were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. A solution of the crude product, 
p-toluenesulfonic acid (0.05 g, 0.30 mmol, 0.03 eq.), MgSO4 (5.00 g) and pinacol 
(1.54 g, 13.07 mmol, 1.5 eq.) in CH2Cl2 (20 mL) was stirred at rt for 24 h. Then, 
the solids were removed by filtration and the filtrate was evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography with 4:1 petrol-Et2O as eluent gave boronate (S)-194 (2.51 g, 
74%) as a viscous yellow oil, [α]D +42.6 (c 1.1 in CH2Cl2) (lit.,19 [α]D +36.7 (c 
0.97 in CH2Cl2)); RF (4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) 
δ 7.29-7.25 (m, 2H, Ph), 7.21-7.17 (m, 3H, Ph), 4.07 (septet, J = 7.0 Hz, 1H, 
CHN), 3.82 (dd, J = 11.0, 4.0 Hz, 1H, CHO), 3.75 (septet, J = 7.0 Hz, 1H, CHN), 
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2.89-2.81 (m, 1H, CH), 2.75-2.68 (m, 1H, CH), 2.08-2.00 (m, 1H, CH), 
1.94-1.88 (m, 1H, CH), 1.16-1.24 (m, 24H, Me). Spectroscopic data consistent 
with those reported in the literature.68 
 
(R)-5-Phenylpent-1-en-3-ol (R)-208 
Vinyl magnesium bromide (1.77 mL of 1 M solution in THF, 1.77 mmol, 2.0 eq.) 
was added dropwise to a stirred solution of boronate (S)-194 (345 mg, 0.89 mmol, 
1.0 eq.) in THF (5 mL) at _78 ºC under Ar. The resulting solution was stirred at 
_78 oC for 1 h. Then, the resulting solution was stirred and heated at reflux for 12 
h. After being allowed to cool to rt, NaOH(aq) (2.13 mL of a 0.5 M solution, 1.06 
mmol, 1.2 eq.) and H2O2 (0.11 mL of a 35 wt% solution in water, 1.24 mmol, 1.4 
eq.) were added and the mixture was stirred for 30 min. Then, the mixture was 
poured into brine (5 mL) and extracted with Et2O (3 × 10 mL). The combined 
organic extracts were washed with saturated Na2S2O3(aq) (3 × 10 mL), dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography with 3:2 petrol-Et2O as eluent gave 
alcohol (R)-208 (74 mg, 52%, 91:9 er by CSP-HPLC) as a viscous yellow oil, 
[α]D +1.9 (c 0.5 in CH2Cl2) (lit.,139 of [α]D +4.2 (c 1.00 in CH2Cl2) for (R)-208 of 
90:10 er); RF (3:2 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.29-7.27 (m, 
2H, Ph), 7.22-7.19 (m, 3H, Ph), 5.92 (ddd, J = 17.0, 10.0, 6.0 Hz, 1H, =CH), 
5.25 (dt, J = 17.0, 2.0 Hz, 1H, =CH), 5.14 (dt, J = 10.0, 2.0 Hz, 1H, =CH), 4.13 
(q, J = 6.0 Hz, 1H, CHOH), 2.84-2.61 (m, 2H, CH2), 1.97-1.78 (m, 2H, CH2Ph), 
1.64 (br s, 1H, OH); 13C NMR (100.6 MHz, CDCl3) (one aromatic resonance not 
resolved) δ 142.0 (ipso-Ph), 141.1 (=CH), 128.6 (Ph), 126.0 (Ph), 115.1 (=CH2), 
72.6 (CHO), 38.6 (CH2), 31.7 (CH2); HPLC: Daicel Chiracel OD, 95:5 
i-PrOH-hexane, 0.5 mL min-1, (S)-208 21.3 min, (R)-208 31.8 min. 
Spectroscopic data consistent with those reported in the literature.140  
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(R)-(3-(Allyloxy)pent-4-enyl)benzene (R)-209 
A solution of alcohol (R)-208 (66 mg, 0.41 mmol, 1.0 eq., 91:9 er) in THF (2 mL) 
was added dropwise to a stirred suspension of NaH (36 mg of 60% wt dispersion 
in mineral oil, 0.81 mmol, pre-washed with Et2O (3 × 5 mL), 2.0 eq.) in THF (5 
mL) at rt under Ar. The resulting mixture was stirred and heated at reflux for 30 
min and then allowed to cool to rt. Allyl bromide (0.07 mL, 0.81 mmol, 2.0 eq.) 
was added and the resulting mixture was stirred and heated at reflux for 2.5 h. 
After being allowed to cool to rt, the solution was poured into saturated NH4Cl(aq) 
(5 mL) and extracted with Et2O (3 × 10 mL). The combined organic extracts 
were dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography with 99:1 petrol-Et2O as 
eluent gave ether (R)-209 (49 mg, 59%, 91:9 er assumed) as a colourless oil, RF 
(99:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.30-7.25 (m, 2H, Ph), 
7.21-7.16 (m, 3H, Ph), 5.92-5.90 (m, 1H, =CH), 5.73 (ddd, J = 17.0, 8.0, 5.0 Hz, 
1H, =CH), 5.27 (dq, J = 17.0, 2.0 Hz, 1H, =CH), 5.22-5.14 (m, 3H, =CH), 4.05 
(ddt, J = 13.0, 5.0, 1.0 Hz, 1H, CHO), 3.80 (ddt, J = 13.0, 6.0, 2.0 Hz, 1H, CHO), 
3.68 (q, J = 7.0 Hz, 1H, CHO), 2.77-2.63 (m, 2H, CH2Ph), 1.94-1.91 (m, 1H, 
CH), 1.83-1.75 (m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 142.2 (ipso-Ph), 
138.9 (=CH), 135.2 (=CH), 128.6 (Ph), 128.4 (Ph), 125.8 (Ph), 117.2 (=CH2), 
116.7 (=CH2), 80.0 (CHO), 69.5 (OCH2), 37.2 (CH2), 31.6 (CH2). Spectroscopic 
data consistent with those reported in the literature.16 
 
(R)-2-Phenethyl-2,5-dihydrofuran (R)-210 
Grubbs’ 1st Generation catalyst 4 (3.9 mg, 0.004 mmol, 0.02 eq.) was added in 
one portion to a stirred solution of diene (R)-209 (42 mg, 0.21 mmol, 1.0 eq.) in 
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CH2Cl2 (1 mL) at rt. The resulting mixture was stirred at rt for 1 h. The solvent 
was evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 99:1 petrol-Et2O as eluent gave cyclic ether 
(R)-210 (48 mg, 57%) as a colourless oil, RF (99:1 petrol-Et2O) 0.3; 1H NMR 
(400 MHz, CDCl3) δ 7.29-7.26 (m, 2H, Ph), 7.21-7.16 (m, 3H, Ph), 5.90 (dq, J = 
8.0, 2.0 Hz, 1H, =CH), 5.78 (dq, J = 8.0, 2.0 Hz, 1H, =CH), 4.90-4.83 (m, 1H, 
CHO), 4.88-4.61 (m, 2H, OCH2), 4.60-4.58 (m, 2H, CH2Ph), 1.98-1.75 (m, 2H, 
CH2); 13C NMR (100.6 MHz, CDCl3) (one aromatic resonance not 
resolved) δ 142.3 (ipso-Ph), 129.6 (=CH), 128.5 (Ph), 126.8 (=CH), 125.8 (Ph), 
85.5 (CHO), 75.2 (OCH2), 37.8 (CH2), 31.6 (CH2). Spectroscopic data consistent 
with those reported in the literature.17 
 
(R)-1-Phenylbut-3-en-1-ol (R)-128 
Allyl magnesium bromide (2.27 mL of 2 M solution in THF, 4.54 mmol, 2.0 eq.) 
was added dropwise to a stirred solution of boronate (S)-194 (883 mg, 2.27 mmol, 
1.0 eq.) in THF (25 mL) at _78 ºC under Ar. The resulting solution was stirred at 
_78 ºC for 1 h. Then, the solution was stirred and heated at reflux for 12 h. After 
being allowed to cool to rt, NaOH(aq) (5.44 mL of a 0.5 M solution, 2.72 mmol, 
1.2 eq.) and H2O2 (0.28 mL of a 35 wt% solution in water, 3.18 mmol, 1.4 eq.) 
were added and the mixture was stirred for 30 min. Then, the mixture was poured 
into brine (5 mL) and extracted with Et2O (3 × 10 mL). The combined organic 
extracts were washed with saturated Na2S2O3(aq) (3 × 10 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 3:2 petrol-Et2O as eluent gave alcohol 
(R)-128 (215 mg, 54%, 99:1 er by CSP-HPLC) as a viscous yellow oil, [α]D +2.4 
(c 0.5 in CH2Cl2) (lit.,141 [α]D +9.30 (c 4.46 in CH2Cl2) for (R)-128 of 90:10 er); 
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HPLC: Daicel Chiracel OD, 95:5 i-PrOH-hexane, 0.5 mL min-1, (S)-128 17.5 
min, (R)-128 25.3 min.  
 
(R)-(3-(Allyloxy)hex-5-enyl)benzene (R)-211 
A solution of alcohol (R)-128 (91 mg, 0.52 mmol, 1.0 eq., 99:1 er) in THF (2 mL) 
was added dropwise to a stirred suspension of NaH (45 mg of 60% wt dispersion 
in mineral oil, 1.14 mmol, pre-washed with Et2O (3 × 5 mL), 2 eq.) in THF (5 
mL) at rt under Ar. The resulting mixture was stirred and heated at reflux for 30 
min and then allowed to cool to rt. Allyl bromide (0.10 mL, 1.14 mmol, 2.0 eq.) 
was added and the resulting mixture was stirred and heated at reflux for 3.5 h. 
After being allowed to cool to rt, the solution was poured into saturated NH4Cl(aq) 
(5 mL) and extracted with Et2O (3 × 10 mL). The combined organic extracts 
were dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography with 99:1 petrol-Et2O as 
eluent gave ether (R)-211 (64 mg, 57%, 99:1 er assumed) as a colourless oil, RF 
(99:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.29-7.24 (m, 2H, Ph), 
7.19-7.15 (m, 3H, Ph), 6.01-5.89 (ddt, J = 17.0, 10.0, 6.0 Hz, 1H, =CH), 5.94 
(ddt, J = 16.0, 10.0, 6.0 Hz, 1H, =CH), 5.30 (dq, J = 17.0, 2.0 Hz, 1H, CH), 5.16 
(dq, J = 10.0, 2.0 Hz, 1H, CH), 5.10-5.02 (m, 2H, =CH), 4.06 (ddt, J = 13.0, 6.0, 
1.0 Hz, 1H, CHO), 3.96 (ddt, J = 13.0, 6.0, 1.0 Hz, 1H, CHO), 3.40 (pentet, J = 
6.0 Hz, 1H, CHO), 2.78 (ddd, J = 14.0, 9.0, 7.0 Hz, 1H, CH), 2.63 (ddd, J = 14.0, 
9.0, 7.0 Hz, 1H, CH), 2.37-2.24 (m, 2H, CH2), 1.86-1.74 (m, 2H, CH2); 13C 
NMR (100.6 MHz, CDCl3) δ 142.4 (ipso-Ph), 135.4 (=CH), 134.8 (=CH), 128.5 
(Ph), 128.4 (Ph), 125.8 (Ph), 117.2 (=CH2), 116.8 (=CH2), 77.8 (CHO), 70.1 
(OCH2), 38.4 (CH2), 35.7 (CH2), 31.7 (CH2). Spectroscopic data consistent with 
those reported in the literature.16 
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(R)-2-Phenethyl-3,6-dihydro-2H-pyran (R)-212 
Grubbs’ 1st Generation catalyst 4 (3.6 mg, 0.004 mmol, 0.02 eq.) was added in 
one portion to a stirred solution of diene (R)-211 (42 mg, 0.22 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) at rt. The resulting mixture was stirred at rt for 2 h. The solvent 
was evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 99:1 petrol-Et2O as eluent gave cyclic ether 
(R)-212 (25 mg, 60%) as a colourless oil, RF (99:1 petrol-Et2O) 0.3; 1H NMR 
(400 MHz, CDCl3) δ 7.31-7.25 (m, 2H, Ph), 7.21-7.11 (m, 3H, Ph), 5.81-5.75 (m, 
1H, =CH), 5.74-5.68 (m, 1H, =CH), 4.25-4.13 (m, 2H, CH2O), 3.51-3.43 (m, 1H, 
CHO), 2.84-2.65 (m, 2H, CH2), 2.10-1.95 (m, 2H, CH2Ph), 1.94-1.82 (m, 1H, 
CH), 1.81-1.70 (m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 142.3 (ipso-Ph), 
128.6 (Ph), 128.5 (Ph), 126.5 (=CH), 125.8 (=CH), 124.3 (Ph), 72.7 (CHO), 66.0 
(OCH2), 37.7 (CH2), 31.8 (CH2), 31.1 (CH2). Spectroscopic data consistent with 
those reported in the literature.17 
 
But-3-enyl N,N-di-i-propylcarbamate 213 
A solution of but-3-en-1-ol (1.2 mL, 13.88 mmol, 1.2 eq.) in Et2O (20 mL) was 
added dropwise over 10 min to a stirred solution of NaH (0.65 g of 60% wt 
dispersion in mineral oil, 22.84 mmol, pre-washed with Et2O (3 × 10 mL), 1.4 
eq.) and a solution of di-i-propylcarbamoyl chloride (1.86 g, 11.56 mmol, 1.0 eq.) 
in Et2O (30 mL) at rt under Ar. The resulting mixture was stirred at rt for 16 h. 
Then, 2 M HCl(aq) (20 mL) was added and the resulting mixture was stirred 
vigorously for 5 min. The two layers were separated and the aqueous layer was 
extracted with Et2O (3 × 10 mL). The combined organic layers were dried (2:1 
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Na2SO4-NaHCO3) and evaporated under reduced pressure to give the crude 
product as a yellow oil. Purification by flash column chromatography on silica 
with 4:1 petrol-Et2O as eluent gave carbamate 213 (2.49 g, 90%) as a colourless 
oil, RF (4:1 petrol-Et2O) 0.2; 1H NMR (400 MHz, CDCl3) δ 5.82 (ddt, J = 17.0, 
10.0, 6.0 Hz, 1H, =CH), 5.11 (dq, J = 17.0, 2.0 Hz,  1H, =CH), 5.06 (dq, J = 
10.0, 2.0 Hz, 1H, =CH), 4.13 (t, J = 6.0 Hz, 2H, CH2O), 3.81 (br s, 2H, CHN), 
2.40 (q, J = 6.0 Hz, 2H, =CHCH2), 1.18 (d, J = 7.0 Hz, 12H, CHMe); HRMS 
(ESI) m/z calcd for C11H21NO2 (M + H) + 200.1645, found 200.1645 (0.1 ppm 
error). 
 
(R)-Methyl 2-(di-i-propylcarbamoyloxy)pent-4-enoate (R)-216  
s-BuLi (0.88 mL of a 1.3 M solution in hexane, 1.14 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of (_)-sparteine (267 mg, 1.14 mmol, 1.2 eq.) in 
Et2O (3 mL) at _78 ºC under Ar. After stirring at _78 oC for 15 min, a solution of 
O-alkyl carbamate 213 (189 mg, 0.95 mmol, 1.0 eq.) in Et2O (2 mL) was added 
dropwise. The resulting solution was stirred at _78 ºC for 1 h. Then, MeCO2Cl 
(0.17 mL, 2.28 mmol, 2.0 eq.) was added and the resulting solution was warmed 
to rt over 16 h. 1 M HCl(aq) (2 mL) was added and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic 
layers were washed with brine (5 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 4:1 petrol-Et2O as eluent gave ester (R)-216 (49 
mg, 19%) as a colourless oil, RF(4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, 
CDCl3) δ 5.83-5.77 (m, 1H, =CH), 5.16 (br s, 1H, CHO), 5.12-5.09 (m, 
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2H,=CH2), 4.11 (br s, 1H, CHN), 3.81 (br s, 1H, CHN), 3.73 (s, 3H, OMe), 
2.62-2.58 (m, 2H, =CHCH2), 1.27-1.20 (m, 12H, CHMe). 
 
1-Hydroxy-1-phenylpent-4-en-2-yl di-i-propylcarbamate 217 
s-BuLi (0.93 mL of a 1.3 M solution in hexane, 1.21 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of (_)-sparteine (320 mg, 1.21 mmol, 1.2 eq.) in 
Et2O (3 mL) at _78 ºC under Ar. After stirring at _78 oC for 15 min, a solution of 
O-alkyl carbamate 213 (209 mg, 1.04 mmol, 1.0 eq.) in Et2O (2 mL) was added 
dropwise. The resulting solution was stirred at _78 ºC for 3 h. Then, 
benzaldehyde (0.20 mL, 2.08 mmol, 2.0 eq.) was added and the resulting solution 
was warmed to rt over 16 h. 1 M HCl(aq) (2 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 4:1 petrol-Et2O as eluent gave a 
65:35 mixture (by 1H NMR spectroscopy) of diastereomeric alcohols 217 (76 mg, 
24%) as a colourless oil, RF(4:1 petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) 
δ 7.40−7.29 (m, 5H, Ph), 5.84-5.72 (m, 1H, =CH), 5.14-5.09 (m, 1H, CHO), 
5.08-5.00 (m, 2H,=CH2), 4.90 (d, J = 3.0 Hz, 0.35H, CHOH), 4.72 (d, J = 3.0 Hz, 
0.65H, CHOH), 3.95 (br s, 2H, CHN), 2.43-2.18 (m, 2H, CH2), 1.23-1.20 (m, 
12H, Me). 
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1-(p-Tolylsulfinyl)-3-phenylpropyl N,N-di-i-propylcarbamate anti-rac-226 
and syn-rac-227 
s-BuLi (1.88 mL of a 1.3 M solution in hexane, 2.45 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of carbamate 193 (538 mg, 2.04 mmol, 1.0 eq.) and 
TMEDA (0.37 mL, 2.45 mmol, 1.2 eq.) in Et2O (10 mL) at _78 ºC under Ar. The 
resulting solution was stirred at _78 ºC for 1 h. Then, methyl p-toluenesulfinate 
(451 mg, 2.65 mmol, 1.3 eq.) was added dropwise and the solution was allowed 
to warm to rt over 16 h. Then, saturated NH4Cl(aq) (10 mL) was added and the 
two layers were separated. The aqueous layer was extracted with Et2O (3 × 10 
mL). The combined organic layers were washed with brine (5 mL), dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 3:1 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide anti-rac-226 (262 mg, 32%) as a viscous 
colourless oil, RF (3:1 petrol-EtOAc) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.55 (d, 
J = 8.0 Hz, 2H, m-C6H4Me), 7.28 (d, J = 8.0 Hz, 2H, o-C6H4Me), 7.21 (t, J = 7.0 
Hz, 2H, m-Ph), 7.16 (d, J = 7.0 Hz, 1H, p-Ph), 7.02 (d, J = 7.0 Hz, 2H, o-Ph), 
5.45 (dd, J = 10.0, 3.0 Hz, 1H, OCH), 3.94 (br s, 2H, NCH), 2.74 (ddd, J = 14.0, 
10.0, 5.0 Hz, 1H, PhCHAHB), 2.56 (ddd, J = 14.0, 10.0, 7.0 Hz, 1H, PhCHAHB), 
2.40 (s, 3H, Me), 2.36-2.25 (m, 1H, OCHCHAHB), 2.06-1.98 (m, 1H, 
OCHCHAHB), 1.26 (br s, 12H, NCHMe2); 13C NMR (100.6 MHz, CDCl3) δ 
153.5 (C=O), 141.2 (ipso-C6H4S(O)), 140.3 (ipso-Ph), 137.4 (ipso-C6H4Me), 
129.7 (Ar), 128.3 (Ar), 128.1 (Ar), 126.0 (Ar), 124.4 (Ar), 91.7 (OCH), 46.7 (br, 
NCH), 46.0 (br, NCH), 31.1 (CH2), 26.0 (CH2), 21.3 (Me), 20.2 (br, Me) and  
sulfoxide syn-rac-227 (188 mg, 23%) as a colourless oil, RF (3:1 petrol-EtOAc) 
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0.2; 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 8.0 Hz, 2H, Ar), 7.28-7.24 (m, 
4H, Ar), 7.21-7.14 (m, 3H, Ar), 5.72 (dd, J = 9.5, 4.0 Hz, 1H, OCH), 3.99 (br s, 
1H, NCH), 3.57 (br s, 1H, NCH), 2.76 (m,  2H, PhCH2), 2.41-2.33 (m, 1H, 
OCHCHAHB), 2.37 (s, 3H, Me), 2.17-2.08 (m, 1H, OCHCHAHB), 1.21-0.99 (m, 
12H, CHMe2); 13C NMR (100.6 MHz, CDCl3) δ 152.3 (C=O), 141.5 (ipso-Ar), 
140.3 (ipso-Ar), 137.4 (ipso-Ar), 129.5 (Ar), 128.5 (Ar), 128.4 (Ar), 126.3 (Ar), 
125.3 (Ar), 86.8 (OCH), 46.3 (br, NCH), 45.9 (br, NCH), 31.7 (CH2), 30.3 (CH2), 
21.3 (Me), 20.2 (Me). Full characterisation and stereochemical assignment proof 
for anti-rac-226 and syn-rac-227 has been carried out in the group.71  
        
(1S)-1-(p-Tolylsulfinyl)-3-phenylpropyl N,N-di-i-propylcarbamate 
anti-(S,Ss)-222 and (1R)-1-(p-Tolylsulfinyl)-3-phenylpropyl 
N,N-di-i-propylcarbamate syn-(R,Ss)-223 
s-BuLi (1.0 mL of a 1.3 M solution in hexane, 1.30 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of carbamate 193 (264 mg, 1.00 mmol, 1.0 eq.), 
diamine 230 (253 mg, 1.20 mmol, 1.2 eq.) and diamine 203 (39 mg, 0.20 mmol, 
0.2 eq.) in Et2O (7 mL) at _78 ºC under Ar. The resulting solution was stirred at 
_78 ºC for 5 h and then added dropwise via cannula transfer to a solution of 
Andersen’s sulfinate (Ss)-224 (383 mg, 1.30 mmol, 1.3 eq.). The resulting 
solution was stirred at  _78 ºC for 1 h and then MeOH (2 mL) was added and the 
resulting solution was allowed to warm to rt over 2 h. Then, saturated NH4Cl(aq) 
(10 mL) was added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 10 mL). The combined organic layers were washed with 
brine (5 mL), dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 3:1 
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petrol-EtOAc + 1% Et3N as eluent gave sulfoxide anti-(S,Ss)-222 (44 mg, 13%, 
85:15 er by CSP-HPLC) as a white solid, HPLC: Chiracel OD (97.2:2.5 
Hexane-iPrOH, 1.0 mL min-1) anti-(R,Rs)-222 13.1 min, anti-(S,Ss)-222 14.2 
min and sulfoxide syn-(R,Ss)-223 (77 mg, 19%, 99:1 er  by CSP-HPLC) as a 
colourless oil, HPLC: Chiracel OD (97.2:2.5 Hexane-iPrOH, 1.0 mL min-1) 
syn-(S,Rs)-223 20.1 min, syn-(R,Ss)-223 23.1 min. 
 
(S)-1-Phenylbut-3-en-1-ol (S)-128 
i-PrMgCl (0.17 mL of a 2.0 M solution in THF, 0.34 mmoL, 1.5 eq.) was added 
dropwise to a stirred solution of  sulfoxide anti-rac-226 (90 mg, 0.22 mmoL, 
1.0 eq.) in THF (8 mL) at rt under Ar. The resulting solution was stirred at rt for 
1 min. Then, allylboronic acid pinacol ester (0.06 mL, 0.34 mmol, 1.5 eq.) was 
added dropwise and the resulting solution was stirred at rt for 30 min and then 
heated to reflux for 16 h. The reaction was cooled to rt and 3 M NaOH(aq) (0.5 
mL) and 30% H2O2(aq) (0.25 mL) were added sequentially. The resulting solution 
was stirred at rt for 2 h and then 3 M NaOH(aq) (5mL) was added. The two layers 
were separated and the aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 3:2 petrol-Et2O as eluent gave alcohol 
rac-128 (11 mg, 28%) as a viscous yellow oil. 
i-PrMgCl (0.19 mL of a 2.0 M solution in THF, 0.37 mmoL, 1.5 eq.) was added 
dropwise to a stirred solution of  sulfoxide anti-rac-226 (100 mg, 0.25 mmoL, 
1.0 eq.) in THF (8 mL) at rt under Ar. The resulting solution was stirred at rt for 
1 min. Then, allylboronic acid pinacol ester (0.07 mL, 0.37 mmol, 1.5 eq.) was 
added dropwise and the resulting solution was stirred at rt for 2 h and then heated 
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to reflux for 16 h. The reaction was cooled to rt and 3 M NaOH(aq) (0.5 mL) and 
30% H2O2(aq) (0.25 mL) were added sequentially. The resulting solution was 
stirred at rt for 2 h and then 3 M NaOH(aq) (5mL) was added. The two layers 
were separated and the aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 3:2 petrol-Et2O as eluent gave alcohol 
rac-128 (17 mg, 39%) as a viscous yellow oil. 
i-PrMgCl (0.18 mL of a 2.0 M solution in THF, 0.37 mmoL, 1.5 eq.) was added 
dropwise to a stirred solution of  sulfoxide anti-rac-226 (98 mg, 0.24 mmoL, 
1.0 eq.) in THF (8 mL) at rt under Ar. The resulting solution was stirred at rt for 
1 min. Then, allylboronic acid pinacol ester (0.07 mL, 0.37 mmol, 1.5 eq.) was 
added dropwise and the resulting solution was stirred at rt for 4 h and then heated 
to reflux for 16 h. The reaction was cooled to rt and 3 M NaOH(aq) (0.5 mL) and 
30% H2O2(aq) (0.25 mL) were added sequentially. The resulting solution was 
stirred at rt for 2 h and then 3 M NaOH(aq) (5mL) was added. The two layers 
were separated and the aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 3:2 petrol-Et2O as eluent gave alcohol 
rac-128 (12 mg, 56%) as a viscous yellow oil. 
i-PrMgCl (0.19 mL of a 2.0 M solution in THF, 0.37 mmoL, 1.5 eq.) was added 
dropwise to a stirred solution of  sulfoxide syn-(R,Ss)-223 (100 mg, 0.25 mmoL, 
1.0 eq.) in THF (8 mL) at rt under Ar. The resulting solution was stirred at rt for 
1 min. Then, allylboronic acid pinacol ester (0.07 mL, 0.37 mmol, 1.5 eq.) was 
added dropwise and the resulting solution was stirred at rt for 4 h and then heated 
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to reflux for 16 h. The reaction was cooled to rt and 3 M NaOH(aq) (0.5 mL) and 
30% H2O2(aq) (0.25 mL) were added sequentially. The resulting solution was 
stirred at rt for 2 h and then 3 M NaOH(aq) (5mL) was added. The two layers 
were separated and the aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 3:2 petrol-Et2O as eluent gave alcohol 
(S)-128 (8 mg, 19%, 93:7 er) as a viscous yellow oil, HPLC: Daicel Chiracel OD, 
95:5 i-PrOH-hexane, 0.5 mL min-1, (S)-128 17.6 min, (R)-128 25.4 min. 
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4.4 Experimental for Chapter 3 
 
t-Butyldimethyl phosphine borane 283 
t-BuMgCl (33.2 mL of a 2.0 M solution in Et2O, 66.6 mL, 1.1 eq.) was added 
dropwise over 30 min to a stirred solution of PCl3 (8.3 g, 60.6 mmol, 1.0 eq.) in 
THF (85 mL) at –78 ºC under Ar. The resulting heterogeneous mixture was 
stirred at –78 ºC for 1 h and allowed to warm to rt and stirred for 1 h. The 
reaction mixture was cooled to 0 ºC and MeMgBr (44.3 mL of a 3.0 M solution 
in Et2O, 133.2 mmol, 2.2 eq.) was added dropwise over 20 min. The resulting 
mixture was allowed to warm to rt over 1 h. Then, the resulting heterogeneous 
mixture was cooled to 0 ºC and BH3·Me2S (36.3 mL of a 2.0 M solution in Et2O, 
72.6 mmol, 1.5 eq.) was added dropwise and the mixture was allowed to warm to 
rt and stirred for 16 h. Then, the mixture was poured onto ice/H2O and conc. 
HCI(aq) (30 mL). The layers were separated and the aqueous layer was extracted 
with EtOAc (3 × 45 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
recrystallisation from hot hexane (40 mL) gave phosphine borane 283 (5.78 g, 
72%) as a white solid, mp 161-162 ºC (lit.,98 164-165 ºC); 1H NMR (400 MHz, 
CDCl3) δ 1.22 (d,  J = 10.0 Hz, 6H, PMe), 1.15 (d, J = 13.5 Hz, 9H, PCMe3), 
0.43 (qd, J = 94.0, 15.0 Hz, PBH3); 13C NMR (100.6 MHz) δ 26.6 (CMe3), 24.7 
(CMe3), 7.2 (Me); 31P{1H} NMR (109 MHz, CDCl3) δ 21.0. Spectroscopic data 
consistent with those reported in the literature.98 
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(1S,2S)-Cyclohexane-1,2-diamine 2,3-dihydroxysuccinate salt (S,S,S,S)-306  
Trans (±)-1,2 Cyclohexane diamine (15.00 mL, 124.8 mmol, 1.0 eq.) was added 
dropwise to a stirred solution of D-tartaric acid (9.37 g, 62.4 mmol, 0.5 eq.) in 
water (45 mL) under air, such that the internal temperature did not exceed 70 °C 
(during this time a white precipitate forms, but this disappears by the point of 
complete addition). Then, AcOH (3.8 mL) was added dropwise such that the 
internal temperature did not exceed 90 °C. The resulting solution was allowed to 
cool to 5 °C over 16 h (refrigerator). The solids were removed by filtration and 
the filter-cake was washed with cold water (≤ 5 °C, 20 mL) and MeOH (5 x 10 
mL) (Washings kept separate). The resulting white solid was dried by suction to 
give the cyclohexane diamine D-tartaric acid salt (S,S,S,S)-306 (12.45 g, 38%) as 
a white solid, 1H NMR (400 MHz, D2O) δ 4.19 (s, 2H, 2 × CHOH), 3.23-3.21 (m, 
2H, 2 × CH), 2.04-2.00 (m, 2H, CH2), 1.70-1.69 (m, 2H, CH2), 1.43-1.35 (m, 2H, 
CH2), 1.25-1.20 (m, 2H, CH2). Spectroscopic data consistent with those reported 
in the literature.142 
 
(1S,2S)-N,N,N’,N’-Tetramethylcyclohexane-1,2-diamine (S,S)-304 
Formic acid (7.14 mL, 189.2 mmol, 1.0 eq.) was added to a stirred solution of 
salt (S,S,S,S)-306 (5.0 g, 18.92 mmol, 10.0 eq) in 37% (w/w) aqueous 
formaldehyde (14.17 mL, 189.2 mmol, 10.0 eq.). The resulting solution was 
stirred and heated at 100 oC for 18 h. After being allowed to cool to rt, the 
solvent was evaporated under reduced pressure. 5 M NaOH(aq) (125 mL) was 
added and the resulting solution was extracted with CHCl3 (3 x 50 mL). The 
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combined organic extracts were washed with saturated brine (50 mL), dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by Kügelrohr distillation gave (S,S)-TMCDA (S,S)-306 (3.08 g, 96%, 
99:1 er by chiral shift 1H NMR spectroscopy) as a colourless oil, b.p 130–138 
oC/5.0 mmHg (lit.,143 50 oC/0.1 mmHg); 1H NMR (400 MHz, CDCl3) δ 2.38-2.36 
(m, 2H, NCH), 2.26 (s, 12H, NMe), 1.84-1.81 (m, 2H, CH), 1.74-1.73 (m, 2H, 
CH), 1.10-1.08 (m, 4H, CH). Spectroscopic data consistent with those reported in 
the literature.144 The enantiomeric ratio was determined by 1H NMR spectroscopy 
in the presence of (S)-2,2,2-trifluoro-1-(9 anthryl)-ethanol: TMCDA (1 mg, 
0.053 mmol) was dissolved in CDCl3 (0.6 mL) and (S)-2,2,2-trifluoro-1-(9- 
anthryl)-ethanol (2.8 mg, 0.22 mmol) was added. Key signal: 1H NMR (400 
MHz, CDCl3) δ 2.21 (s, 12H, NMe, major), 2.18 (s, 12H, NMe, minor). 
Integration of the major and minor NMe signals in the 1H NMR spectrum 
indicated that TMCDA (S,S)-304 was present in 99:1 er. 
 
3-Methyl-7-((S)-1-phenylethyl)-3,7-diazabicyclo[3.3.1]nonan-9-one (S)-310 
(S)-Phenylethylamine (2.15 mL, 16.89 mmol, 1.0 eq.) was added dropwise to a 
stirred solution of 1-methyl-4-piperidone (1.91 g, 16.89 mmol, 1.0 eq., freshly 
distilled), paraformaldehyde (1.53 g, 50.64 mmol, 3.0 eq.) and AcOH (1.15 mL, 
16.89 mmol, 1.0 eq.) in EtOH (45 mL) at rt under Ar. The resulting solution was 
stirred and heated at reflux for 18 h. The solution was cooled to rt and the solvent 
was evaporated under reduced pressure. 50% KOH(aq) solution (50 mL) and Et2O 
(50 mL) were added to the residue and the layers were separated. The aqueous 
layers was extracted with Et2O (3 x 50 mL) and the combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude 
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product. Purification by Kügelrohr distillation gave bispidone (S)-310 (2.16 g, 
50%) as a clear viscous yellow oil, bp 240-244 oC/4.0 mmHg; 1H NMR (400 
MHz, CDCl3) δ 7.39-7.23 (m, 5H, Ph), 3.59 (q, J = 7.0 Hz, 1H, PhCHN), 
3.10-3.07 (m, 1H, NCH), 3.07-2.90 (m, 5H, 5 × NCH) 2.72-2.64 (m, 2H, 2 × 
(CH)C=O), 2.59-2.53 (m, 2H, 2 × NCH), 2.30 (s, 3H, NMe), 1.37 (d, J = 7.0 Hz, 
3H, CHMe).  
 
3-Methyl-7-((S)-1-phenylethyl)-3,7-diazabicyclo[3.3.1]nonane (S)-307 
Hydrazine monohydrate (4.26 mL, 85.15 mmol, 5.5 eq.) was added dropwise to a 
stirred mixture of bispidone (S)-310 (4.0 g, 15.48 mmol, 1.0 eq.) and KOH 
(10.16 g, 181.12 mmol, 11.7 eq.) in diethylene glycol (120 mL) at rt under Ar. 
The mixture was stirred and heated at reflux for 20 h. After cooling to 60 oC (if 
the diethylene glycol solution is cooled to rt before addition of H2O then the 
mixture becomes very viscous and too difficult to work with), the mixture was 
transferred to a separating funnel. H2O (200 mL) and Et2O (80 mL) were added 
and the layers were separated. The aqueous layer was extracted with Et2O (6 x 90 
mL). The combined organic layers were washed with 20% NaOH(aq) (6 x 50 mL), 
dried (Na2SO4) and evaporated under reduced pressure to give the crude product. 
Purification by Kügelrohr distillation gave N-Me bispidine (S)-307 (2.06 g, 53%) 
as a clear yellow oil, bp 180-190 oC/2.5 mmHg (lit.,6 120-130 oC/0.25 mmHg); 
1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 7.0 Hz, 2H, o-Ph), 7.31 (t, J = 7.0 Hz, 
2H, m-Ph), 7.23 (t, J = 7.0 Hz, 1H, p-Ph), 3.40 (q, J = 7.0 Hz, 1H, PhCHN), 
2.78-2.75 (m, 1H, NCH), 2.65-2.59 (m, 1H, NCH), 2.58-2.48 (m, 4H, 4 × NCH), 
2.30-2.25 (m, 2H, 2 × NCH), 2.24 (s, 3H, NMe), 1.97-1.90 (m, 2H, CH), 
1.63-1.59 (m, 1H, CH), 1.36-1.28 (m, 1H, CH), 1.32 (d, J = 7.0 Hz, 3H, CHMe); 
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13C NMR (100.6 MHz) (one Ph resonance not resolved) δ 128.0 (Ph), 127.5 (Ph), 
126.4 (Ph), 64.3 (NCH), 59.0 (NCH2), 58.9 (NCH2), 55.6 (NCH2), 54.5 (NCH2), 
46.2 (NMe), 29.1 (CH or Me),  28.9 (CH or Me), 28.7 (CH2), 19.0 (CH or Me). 
Spectroscopic data consistent with those reported in the literature.107 
 
3-((R)-1-Phenylethyl)-7-propyl-3,7-diazabicyclo[3.3.1]nonan-9-one (R)-312 
(R)-Phenylethylamine (4.30 g, 35.41 mmol, 1.0 eq.) was added dropwise to a 
stirred solution of 1-propyl-4-piperidone (5.00 g, 35.41 mmol, 1.0 eq. freshly 
distilled), paraformaldehyde (3.22 g, 106.23 mmol, 3.0 eq.) and AcOH (2.13 mL, 
35.41 mmol, 1.0 eq.) in EtOH (70 mL) at rt under Ar. The resulting solution was 
stirred and heated at reflux for 18 h. The solution was cooled to rt and the solvent 
was evaporated under reduced pressure. 50% KOH(aq) solution (70 mL) was 
added and the mixture was extracted with Et2O (3 x 100 mL). The combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product. Purification by Kügelrohr distillation gave bispidone 
(R)-312 (5.07 g, 50%) as a clear viscous yellow oil, b.p. 254-256 oC/6.0 mmHg; 
1H NMR (400 MHz, CDCl3) δ 7.38-7.29 (m, 4H, Ph), 7.25-7.21 (m, 1H, Ph), 
3.54 (q, J = 7.0 Hz, 1H, PhCHN), 3.10-2.95 (m, 4H, 4 × NCH), 2.86-2.70 (m, 4H, 
4 × NCH), 2.57-2.50 (m, 2H, CH), 2.32 (t, J = 7.0 Hz, 2H, NCH2), 1.50-1.42 (m, 
2H, CH), 1.35 (d, J = 7.0 Hz, 3H, CHMe), 0.88 (t, J = 7.5 Hz, 3H, CH2Me). 
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3-((R)-1-Phenylethyl)-7-propyl-3,7-diazabicyclo[3.3.1]nonane (R)-308 
Hydrazine monohydrate (5.6 mL, 0.116 mmol) was added dropwise to a stirred 
mixture of bispidone (R)-312 (5.69 g, 21.0 mmol) and KOH (19.69 g, 351 mmol) 
in diethylene glycol (150 mL) at rt under Ar. The mixture was stirred and heated 
at reflux for 20 h. After cooling to 60 oC (if the diethylene glycol solution is 
cooled to rt before addition of H2O then the mixture becomes very viscous and 
too difficult to work with), the mixture was transferred to a separating funnel. 
H2O (150 mL) and Et2O (80 mL) were added and the layers were separated. The 
aqueous layer was extracted with Et2O (6 x 60 mL). The combined organic layers 
were washed with 20% NaOH(aq) (6 x 50 mL), dried (Na2SO4) and evaporated 
under reduced pressure to give the crude product. Purification by Kügelrohr 
distillation gave N-Pr bispidine (R)-308 (3.84 g, 71%) as a viscous pale yellow 
oil, bp 198-204 oC/4.5 mmHg; 1H NMR (400 MHz, CDCl3) δ 7.47-7.45 (m, 2H, 
Ph), 7.30 (t, J = 7.0 Hz, 2H, Ph), 7.23-7.19 (m, 1H, Ph), 3.35 (q, J = 6.5 Hz, 1H, 
PhCHN), 2.83-2.80 (m, 1H, NCH), 2.69-2.62 (m, 3H, 3 × NCH), 2.43-2.36 (m, 
2H, 2 × NCH), 2.33-2.27 (m, 2H, 2 × NCH), 2.26-2.20 (m, 2H, 2 × NCH), 
1.93-1.83 (m, 2H, CH), 1.59-1.38 (m, 3H, CH), 1.43-1.34 (m, 1H, CH), 1.30 (d, 
J = 6.5 Hz, 3H, CHMe), 0.96 (t, J = 7 Hz, 3H, CH2Me); MS (ESI) m/z 273 [M +, 
100]; HRMS (ESI) m/z calcd for C18H29N2 M + 273.2325, found 273.2325 (0.4 
ppm error). 
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Attempted synthesis of rac-314 
s-BuLi (0.64 mL of a 1.3 M in hexane, 0.83 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of phosphine borane 283 (100 mg, 0.76 mmol, 1.0 eq.) in 
THF (10 mL) at 0 ºC under Ar. The resulting solution was stirred at 0 ºC for 30 
min. Then, PhNCO (0.09 mL, 0.83 mmol, 1.1 eq.) was added dropwise and the 
mixture was allowed to warm to rt over 1 h. 1 M HCl(aq) (10 mL) was added and 
the layers were separated. The aqueous layer was extracted with Et2O (3 × 10 
mL). The combined organic layers were washed with brine (5 mL), dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. No 
evidence of the desired product was observed in the 1H NMR spectrum of the 
crude product. 
 
Attempted synthesis of rac-315 
s-BuLi (0.74 mL of a 1.3 M in hexane, 0.97 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of phosphine borane 283 (116 mg, 0.88 mmol, 1.0 eq.) in 
THF (10 mL) at 0 ºC under Ar. The resulting solution was stirred at 0 ºC for 30 
min. Then, a solution of PhSSPh (211 mg, 0.97 mmol, 1.1 eq.) in THF (2 mL) 
was added dropwise and the mixture was allowed to warm to rt over 1 h. 1 M 
HCl(aq) (10 mL) was added and the layers were separated. The aqueous layer was 
extracted with Et2O (3 × 10 mL). The combined organic layers were washed with 
brine (5 mL), dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. No evidence of the desired product was observed in the 1H NMR 
spectrum of the crude product. 
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rac-2-[Boranylidene(t-butyl)methylphosphanyl]-1-phenylethan-1-one 
rac-316 
s-BuLi (0.71 mL of a 1.3 M in hexane, 0.92 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of phosphine borane 283 (110 mg, 0.83 mmol, 1.0 eq.) in 
THF (10 mL) at 0 ºC under Ar. The resulting solution was stirred at 0 ºC for 30 
min. Then, Weinreb amide 313 (151 mg, 0.92 mmol, 1.1 eq.) was added 
dropwise and the mixture was allowed to warm to rt over 1 h. 1 M HCl(aq) (10 
mL) was added and the layers were separated. The aqueous layer was extracted 
with Et2O (3 × 10 mL). The combined organic layers were washed with brine (5 
mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash colum chromatography with 8:2 petrol-Et2O as 
eluent gave ketone rac-316 (132 mg, 67%) as a colourless oil. 
 
 (S)-2-[Boranylidene(t-butyl)methylphosphanyl]-1-phenylethan-1-one 
(S)-316 
(Table 3.11, entry 1) 
s-BuLi (0.71 mL of a 1.3 M in hexane, 0.92 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of (_)-sparteine (213 mg, 0.91 mmol, 1.2 eq.) in Et2O (8 mL) 
at ˗78 ºC. After stirring for 15 min, a solution of phosphine borane 283 (100 mg, 
0.76 mmol, 1.0 eq.) in Et2O (2 mL) was added dropwise. The resulting solution 
was stirred at ˗78 ºC for 3 h. Then, Weinreb amide 313 (134 mg, 0.83 mmol, 1.1 
eq.) was added dropwise and the mixture was allowed to warm to rt overnight. 1 
M HCl(aq) (10 mL) was added and the layers were separated. The aqueous layer 
was extracted with Et2O (3 × 10 mL). The combined organic layers were washed 
with brine (5 mL), dried (MgSO4) and evaporated under reduced pressure to give 
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the crude product. Purification by flash column chromatography with 8:2 
petrol-Et2O as eluent gave ketone (S)-316 (100 mg, 56%, 91:9 er by CSP-HPLC) 
as a colourless oil, [α]D +49.7 (c 1 in CH3Cl); RF (8:2 petrol-Et2O) 0.2; 1H NMR 
(400 MHz, CDCl3) δ 7.98-7.96 (m, 2H, Ph), 7.61-7.56 (m, 1H, Ph), 7.49-7.27 (m, 
2H, Ph), 3.64 (dd, J = 13.0, 8.0 Hz, 1H, PCHAHB), 3.05 (t, J = 13.0 Hz, 1H, 
PCHAHB), 1.35 (d, J = 10.0 Hz, 3H, PMe), 1.22 (d, J = 14.0 Hz, 9H, PCMe3), 
0.43 (qd, J = 94.0, 15.0 Hz, PBH3); 13C NMR (100.6 MHz) δ 194.9 (C=O), 137.0 
(ipso-Ph), 133.7 (Ph), 128.9 (Ph), 128.6 (Ph), 31.3 (CH2), 28.4 (CMe3), 24.9 
(CMe3), 5.6 (Me); MS (ESI) m/z 1235 [M +, 100]; HRMS (ESI) m/z calcd for 
C13H21BOP M + 235.1415, found 235.1420 (_3.4 ppm error); HPLC: Daicel 
Chiracel OD, 90:10 hexane-i-PrOH, 1 mL min -1, (S)-316 7.72 min, (R)-316 8.51 
min. 
(Table 3.11, entry 2) 
s-BuLi (0.49 mL of a 1.3 M in hexane, 0.63 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of diamine 203 (177 mg, 0.91 mmol, 1.2 eq.) in Et2O (8 mL) 
at ˗78 ºC. After stirring for 15 min, a solution of phosphine borane 283 (77 mg, 
0.58 mmol, 1.0 eq.) in Et2O (2 mL) was added dropwise. The resulting solution 
was stirred at ˗78 ºC for 3 h. Then, Weinreb amide 313 (105 mg, 0.63 mmol, 1.1 
eq.) was added dropwise and the mixture was allowed to warm to rt and stirred at 
rt for 16 h. 1 M HCl(aq) (10 mL) was added and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic 
layers were washed with brine (5 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography with 8:2 petrol-Et2O as eluent gave ketone (R)-316 (88 mg, 65%, 
91:9 er by CSP-HPLC) as a colourless oil, [α]D _45.8 (c 1 in CH3Cl); HPLC: 
Daicel Chiracel OD, 90:10 hexane-i-PrOH, 1 mL min -1, (S)-316 7.71 min, 
(R)-316 8.48 min. 
222 
 
(Table 3.11, entry 3) 
s-BuLi (0.64 mL of a 1.3 M in hexane, 0.83 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of diamine (S,S)-304 (154 mg, 0.91 mmol, 1.2 eq.) in Et2O (8 
mL) at ˗78 ºC. After stirring for 15 min, a solution of phosphine borane 283 (100 
mg, 0.78 mmol, 1.0 eq.) in Et2O (2 mL) was added dropwise. The resulting 
solution was stirred at ˗78 ºC for 3 h. Then, Weinreb amide 313 (134 mg, 0.83 
mmol, 1.1 eq.) was added dropwise and the mixture was allowed to warm to rt 
and stirred at rt for 16 h. 1 M HCl(aq) (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 8:2 petrol-Et2O as eluent gave ketone (R)-316 
(87 mg, 50%, 78:22 er by CSP-HPLC) as a colourless oil, [α]D -31.8 (c 1 in 
CH2Cl2); HPLC: Daicel Chiracel OD, 90:10 hexane-i-PrOH, 1 mL min -1, 
(S)-316 7.65 min, (R)-316 8.38 min. 
(Table 3.11, entry 4) 
s-BuLi (0.62 mL of a 1.3 M in hexane, 0.80 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of diamine (S)-307 (237 mg, 0.87 mmol, 1.2 eq.) in Et2O (8 
mL) at ˗78 ºC. After stirring for 15 min, a solution of phosphine borane 283 (96 
mg, 0.73 mmol, 1.0 eq.) in Et2O (2 mL) was added dropwise. The resulting 
solution was stirred at ˗78 ºC for 3 h. Then, Weinreb amide 313 (132 mg, 0.80 
mmol, 1.1 eq.) was added dropwise and the mixture was allowed to warm to rt 
and stirred at rt for 16 h. 1 M HCl(aq) (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 8:2 petrol-Et2O as eluent gave ketone (R)-316 
223 
 
(71 mg, 41%, 61:39 er by CSP-HPLC) as a colourless oil, [α]D -6.6 (c 1 in 
CH3Cl); HPLC: Daicel Chiracel OD, 90:10 hexane-i-PrOH, 1 mL min -1, (S)-316 
7.55 min, (R)-316 8.32 min. 
(Table 3.11, entry5) 
s-BuLi (0.68 mL of a 1.3 M in hexane, 0.88 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of diamine (R)-308 (263 mg, 0.96 mmol, 1.2 eq.) in Et2O (8 
mL) at ˗78 ºC. After stirring for 15 min, a solution of phosphine borane 283 (106 
mg, 0.80 mmol, 1.0 eq.) in Et2O (2 mL) was added dropwise. The resulting 
solution was stirred at ˗78 ºC for 3 h. Then, Weinreb amide 313 (146 mg, 0.88 
mmol, 1.1 eq.) was added dropwise and the mixture was allowed to warm to rt 
and stirred at rt for 16 h. 1 M HCl(aq) (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 8:2 petrol-Et2O as eluent gave ketone (S)-316 
(52 mg, 33%, 55:45 er by CSP-HPLC) as a colourless oil, [α]D +5.7 (c 1 in 
CH2Cl2); HPLC: Daicel Chiracel OD, 90:10 hexane-i-PrOH, 1 mL min -1, 
(S)-316 7.54 min, (R)-316 8.32 min. 
(Table 3.11, entry 6) 
s-BuLi (0.74 mL of a 1.3 M in hexane, 0.97 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of diamine (S,S)-317 (366 mg, 1.05 mmol, 1.2 eq.) in Et2O (8 
mL) at ˗78 ºC. After stirring for 15 min, a solution of phosphine borane 283 (116 
mg, 0.88 mmol, 1.0 eq.) in Et2O (2 mL) was added dropwise. The resulting 
solution was stirred at ˗78 ºC for 3 h. Then, Weinreb amide 313 (160 mg, 0.97 
mmol, 1.1 eq.) was added dropwise and the mixture was allowed to warm to rt 
and stirred at rt for 16 h. 1 M HCl(aq) (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL). The 
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combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 8:2 petrol-Et2O as eluent gave ketone (S)-316 
(140 mg, 67%, 45:55 er by CSP-HPLC) as a colourless oil, HPLC: Daicel 
Chiracel OD, 90:10 hexane-i-PrOH, 1 mL min -1, (S)-316 7.48 min, (R)-316 8.26 
min. 
 
rac-t-Butylmethylphosphinothioyl(methyl)dimethylphenylsilane rac-293 
s-BuLi (0.70 mL of a 1.3 M in hexane, 0.91 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of phosphine borane 283 (109 mg, 0.83 mmol, 1.0 eq.) in 
THF (10 mL) at 0 ºC under Ar. The resulting solution was stirred at 0 ºC for 30 
min. Then, PhMe2SiCl (155 mg, 0.92 mmol, 1.1 eq.) was added dropwise and the 
mixture was allowed to warm to rt over 1 h. 1 M HCl(aq) (10 mL) was added and 
the layers were separated. The aqueous layer was extracted with Et2O (3 × 10 
mL). The combined organic layers were washed with brine (5 mL), dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography with 98:2 petrol-Et2O as eluent 
gave silyl phosphine borane rac-293 (162 mg, 60%) as a colourless oil. 
 
P,P-Dimethylphenylphosphine borane 261 
MeMgBr (41.2 mL of a 3.0 M solution in Et2O, 123.63 mmol, 2.2 eq.) was added 
dropwise to a stirred solution of PhPCl2 (5.3 mL, 56.20 mmol, 1.0 eq.) in THF 
(100 mL) at 0 ºC under Ar. The resulting solution was stirred at rt for 16 h. Then, 
BH3·Me2S (33.7 mL of a 2.0 M solution in THF, 67.43 mmol, 1.2 eq.) was added 
dropwise, and the resulting solution was stirred at rt for 2 h. The solution was 
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poured onto a mixture of ice and conc. HCl(aq) (100 mL). The layers were 
separated and the aqueous layer was extracted with EtOAc (3 × 20 mL). The 
combined organic layers were washed with brine (60 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography with 9:1 petrol-EtOAc as eluent gave phosphine 
borane 261 (5.3 g, 88%) as a colourless oil, RF (9:1 petrol-EtOAc) 0.2; 1H NMR 
(400 MHz, CDCl3) δ 7.76-7.71 (m, 2H, Ph), 7.50-7.48 (m, 3H, Ph), 1.58 (d, J = 
10.5 Hz, 6H, Me), 1.17-0.44 (m, 3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  
131.2 (d, J = 2.0 Hz, Ph), 130.9 (d, J = 55.0 Hz, ipso-Ph), 130.7 (d, J = 9.5 Hz, 
Ph), 128.8 (d, J = 10.0 Hz, Ph), 12.9 (d, J = 39.0 Hz, PMe); 31P NMR (109 MHz, 
CDCl3) δ 3.40 (q, J = 40.0 Hz). Spectroscopic data consistent with those reported 
in the literature.93 
 
(S)-Methyl-(3-methylbut-3-en-1-yl)phenylphosphine borane (S)- 345 
Using procedure E, s-BuLi (1.63 mL of a 1.3 M solution in hexane, 2.12 mmol, 
1.1 eq.) and (_)-sparteine (543 mg, 2.32 mmol, 1.2 eq.) in Et2O (8 mL), 
phosphine borane 261 (300 mg, 1.93 mmol, 1.0 eq.) in Et2O (2 mL) and 
methallyl bromide (0.33 mL, 2.32 mmol, 1.2 eq.) gave the crude product. 
Purification by flash column chromatography with 95:5 petrol-Et2O as eluent 
gave allylated phosphine borane (S)-345 (291 mg, 73%, 89:11 er by CSP-HPLC) 
as a colourless oil, [α]D _1.0 (c 1.0 in CHCl3); RF (8:2 petrol-Et2O) 0.4; IR (film) 
3030, 2925, 2892, 2868, 2338, 2300, 1625 (C=C), 1414, 1396, 1117, 1099, 1049, 
940, 884, 733, 684, 576 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.76-7.71 (m, 2H, 
Ph), 7.55-7.47 (m, 3H, Ph), 4.73 (br s, 1H, =CH), 4.69 (br s, 1H, =CH), 2.25-1.94 
(m, 4H, CH), 1.70 (s, 3H, =CMe), 1.58 (d, J = 10.5 Hz, 3H, PMe), 1.09-0.38 (m, 
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3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  144.4 (d, J = 14.0 Hz, C=CH2), 
131.3 (d, J = 9.0 Hz, Ph), 131.2 (d, J = 2.0 Hz, Ph), 129.5 (d, J = 53.0 Hz, 
ipso-Ph), 128.7 (d, J = 10.0 Hz, Ph), 110.2 (=CH2), 30.6 (CH2), 25.5 (d, J = 36.0 
Hz, PCH2), 22.3 (Me), 10.8 (d, J = 39.0 Hz, PMe); 31P{1H} NMR (109 MHz, 
CDCl3) δ 10.0 (q, J = 26.0 Hz); MS (ESI) m/z 229 [(M + Na)+, 100]; HRMS (ESI) 
m/z calcd C12H20BP (M + Na)+ 229.1285, found 229.1290 (1.6 ppm error); HPLC: 
Daicel Chiracel AD-H, 99.5:0.5 hexane-i-PrOH, 0.5 mL min -1, (R)-345 20.6 min, 
(S)-345 27.2 min. 
 
Methyl-(3-methylbut-3-en-1-yl)phenylphosphine borane rac-345 
s-BuLi (3.82 mL of a 1.3 M solution in hexane, 4.97 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of phosphine borane 261 (630 mg, 4.14 mmol, 1.0 
eq.) in THF (10 mL) at _78 ºC under Ar. The resulting solution was stirred at _78 
ºC for 1 h. Then, methallyl bromide (0.63 mL, 4.97 mmol, 1.2 eq.) was added 
dropwise and the mixture was allowed to warm to rt over 1 h. 1 M HCl(aq) (10 
mL) was added and the layers were separated. The aqueous layer was extracted 
with Et2O (3 × 10 mL). The combined organic layers were washed with brine (10 
mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography with 8:2 petrol-Et2O as 
eluent gave allylated phosphine borane rac-345 (760 mg, 90%) as a colourless 
oil. 
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2-Boranyl-(3-methylbut-3-en-1-yl)(phenylphosphaniumyl)ethan-1-ol rac-346 
s-BuLi (0.76 mL of a 1.3 M in solution hexane, 0.99 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of allylated phosphine borane rac-345 (170 mg, 
0.83 mmol, 1.0 eq.) in THF (5 mL) at _78 ºC under Ar. The resulting solution 
was stirred at _78 ºC for 1 h. Then, a solution of paraformaldehyde (37 mg, 1.24 
mmol, 1.5 eq.) in THF (5 mL) was added dropwise and the mixture was allowed 
to warm to rt over 16 h. 1 M HCl(aq) (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL). The combined 
organic layers were washed with brine (10 mL), dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography with 6:4 petrol-Et2O as eluent gave hydroxy phosphine borane 
rac-346 (93 mg, 48%) as a colourless oil, RF (6:4 petrol-Et2O) 0.1; IR (CDCl3) 
3198, 2860, 2334, 2306, 1412, 1096, 1050, 1020, 969, 879, 655 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.77-7.73 (m, 2H, Ph), 7.57-7.48 (m, 3H, Ph), 4.74 (br s, 
1H, =CH), 4.69 (br s, 1H, =CH), 3.96-3.78 (m, 2H, CH2OH), 2.29-2.20 (m, 3H, 
CH), 2.10-1.85 (m, 3H, CH), 1.70 (s, 3H, =CMe), 1.15-0.45 (m, 3H, BH3); 13C 
NMR (100.6 MHz, CDCl3) δ  144.5 (d, J = 13.5 Hz, C=CH2), 131.8 (d, J = 9.0 
Hz, Ph), 131.5 (d, J = 2.0 Hz, Ph), 129.8 (d, J = 10.0 Hz, Ph), 127.5 (d, J = 53.0 
Hz, ipso-Ph), 110.3 (=CH2), 57.4 (OCH2), 30.3 (CH2), 29.0 (d, J = 35.0 Hz, 
PCH2), 24.3 (d, J = 36.0 Hz, PCH2), 22.2 (Me); 31P{1H} NMR (109 MHz, CDCl3) 
δ 12.6 (q, J = 26.0 Hz); MS (ESI) m/z 259 [(M + Na)+, 60], 90 (100); HRMS 
(ESI) m/z calcd C13H22BP (M + Na)+ 259.1399, found 259.1396 (_1.1 ppm error). 
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2-Boranyl-(3-methylbut-3-en-1-yl)(phenylphosphaniumyl)ethyl 
4-methylbenzene-1- sulfinate rac-347 
A solution of p-toluenesulfonyl chloride (109 mg, 0.57 mmol, 1.5 eq.) in CH2Cl2 
(2 mL) was added dropwise to a stirred solution of phosphine borane rac-346 (90 
mg, 0.38 mmol, 1.0 eq.) and pyridine (15 mg, 0.19 mmol, 0.5 eq.) in CH2Cl2 (2 
mL) at rt under Ar. The resulting mixture was stirred at rt for 16 h. 2 M HCl(aq) 
(10 mL) was added and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 (3 × 5 mL). The combined organic layers were washed 
with brine (5 mL), dried (MgSO4) and evaporated under reduced pressure to give 
the crude product. Purification by flash column chromatography with 8:2 
petrol-Et2O as eluent gave tosylate rac-347 (50 mg, 34%) as a white solid, mp 
90-91 ºC; RF (8:2 petrol-Et2O) 0.3; IR (film) 3031, 2923, 2872, 2349, 1415, 1340, 
1158, 1080, 1050, 947, 735, 652 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.72-7.66 
(m, 4H, Ar), 7.58-7.47 (m, 3H, Ar), 7.33 (d, J = 8.0 Hz, 2H, Ar), 4.73 (br s, 1H, 
=CH), 4.67 (br s, 1H, =CH), 4.33-4.24 (m, 1H, OCHAHB), 4.12-4.03 (m, 1H, 
OCHAHB), 2.46 (s, 3H, MeC6H4),  2.39-1.92 (m, 6H, CH), 1.68 (s, 3H, =CMe), 
1.02-0.24 (m, 3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  145.1 (ipso-Ar), 
144.1 (d, J = 14.0 Hz, C=CH2), 132.4 (ipso-Ar), 131.9 (Ar), 131.8 (d, J = 9.0 Hz, 
Ar), 129.9 (Ar), 129.0 (d, J = 10.0 Hz, Ar), 127.8 (Ar), 126.4 (d, J = 52.0 Hz, 
ipso-Ph), 110.5 (=CH2), 65.0 (d, J = 5.0 Hz, OCH2), 30.2 (CH2), 26.0 (d, J = 34.0 
Hz, PCH2), 24.2 (d, J = 36.0 Hz, PCH2), 22.2 (Me), 21.6 (Me); 31P{1H} NMR 
(109 MHz, CDCl3) δ 13.9-13.4 (m); MS (ESI) m/z 389 M+ (100); HRMS (ESI) 
m/z calcd C20H27BO3PS M+ 389.1516, found 389.1510 (_2.5 ppm error). 
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(R)-Ethenyl-(3-methylbut-3-en-1-yl)phenylphosphine borane (R)-348 
Using general procedure F, s-BuLi (0.81 mL of a 1.3 M solution in hexane, 1.05 
mmol, 1.2 eq.), allylated phosphine borane (S)-345 (180 mg, 0.87 mmol, 1.0 eq.) 
in THF (5 mL) and paraformaldehyde (40 mg, 1.05 mmol, 1.2 eq.) in THF (5 
mL), followed by p-toluenesulfonyl chloride (230 mg, 1.21 mmol) in CH2Cl2 (5 
mL) and pyridine (0.10 mL, 1.21 mmol) in CH2Cl2 (5 mL) and then KOt-Bu 
(212 mg, 1.89 mmol) in Et2O (5 mL) gave the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave vinyl 
phosphine borane (R)-348 (108 mg, 58%) as a colourless oil, [α]D _29.7 (c 0.5 in 
CHCl3); RF (95:5 petrol-Et2O) 0.3; IR (film) 3031, 2925, 2890, 2870, 2346, 2305, 
1415, 1094, 1048, 967, 878, 733, 684 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.74-7.69 (m, 2H, Ph), 7.51-7.48 (m, 3H, Ph), 6.40 (dt, J = 18.0, 13.0 Hz, 1H, 
PCH=), 6.27-6.14 (m, 2H, PCH=CH2), 4.75 (br s, 1H, =CH), 4.70 (br s, 1H, 
=CH), 2.21-2.04 (m, 4H, CH), 1.72 (s, 3H, Me),  1.13-0.43 (m, 3H, BH3); 13C 
NMR (100.6 MHz, CDCl3) δ  144.6 (d, J = 14.0 Hz, C=CH2), 134.6 (d, J = 5.0 
Hz, PCH=CH2), 131.6 (d, J = 9.0 Hz, Ph), 131.3 (d, J = 2.0 Hz, Ph), 128.8 (d, J = 
10.0 Hz, Ph), 128.4 (d, J = 57.0 Hz, ipso-Ph), 127.9 (d, J = 52.0 Hz, PCH=), 
110.3 (=CH2), 30.5 (CH2), 24.2 (d, J = 38.0 Hz, PCH2), 22.5 (Me); 31P{1H} 
NMR (109 MHz, CDCl3) δ 13.3 (q, J = 30.5 Hz); MS (ESI) m/z 241 [(M + Na)+, 
100]; HRMS (ESI) m/z calcd C13H20BP (M + Na)+ 241.1283, found 241.1290 
(2.7 ppm error). 
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Ethenyl-(3-methylbut-3-en-1-yl)phenylphosphine borane rac-348 
KOt-Bu (209 mg, 1.86 mmol, 2.2 eq.) was added in one portion to a stirred 
solution of tosylate rac-345 (330 mg, 0.85 mmol, 1.0 eq.) in Et2O (8 mL) at rt 
under Ar. The resulting mixture was stirred at rt for 2 h. Then, the solid was 
removed by filtration through Celite®. The solid was washed with Et2O (3 × 5 
mL) and the combined organics were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography with 95:5 petrol-Et2O as eluent gave vinyl phosphine borane 
rac-348 (180 mg, 98%) as a colourless oil. 
Using general procedure B, s-BuLi (2.62 mL of a 1.3 M solution in hexane, 3.41 
mmol, 1.2 eq.), allylated phosphine borane rac-345 (586 mg, 2.84 mmol, 1.0 eq.) 
in THF (10 mL) and paraformaldehyde (128 mg, 3.41 mmol, 1.2 eq.) in THF (10 
mL), followed by p-toluenesulfonyl chloride (545 mg, 2.86 mmol) in CH2Cl2 (5 
mL) and pyridine (0.23 mL, 2.86 mmol) in CH2Cl2 (5 mL) and then KOt-Bu 
(506 mg, 4.51 mmol) in Et2O (10 mL) gave the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave vinyl 
phosphine borane rac-348 (530 mg, 86%) as a colourless oil. 
 
(R)-4-Methyl-1-phenyl-2,3-dihydro-1H-phosphol-1-ane borane (R)-349 
Using general procedure G, Grubbs-Hoveyda 2nd generation catalyst 350 (14 mg, 
0.02 mmol, 0.1 eq.) and vinyl phosphine borane (R)-348 (50 mg, 0.23 mmol, 1.0 
eq.) in CH2Cl2 (2 mL) gave the crude product. Purification by flash column 
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chromatography with 99:1 petrol-Et2O as eluent gave cyclic phosphine borane 
(R)-349 (20 mg, 46%) as a colourless oil, [α]D +75.7 (c 0.3 in CHCl3); RF (99:1 
petrol-Et2O) 0.3; IR (film) 2926, 2870, 2340, 2210, 1588, 1415, 1093, 1044, 896, 
722, 683 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.71-7.67 (m, 2H, Ph), 7.49-7.42 
(m, 3H, Ph), 5.70 (ddd, J = 32.0, 3.0, 1.5 Hz, 1H, PCH=), 2.83-2.76 (m, 2H, CH), 
2.40-2.32 (m, 1H, CH), 2.20-2.10 (m, 1H, CH), 2.09 (s, 3H, Me), 1.24-0.53 (m, 
3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  161.6 (d, J = 10.0 Hz, =CMe), 
131.7 (d, J = 10.0 Hz, Ph), 131.4 (d, J = 47.0 Hz, ipso-Ph), 131.2 (d, J = 2.0 Hz, 
Ph), 128.7 (d, J = 10.0 Hz, Ph), 116.3 (d, J = 56.5 Hz, =CH), 37.3 (Me), 24.8 (d, 
J = 39.0 Hz, PCH2), 20.2 (d, J = 13.0 Hz, CH2); 31P{1H} NMR (109 MHz, 
CDCl3) δ 45.6 (q, J = 35.0 Hz); MS (ESI) m/z 213 [(M + Na)+, 100]; HRMS (ESI) 
m/z calcd C11H16BP (M + Na)+ 213.0968, found 213.0977 (3.7 ppm error).  
 
4-Methyl-1-phenyl-2,3-dihydro-1H-phosphol-1-ane borane rac-349 
(Table 3.12, entry 1) 
Grubbs 1st generation catalyst 4 (2 mg, 0.002 mmol, 0.02 eq.) was added in one 
portion to a stirred solution of vinyl phosphine borane rac-348 (25 mg, 0.11 
mmol, 1.0 eq.) in CH2Cl2 (1 mL) at rt. The resulting mixture was stirred at rt for 
16 h. The solvent was evaporated under reduced pressure to give the crude 
product which contained a 100:0 ratio of rac-348 and rac-349 (by 1H NMR 
spectroscopy). 
(Table 3.12, entries 2 and 3) 
Grubbs 2nd generation catalyst 5 (8 mg, 0.009 mmol, 0.02 eq.) was added in one 
portion to a stirred solution of vinyl phosphine borane rac-348 (100 mg, 0.46 
mmol, 1.0 eq.) in CH2Cl2 (2 mL) at rt. The resulting mixture was stirred at rt for 
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72 h. The solvent was evaporated under reduced pressure to give the crude 
product which contained a 77:23 ratio of rac-348 and rac-349 (by the 1H NMR 
spectroscopy). The crude mixture was then dissolved in CH2Cl2 (2 mL) and 
stirred and heated at reflux for 16 h. After being allowed to cool to rt, the solvent 
was evaporated under reduced pressure to give the crude product which 
contained an 83:17 ratio of rac-348 and rac-349 (by 1H NMR spectroscopy).  
(Table 3.12, entry 4) 
Grubbs 2nd generation catalyst 5 (5 mg, 0.008 mmol, 0.02 eq.) was added in one 
portion to a stirred solution of vinyl phosphine borane rac-348 (85 mg, 0.39 
mmol, 1.0 eq.) in toluene (2 mL) at rt. The resulting mixture was stirred and 
heated at reflux for 16 h. The solvent was evaporated under reduced pressure to 
give the crude product which contained a 78:22 ratio of rac-348 and rac-349 (by 
1H NMR spectroscopy). 
(Table 3.13, entries 1-5) 
Grubbs-Hoveyda 2nd generation catalyst 350 (3 mg, 0.005 mmol, 0.02 eq.) was 
added in one portion to a stirred solution of vinyl phosphine borane rac-348 (50 
mg, 0.23 mmol, 1.0 eq.) in CH2Cl2 (2 mL) at rt. The resulting mixture was stirred 
at rt for 16 h. The solvent was evaporated under reduced pressure to give the 
crude product which contained an 87:13 ratio of rac-348 and rac-349 (by 1H 
NMR spectroscopy). The crude mixture was dissolved in CH2Cl2 (2 mL) and 
Grubbs-Hoveyda 2nd generation catalyst 350 (13 mg, 0.02 mmol, 0.1 eq.) was 
added the resulting mixture was stirred at rt for 16 h. The solvent was evaporated 
under reduced pressure to give the crude product which contained a 50:50 ratio 
of rac-348 and rac-349 (by 1H NMR spectroscopy). The crude mixture was then 
dissolved in CH2Cl2 (2 mL) and stirred at rt for 26 h. The solvent was evaporated 
under reduced pressure to give the crude product which contained a 40:60 ratio 
of rac-348 and rac-349 (by 1H NMR spectroscopy). The crude mixture was then 
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dissolved in CH2Cl2 (2 mL) and stirred at rt for 24 h. The solvent was evaporated 
under reduced pressure to give the crude product which contained a 40:60 ratio 
of rac-348 and rac-349 (by 1H NMR spectroscopy). The crude mixture was then 
dissolved in CH2Cl2 (2 mL) and stirred and heated at reflux for 16 h. After being 
allowed to cool to rt, the solvent was evaporated under reduced pressure. Neither 
rac-348 and rac-349 was observed by 1H NMR spectroscopy of the crude 
product. 
 
(S)-Methyl-(but-3-en-1-yl)phenylphosphine borane (S)-351 
Using procedure E, s-BuLi (2.41 mL of a 1.3 M solution in hexane, 3.13 mmol, 
1.1 eq.) and (_)-sparteine (802 mg, 3.42 mmol, 1.2 eq.) in Et2O (8 mL), 
phosphine borane 261 (433 mg, 2.85 mmol, 1.0 eq.) in Et2O (2 mL) and allyl 
bromide (0.30 mL, 3.42 mmol, 1.2 eq.) gave the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave allylated 
phosphine borane (S)-351 (312 mg, 57%, 88:12 er by CSP-HPLC) as a colourless 
oil, [α]D +0.1 (c 1.0 in CHCl3); RF (95:5 petrol-Et2O) 0.3; IR (film) 3031, 2934, 
2870, 2335, 1615, 1414, 1395, 1118, 1100, 1046, 982, 903, 733, 683 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.75-7.71 (m, 2H, Ph), 7.53-7.46 (m, 3H, Ph), 
5.84-5.75 (m, 1H, =CH), 5.03 (dq, J = 17.0, 2.0 Hz, 1H, =CHAHB), 5.00-4.97 (m, 
1H, =CHAHB), 2.34-2.07 (m, 2H, CH), 1.98-1.91 (m, 2H, CH), 1.58 (d, J = 10.0 
Hz, 3H, Me), 1.08-0.37 (m, 3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  137.1 (d, 
J = 14.0 Hz, =CH), 131.3 (d, J = 9.0 Hz, Ph), 131.2 (d, J = 2.0 Hz, Ph), 129.4 (d, 
J = 53.0 Hz, ipso-Ph), 128.7 (d, J = 10.0 Hz, Ph), 115.3 (=CH2), 27.0 (CH2), 26.5 
(d, J = 36.0 Hz, PCH2), 10.6 (d, J = 39.0 Hz, PMe); 31P{1H} NMR (109 MHz, 
CDCl3) δ 9.6 (q, J = 26.0 Hz); MS (ESI) m/z 215 [(M + Na)+, 100]; HRMS (ESI) 
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m/z calcd C11H18BP (M + Na)+ 215.1128, found 215.1133 (1.6 ppm error); HPLC: 
Daicel Chiracel AD-H, 99.5:0.5 hexane-i-PrOH, 0.5 mL min -1, (R)-351 19.4 min, 
(S)-351 31.3 min. 
 
(R)-Ethenyl-(but-3-en-1-yl)phenylphosphine borane (R)-356 
Using general procedure F, s-BuLi (0.99 mL of a 1.3 M solution in hexane, 1.29 
mmol, 1.2 eq.), allylated phosphine borane (S)-351 (206 mg, 1.07 mmol, 1.0 eq.) 
in THF (10 mL) and paraformaldehyde (40 mg, 1.29 mmol, 1.2 eq.) in THF (5 
mL), followed by p-toluenesulfonyl chloride (338 mg, 1.77 mmol) in CH2Cl2 (5 
mL) and pyridine (0.14 mL, 1.77 mmol) in CH2Cl2 (5 mL) and then KOt-Bu 
(373 mg, 3.32 mmol) in Et2O (10 mL) gave the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave vinyl 
phosphine borane (R)-356 (156 mg, 71%) as a colourless oil, [α]D _52.6 (c 0.5 in 
CHCl3); RF (95:5 petrol-Et2O) 0.3; IR (film) 3381, 2916, 2826, 2345, 2310, 1440, 
1053, 1007, 876, 624 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.73-7.69 (m, 2H, Ph), 
7.54-7.46 (m, 3H, Ph), 6.45-6.34 (m, 1H, PCH=), 6.27-6.14 (m, 2H, PCH=CH2), 
5.80 (ddt, J = 16.5, 10.0, 6.0 Hz, 1H, =CH), 5.06-4.98 (m, 2H, =CH2), 2.33-2.13 
(m, 2H, CH), 2.06-2.00 (m, 2H, CH), 1.14-0.45 (m, 3H, BH3); 13C NMR (100.6 
MHz, CDCl3) δ  137.2 (d, J = 15.0 Hz, =CH), 134.6 (d, J = 5.0 Hz, =CH2), 134.6 
(d, J = 5.0 Hz, Ph), 131.7 (d, J = 9.0 Hz, Ph), 131.3 (d, J = 2.0 Hz, Ph), 128.2 
(=CH), 128.0 (d, J = 52.0 Hz, ipso-Ph), 115.3 (=CH2), 26.9 (CH2), 25.1 (d, J = 
37.0 Hz, PCH2); 31P{1H} NMR (109 MHz, CDCl3) δ 13.2 (q, J = 33.0 Hz); MS 
(ESI) m/z 227 [(M + Na)+, 100]; HRMS (ESI) m/z calcd C12H18BP (M + Na)+ 
227.1119, found 227.1134 (4.9 ppm error). 
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(R)-1-Phenyl-2,3-dihydro-1H-phosphol-1-ane borane (R)-359 
Using general procedure G, Grubbs-Hoveyda 2nd generation catalyst 350 (2 mg, 
0.02 mmol, 0.01 eq.) and vinyl phosphine borane (R)-356 (50 mg, 0.24 mmol, 
1.0 eq.) gave the crude product. Purification by flash column chromatography 
with 99:1 petrol-Et2O as eluent gave cyclic phosphine borane (R)-359 (32 mg, 
71%, 87:13 er by CSP-HPLC) as a colourless oil, [α]D +82.3 (c 0.3 in CHCl3); RF 
(99:1 petrol-Et2O) 0.3; IR (film) 2347, 1417, 1045, 894, 722 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.71-7.66 (m, 2H, Ph), 7.51-7.43 (m, 3H, Ph), 6.90 (ddt, J = 33.0, 
8.0, 2.5 Hz, 1H, PCH=), 6.15 (ddt, J = 32.0, 8.0, 2.0 Hz, 1H, =CH), 2.94-2.88 (m, 
2H, CH), 2.35-2.27 (m, 1H, CH), 2.18-2.09 (m, 1H, CH), 1.23-0.56 (m, 3H, 
BH3); 13C NMR (100.6 MHz, CDCl3) δ  149.8 (d, J = 9.5 Hz, =CH), 131.8 (d, J 
= 10.0 Hz, Ph), 131.4 (d, J = 2.0 Hz, Ph), 130.3 (d, J = 47.0 Hz, ipso-Ph), 128.7 
(d, J = 10.0 Hz, Ph), 122.8 (d, J = 51.0 Hz, PCH=), 33.2 (CH2), 23.6 (d, J = 39.0 
Hz, CH2); 31P{1H} NMR (109 MHz, CDCl3) δ 43.6 (q, J = 30.5 Hz); MS (ESI) 
m/z 199 [(M + Na)+, 100]; HRMS (ESI) m/z calcd C10H14BP (M + Na)+ 199.0827, 
found 199.0820 (_4.2 ppm error); HPLC: Daicel Chiracel AD-H, 99.5:0.5 
hexane-i-PrOH, 0.5 mL min -1, (S)-359 43.3 min, (R)-359 47.8 min.  
 
(S)-t-Butylmethyl-(3-methylbut-3-en-1-yl)phosphine borane (S)-352 
Using procedure E, s-BuLi (3.20 mL of a 1.3 M solution in hexane, 4.16 mmol, 
1.1 eq.) and (_)-sparteine (1.1 g, 4.54 mmol, 1.2 eq.) in Et2O (8 mL), phosphine 
borane 283 (500 mg, 3.78 mmol, 1.0 eq.) in Et2O (2 mL) and methallyl bromide 
(0.46 mL, 4.54 mmol, 1.2 eq.) gave the crude product. Purification by flash 
column chromatography with 95:5 petrol-Et2O as eluent gave allylated 
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phosphine borane (S)-352 (400 mg, 57%, 96:4 er by CSP-HPLC of phosphine 
sulfide (S)-354) as a colourless oil, [α]D _9.3 (c 1.0 in CHCl3); RF (95:5 
petrol-Et2O) 0.3; IR (film) 2929, 2827, 2334, 1616, 1442, 1398, 1347, 1277, 
1048, 1003, 981, 901 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.77 (br s, 1H, =CH), 
4.74 (br s, 1H, =CH), 2.42-2.30 (m, 1H, CH), 2.15-2.06 (m, 1H, CH), 1.76 (s, 3H, 
=CMe), 1.79-1.59 (m, 2H, CH), 1.20 (d, J = 11.0 Hz, 3H, PMe), 1.16 (d, J = 13.5 
Hz, 9H, PCMe3), 0.78-0.07 (m, 3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  
145.0 (d, J = 13.0 Hz, C=CH2), 110.2 (=CH2), 30.9 (CH2), 27.5 (d, J = 36.0 Hz, 
PCMe3), 25.0 (PCMe3), 22.4 (Me), 19.4 (d, J = 32.0 Hz, PCH2), 5.0 (d, J = 34.0 
Hz, PMe); 31P{1H} NMR (109 MHz, CDCl3) δ 26.5 (q, J = 37.0 Hz); MS (ESI) 
m/z 209 [(M + Na)+, 100]; HRMS (ESI) m/z calcd C10H24BP (M + Na)+ 209.1597, 
found 209.1603 (2.1 ppm error). 
 
(R)-t-Butylmethyl-(3-methylbut-3-en-1-yl)phosphine sulfide 354 
Using general procedure H, phosphine borane (S)-352 (20 mg, 0.11 mmol, 1.0 
eq.), DABCO (27 mg, 0.24 mmol, 2.2 eq.) and sulfur (17 mg, 0.54 mmol, 5.0 eq.) 
gave the crude product. Purification by flash column chromatography with 8:2 
petrol-Et2O as eluent gave phosphine sulfide 354 (19 mg, 87%, 96:4 er by 
CSP-HPLC) as a white solid, mp 88-89 ºC; [α]D +2.4 (c 1.0 in CHCl3); RF (99:1 
petrol-Et2O) 0.3; IR (film) 2927, 2862, 2825, 1615, 1441, 1394, 1344, 1273, 981, 
902, 866, 738 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.77 (br s, 1H, =CH), 4.74 (br 
s, 1H, =CH), 2.60-2.49 (m, 1H, CH), 2.24-2.23 (m, 1H, CH), 1.95-1.94 (m, 2H, 
CH), 1.76 (s, 3H, =CMe), 1.58 (d, J = 11.5 Hz, 3H, PMe), 1.24 (d, J = 16.0 Hz, 
9H, PCMe3); 13C NMR (100.6 MHz, CDCl3) δ  144.7 (d, J = 14.5 Hz, C=CH2), 
110.3 (=CH2), 30.0 (d, J = 51.0 Hz, PCMe3), 30.4 (CH2), 25.4 (d, J = 48.0 Hz, 
PCH2), 24.5 (PCMe3), 22.5 (Me), 14.0 (d, J = 50.0 Hz, PMe); 31P{1H} NMR 
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(109 MHz, CDCl3) δ 60.4; MS (ESI) m/z 205 M+ (100); HRMS (ESI) m/z calcd 
C10H21PS (M + H)+ 205.1171, found 205.1174 (0.9 ppm error); HPLC: Daicel 
Chiracel AD-H, 99.5:0.5 hexane-i-PrOH, 0.5 mL min -1, (S)- 354 18.2 min, 
(R)-354 33.3 min. 
 
(R)-t-Butylethenyl-(3-methylbut-3-en-1-yl)phosphine borane (R)-357 
Using general procedure F, s-BuLi (0.74 mL of a 1.3 M solution in hexane, 0.97 
mmol, 1.2 eq.), allylated phosphine borane (S)-352 (150 mg, 0.81 mmol, 1.0 eq.) 
in THF (10 mL) and paraformaldehyde (29 mg, 0.97 mmol, 1.2 eq.) in THF (5 
mL), followed by p-toluenesulfonyl chloride (111 mg, 0.99 mmol) in CH2Cl2 (5 
mL) and pyridine (0.06 mL, 0.99 mmol) in CH2Cl2 (5 mL) and then KOt-Bu 
(344 mg, 3.07 mmol) in Et2O (10 mL) gave the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave vinyl 
phosphine borane (R)-357 (89 mg, 56%) as a colourless oil, [α]D +17.8 (c 0.3 in 
CHCl3); RF (95:5 petrol-Et2O) 0.4; IR (film) 3032, 2345, 2306, 1616, 1415, 1373, 
1094, 1045, 1004, 971, 903, 781, 733, 684 cm-1; 1H NMR (400 MHz, CDCl3) δ 
6.33-6.20 (m, 2H, CH=CH2), 6.12 (ddd, J = 17.5, 12.0, 8.5 Hz, 1H, PCH=), 4.75 
(br s, 1H, =CH), 4.71 (br s, 1H, =CH), 2.35-2.25 (m, 1H, CH), 2.00-1.91 (m, 1H, 
CH), 1.80-1.72 (m, 2H, CH), 1.74 (s, 3H, =CMe), 1.15 (d, J = 13.5 Hz, 9H, 
PCMe3), 0.78-0.08 (m, 3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  145.2 (d, J = 
13.0 Hz, C=CH2), 137.3 (d, J = 5.5 Hz, =CH2), 125.0 (d, J = 46.0 Hz, PCH=), 
110.0 (=CH2),  30.8 (CH2), 28.1 (d, J = 35.0 Hz, PCMe3), 25.3 (PCMe3), 22.5 
(Me), 18.1 (d, J = 34.0 Hz, PCH2); 31P{1H} NMR (109 MHz, CDCl3) δ 30.2 (q, J 
= 33.0 Hz); MS (ESI) m/z 221 [(M + Na)+, 100]; HRMS (ESI) m/z calcd 
C11H24BP (M + Na)+ 221.1594, found 221.1603 (3.0 ppm error).  
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(R)-t-Butyl-4-methyl-2,3-dihydro-1H-phosphol-1-ane borane (R)-360 
Using general procedure G, Grubbs-Hoveyda 2nd generation catalyst 350 (41 mg, 
0.07 mmol, 0.1 eq.) and vinyl phosphine borane (R)-357 (130 mg, 0.66 mmol, 
1.0 eq.) in CH2Cl2 (2 mL) gave the crude product. Purification by flash column 
chromatography with 95:5 petrol-Et2O as eluent gave cyclic phosphine borane 
(R)-360 (46 mg, 41%) as a white solid, mp 71-72 ºC; [α]D +22.5 (c 0.7 in CHCl3); 
RF (95:5 petrol-Et2O) 0.3; IR (CDCl3) 2913, 2899, 2824, 2339, 2210, 1589, 1439, 
1048, 900, 889, 713, 640 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.52 (ddd, J = 31.0, 
3.0, 1.5 Hz, 1H, PCH=), 2.69-2.62 (m, 2H, CH), 2.07-1.98 (m, 2H, CH), 1.95 (s, 
3H, Me), 1.12 (d, J = 13.5 Hz, 9H, PCMe3), 0.91-0.21 (m, 3H, BH3); 13C NMR 
(100.6 MHz, CDCl3) δ  160.6 (d, J = 8.5 Hz, =CMe), 114.2 (d, J = 52.0 Hz, 
PCH=), 37.7 (CH2), 29.3 (d, J = 28.5 Hz, PCMe3), 25.1 (PCMe3), 20.2 (d, J = 
12.0 Hz, Me), 18.0 (d, J = 35.5 Hz, PCH2); 31P{1H} NMR (109 MHz, CDCl3) δ 
68.2 (q, J = 38.0 Hz); MS (ESI) m/z 193 [(M + Na)+, 100); HRMS (ESI) m/z 
calcd C9H20BP (M + Na)+ 193.1285, found 193.1290 (1.2 ppm error). 
 
(S)-t-Butylmethyl-(but-3-en-1-yl)phosphine borane (S)-353 
Using procedure E, s-BuLi (2.24 mL of a 1.3 M solution in hexane, 2.91 mmol, 
1.1 eq.) and (_)-sparteine (745 mg, 3.18 mmol, 1.2 eq.) in Et2O (8 mL), 
phosphine borane 283 (350 mg, 2.65 mmol, 1.0 eq.) in Et2O (2 mL) and allyl 
bromide (0.28 mL, 3.18 mmol, 1.2 eq.) gave the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave allylated 
phosphine borane (S)-353 (247 mg, 58%, 93:7 er by CSP-HPLC of phosphine 
sulfide (S)-355) as a colourless oil, [α]D _10.2 (c 1.0 in CHCl3); RF (95:5 
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petrol-Et2O) 0.3; IR (film) 2929, 2826, 2335, 1616, 1442, 1398, 1375, 1347, 
1277, 1118, 1048, 1003, 981, 902, 807, 780 cm-1; 1H NMR (400 MHz, CDCl3) δ 
5.91-5.80 (m, 1H, =CH), 5.11-5.01 (m, 2H, =CH2), 2.41-2.39 (m, 1H, CH), 
2.26-2.14 (m, 1H, CH), 1.78-1.55 (m, 2H, CH), 1.20 (d, J = 10.0 Hz, 3H, Me), 
1.16 (d, J = 13.5 Hz, 9H, PCMe3), 0.75-0.03 (m, 3H, BH3); 13C NMR (100.6 
MHz, CDCl3) δ  137.8 (d, J = 13.0 Hz, C=CH2), 115.2 (=CH2), 27.3 (CH2), 27.2 
(d, J = 34.0 Hz, PCMe3), 25.0 (PCMe3), 20.4 (d, J = 31.5 Hz, PCH2), 5.2 (d, J = 
34.0 Hz, PMe); 31P{1H} NMR (109 MHz, CDCl3) δ 26.5 (q, J = 40.0 Hz); MS 
(ESI) m/z 195 [(M + Na)+, 100]; HRMS (ESI) m/z calcd C9H22BP (M + Na)+ 
195.1439, found 195.1446 (2.5 ppm error). 
 
(R)-t-Butylmethyl-(but-3-en-1-yl)phosphine sulfide 355 
Using general procedure H, phosphine borane (S)-353 (20 mg, 0.12 mmol, 1.0 
eq.), DABCO (29 mg, 0.26 mmol, 2.2 eq.) and sulfur (19 mg, 0.58 mmol, 5.0 eq.) 
gave the crude product. Purification by flash column chromatography with 8:2 
petrol-Et2O as eluent gave phosphine sulfide 355 (19 mg, 80%, 93:7 er by 
CSP-HPLC) as a white solid, mp 80-82 ºC; [α]D +0.6 (c 0.8 in CHCl3); RF (99:1 
petrol-Et2O) 0.3; IR (film) 2928, 2862, 2825, 1616, 1442, 1394, 1344, 1273, 981, 
902, 867, 801, 738, 686, 628 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.92-5.82 (m, 
1H, =CH), 5.11 (dq, J = 17.0, 2.0 Hz, 1H, =CHAHB), 5.05-5.01 (m, 1H, 
=CHAHB), 2.69-2.57 (m, 1H, CH), 2.34-2.22 (m, 1H, CH), 1.91-1.83 (m, 2H, 
CH), 1.59 (d, J = 11.5 Hz, 3H, PMe), 1.24 (d, J = 16.0 Hz, 9H, PCMe3); 13C 
NMR (100.6 MHz, CDCl3) δ  137.4 (d, J = 15.5 Hz, CH=), 115.5 (=CH2), 33.0 
(d, J = 51.0 Hz, PCMe3), 26.8 (d, J = 3.0 Hz, PCH2CH2), 26.5 (d, J = 47.5 Hz, 
PCH2), 24.5 (d, J = 1.5 Hz, PCMe3), 14.0 (d, J = 50.0 Hz, PMe); 31P{1H} NMR 
(109 MHz, CDCl3) δ 60.1; MS (ESI) m/z 213  [(M + Na)+, 100]; HRMS (ESI) 
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m/z calcd C9H19PS (M + Na)+ 213.0838, found 213.0837 (_1.7 ppm error); HPLC: 
Daicel Chiracel AD-H, 99.5:0.5 hexane-i-PrOH, 0.5 mL min -1, (S)-355 19.3 min, 
(R)-355 30.0 min. 
 
(R)-t-Butylethenyl-(but-3-en-1-yl)phosphine borane (R)-358 
Using general procedure F, s-BuLi (1.50 mL of a 1.3 M solution in hexane, 1.94 
mmol, 1.2 eq.), allylated phosphine borane (S)-353 (256 mg, 1.62 mmol, 1.0 eq.) 
in THF (10 mL) and paraformaldehyde (58 mg, 1.94 mmol, 1.2 eq.) in THF (5 
mL), followed by p-toluenesulfonyl chloride (326 mg, 1.71 mmol) in CH2Cl2 (5 
mL) and pyridine (0.14 mL, 1.71 mmol) in CH2Cl2 (5 mL) and then KOt-Bu 
(492 mg, 4.40 mmol) in Et2O (10 mL) gave the crude product. Purification by 
flash column chromatography with 95:5 petrol-Et2O as eluent gave vinyl 
phosphine borane (R)-358 (175 mg, 60%) as a colourless oil, [α]D +14.5 (c 0.4 in 
CHCl3); RF (95:5 petrol-Et2O) 0.4; IR (film) 2929, 2914, 2344, 2309, 1440, 1373, 
1346, 1047, 1006, 974, 901 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.33-6.06 (m, 
3H, PCH=, =CH2), 5.85 (ddt, J = 17.0, 10.0, 6.0 Hz, 1H, =CH), 5.05 (dq, J = 
17.0, 1.5 Hz, 1H, =CHAHB), 5.01-4.97 (m, 1H, =CHAHB), 2.43-2.32 (m, 1H, CH), 
2.11-2.01 (m, 1H, CH), 1.75-1.68 (m, 2H, CH), 1.15 (d, J = 13.5 Hz, 9H, 
PCMe3), 0.83-0.06 (m, 3H, BH3); 13C NMR (100.6 MHz, CDCl3) δ  137.9 (d, J = 
14.0 Hz, =CH), 137.4 (d, J = 6.0 Hz, PCH=CH2), 125.1 (d, J = 46.0 Hz, PCH=), 
115.1 (=CH2), 28.0 (d, J = 35.0 Hz, PCMe3), 27.2 (CH2), 25.2 (d, J = 2.0 Hz, 
PCMe3), 19.2 (d, J = 34.0 Hz, PCH2); 31P{1H} NMR (109 MHz, CDCl3) δ 30.0 
(q, J = 39.0 Hz); MS (ESI) m/z 207 [(M + Na)+, 100]; HRMS (ESI) m/z calcd 
C10H22BP (M + Na)+ 207.1449, found 207.1446 (_3.6 ppm error). 
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(R)-t-Butyl-2,3-dihydro-1H-phosphol-1-ane borane (R)-361 
Using general procedure G, Grubbs-Hoveyda 2nd generation catalyst 350 (2 mg, 
0.03 mmol, 0.01 eq.) and vinyl phosphine borane (R)-358 (50 mg, 0.27 mmol, 
1.0 eq.) gave the crude product. Purification by flash column chromatography 
with 99:1 petrol-Et2O as eluent gave cyclic phosphine borane (R)-361 (36 mg, 
85%) as a white solid, mp 68-69 ºC; [α]D +8.5 (c 0.8 in CHCl3); RF (99:1 
petrol-Et2O) 0.3; IR (CDCl3) 2914, 2339, 2219, 891, 716, 640 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 6.70 (ddt, J = 31.0, 8.0, 2.5 Hz, 1H, PCH=), 6.00 (ddt, J = 
30.0, 8.0, 2.0 Hz, 1H, =CH), 2.88-2.66 (m, 2H, CH), 2.07-1.88 (m, 2H, CH), 
1.13 (d, J = 14.0 Hz, 9H, PCMe3), 0.92-0.21 (m, 3H, BH3); 13C NMR (100.6 
MHz, CDCl3) δ  149.0 (d, J = 7.5 Hz, =CH), 120.0 (d, J = 46.0 Hz, PCH=), 33.7 
(CH2), 29.2 (d, J = 28.5 Hz, PCMe3), 25.2 (PCMe3), 17.0 (d, J = 35.0 Hz, PCH2); 
31P{1H} NMR (109 MHz, CDCl3) δ 66.8 (q, J = 36.5 Hz); MS (ESI) m/z 179 [(M 
+ Na)+, 100]; HRMS (ESI) m/z calcd C8H18BP (M + Na)+ 179.1137, found 
179.1133 (_2.9 ppm error).  
 
1-t-Butyl-2,3-dihydro-1H-phosphine sulfide (R)-362 
Using general procedure H, phosphine borane (R)-361 (20 mg, 0.13 mmol, 1.0 
eq.), DABCO (32 mg, 0.28 mmol, 2.2 eq.) and sulfur (20 mg, 0.64 mmol, 5.0 eq.) 
gave the crude product. Purification by flash column chromatography with 99:1 
Et2O-petrol as eluent gave phosphine sulfide (R)-362 (6 mg, 27%, 93:7 er by 
CSP-HPLC) as a white solid, [α]D +19.5 (c 0.5 in CHCl3); RF (99:1 Et2O-petrol) 
0.1; 1H NMR (400 MHz, CDCl3) δ 6.75 (ddt, J = 41.0, 8.0, 2.5 Hz, 1H, PCH=), 
6.15-6.05 (ddt, J = 28.0, 8.0, 2.5 Hz, 1H, =CH), 2.99-2.88 (m, 1H, CH), 
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2.72-2.61 (m, 1H, CH), 2.48-2.40 (m, 1H, CH), 2.09-1.98 (m, 1H, CH), 1.23 (d, 
J = 17.0 Hz, 9H, PCMe3); 31P{1H} NMR (109 MHz, CDCl3) δ 91; MS (ESI) m/z 
197  [(M + Na)+, 100]; HRMS (ESI) m/z calcd C8H15PS (M + Na)+ 197.0522, 
found 197.0524 (0.7 ppm error); HPLC: Daicel Chiracel AD-H, 99.5:0.5 
hexane-i-PrOH, 0.5 mL min -1, (S)-362 19.3 min, (R)-362 30.0 min. 
 
Methyl-(2-hydroxyethyl)-phenylphosphine borane rac-364 
s-BuLi (3.10 mL of a 1.3 M in solution hexane, 4.02 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of phosphine borane 261 (510 mg, 3.35 mmol, 1.0 
eq.) in THF (15 mL) at _78 ºC under Ar. The resulting solution was stirred at _78 
ºC for 1 h. Then, a solution of paraformaldehyde (121 mg, 4.02 mmol, 1.2 eq.) in 
THF (10 mL) was added dropwise and the mixture was allowed to warm to rt 
over 16 h. 1 M HCl(aq) (25 mL) was added and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic 
layers were washed with brine (25 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography with 6:4 petrol-Et2O as eluent gave hydroxy phosphine borane 
rac-364 (317 mg, 52%) as a colourless oil, RF (6:4 petrol-Et2O) 0.1; 1H NMR 
(400 MHz, CDCl3) δ 7.77-7.75 (m, 2H, Ph), 7.54-7.47 (m, 3H, Ph), 3.96-3.79 (m, 
2H, CH2OH), 2.21-2.15 (m, 2H, CH2), 1.63 (d, J = 10.5 Hz, 3H, PMe), 1.15-0.45 
(m, 3H, BH3); 31P{1H} NMR (109 MHz, CDCl3) δ 6.85-5.78 (m). 
 
Ethenyl-methylphenylphosphine borane rac-365 
A solution of p-toluenesulfonyl chloride (471mg, 2.47 mmol, 1.5 eq.) in CH2Cl2 
(15 mL) was added dropwise to a stirred solution of hydroxy phosphine borane 
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rac-364 (300 mg, 1.65 mmol, 1.0 eq.) and pyridine (0.20 mL, 2.47 mmol, 1.5 eq.) 
in CH2Cl2 (5 mL) at rt under Ar. The resulting mixture was stirred at rt for 16 h. 
2 M HCl(aq) (20 mL) was added and the layers were separated. The aqueous layer 
was extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were 
washed with brine (20 mL), dried (MgSO4) and evaporated under reduced 
pressure to give the crude tosylate. KOt-Bu (389 mg, 3.47 mmol, 2.2 eq.) was 
added in one portion to a stirred solution of the crude tosylate in Et2O (15 mL) at 
rt under Ar. The resulting mixture was stirred at rt for 2 h. Then, the solid was 
removed by filtration through Celite®. The solid was washed with Et2O (3 × 15 
mL) and the combined organics were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography with 95:5 petrol-Et2O as eluent gave vinyl phosphine borane 
rac-365 (191 mg, 70%) as a colourless oil, RF (95:5 petrol-Et2O) 0.1; IR (film) 
3011, 2346, 2304, 1415, 1394, 1373, 1118, 1096, 1048, 1006, 967, 890, 883, 768, 
732, 715, 684 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.73-7.68 (m, 2H, Ph), 
7.52-7.45 (m, 3H, Ph), 6.42-6.31 (m, 1H, PCH=), 6.21-6.07 (m, 2H, =CH2), 1.65 
(d, J = 10.5 Hz, 3H, PMe), 1.18-0.45 (m, 3H, BH3); 13C NMR (100.6 MHz, 
CDCl3) δ  133.1 (d, J = 3.5 Hz, =CH2), 131.3 (d, J = 9.0 Hz, Ph), 131.2 (d, J = 
2.0 Hz, Ph), 129.6 (d, J = 52.0 Hz, ipso-Ph), 129.5 (d, J = 57.0 Hz, PCH=), 128.8 
(d, J = 10.0 Hz, =CH), 11.3 (d, J = 40.5 Hz, Me); 31P{1H} NMR (109 MHz, 
CDCl3) δ 7.61-6.54 (m); MS (ESI) m/z 187  [(M + Na)+, 100], 163 (90); HRMS 
(ESI) m/z calcd C9H14BP (M + Na)+ 187.0815, found 187.0820 (2.6 ppm error); 
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Methyl(6-methyloct-1-en-4-yl)(phenyl)phosphine borane rac-368 
s-BuLi (0.41 mL of a 1.3 M solution in hexane, 0.53 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of vinyl phosphine borane rac-365 (72 mg, 0.44 
mmol, 1.0 eq.) at _78 ºC under Ar. The resulting solution was stirred at _78 ºC for 
1 h. Then, allyl bromide (0.05 mL, 0.53 mmol, 1.2 eq.) was added dropwise and 
the mixture was allowed to warm to rt over 1 h. Sat. NH4Cl(aq) (10 mL) was 
added and the layers were separated. The aqueous layer was extracted with Et2O 
(3 × 10 mL). The combined organic layers were washed with brine (10 mL), 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography with 9:1 petrol-Et2O as eluent gave 
substituted phosphine borane rac-368 (27 mg, 8%) as a colourless oil, RF (9:1 
petrol-Et2O) 0.3; 1H NMR (400 MHz, CDCl3) δ 7.76-7.70 (m, 2H, Ph), 7.53-7.45 
(m, 3H, Ph), 5.82-5.57 (m, 1H, =CH), 5.11-4.91 (m, 2H, =CH2), 2.55-1.79 (m, 
3H, CH), 1.59 (d, J = 10.0 Hz, 0.75 H, PMe), 1.58 (d, J = 10.0 Hz, 0.75 H, PMe), 
1.57 (d, J = 9.5 Hz, 0.75 H, PMe), 1.56 (d, J = 10.0 Hz, 0.75 H, PMe), 1.52-0.95 
(m, 5H, CH), 0.87-0.61 (m, 6H, Me); MS (ESI) m/z 197  [(M + Na)+, 100]; 
HRMS (ESI) m/z calcd C8H15PS (M + Na)+ 197.0522, found 197.0524 (0.7 ppm 
error); MS (ESI) m/z 285  [(M + Na)+, 100], 261 (95); HRMS (ESI) m/z calcd 
C16H28PS (M + Na)+ 285.1912, found 285.1917 (0.5 ppm error). 
Chapter 5. Definitions 
Abbreviations 
δ                 chemical shift 
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[α]    specific rotation 
ΑΙΒΝ      azobis-i-butylonitrile 
aq    aqueous 
Ar     aromatic 
Atm   atmosphere 
9-BBN       9-borabicyclo[3.3.1]nonabe 
BINAP      2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn       benzyl 
bp          boiling point 
br           broad 
calcd        calculated 
CETBA     cetyltrimethylammonium bromide 
cm-1            wavenumber 
Cy            cyclohexyl 
d     doublet 
DABCO      1,4-diazabicyclo[2.2.2]octane 
DEPT     distortionless enhancement by polarisation transfer 
DMPU    1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMP      Dess-Martin periodinane 
DMSO    dimethyl sulfoxide 
dppf       1,1'-bis(diphenylphosphino)ferrocene 
dr     diastereoisomeric ratio 
E      electrophile 
eq.    equivalents 
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EI      electron impact 
er     enantiomeric ratio 
ESI    electrospray ionisation 
h           hour 
HPLC    high performance liquid chromatography 
HRMS    high resolution mass spectrometry 
Hz       hertz 
IR     infrared 
J     coupling constant 
LDA    lithium di-iso-propylamide 
Lit.        literature 
M       molar (mol dm-3) 
m     multiplet 
m         meta 
m-CPBA     m-chloroperoxybenzoic acid 
Me        methyl 
Mes          1,3,5-trimethylbenzene 
mg           milligram 
min       mintue 
mL        millilitre 
mmol    millimoles 
mp    melting point 
MS    mass spectrometry 
Ms     mesylate 
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4 Å MS   molecular sieves with a pore size of 4 Ångströms 
NMR    nuclear magnetic resonance 
o       ortho 
p       para 
PCC          pyridinium chlorochromate 
Ph     phenyl 
PMB         p-methoxybenzyl 
PMDETA   N,N,N’,N’’,N’’-pentamethyldiethylenetriamine 
ppm    parts per million 
PPTS          pyridiumn p-toluenesulfonate 
q          quartet 
quin           quintet 
R      alkyl group 
rac      racemic 
RCM      ring-closing metathesis 
RF     retention time 
rt     room temperature 
s     singlet 
t     triplet 
TBAI          tetrabutylammonium iodide 
TBAF          tetra-n-butylammonium fluoride 
TBDPS       t-butyldiphenylsilyl 
THF    tetrahydrofuran 
THP      tetrahydropyran 
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TLC   thin layer chromatography 
TMCDA      N,N,N’,N’-tetramethylcyclohexane-1,2-diamine 
TMEDA   N,N,N’,N’-tetramethylethane-1,2-diamine 
TMS    trimethylsilyl 
Ts     tosylate 
UV     ultraviolet 
Vis      visable 
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